##	TAG	<div1>
##	TAG	<head>
1	TOK	THE	BOS	the\AT---6
2	TOK	TREATMENT		treatment\N5S
3	TOK	OF		OF\N5S
4	TOK	GENETIC		GENETIC\N5S
5	TOK	DISEASE	EOS	disease\N5S
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
7	TOK	In	BOS	in\P
8	TOK	the		the\AT---6
9	TOK	corning		corn\VMG----
10	TOK	decades		decade\N5P
---	DLD	,		=\DELIM
11	TOK	the		the\AT---6
12	TOK	impact		impact\N5S
13	TOK	of		of\P
14	TOK	molecular		molecular\JA
15	TOK	biology		biology\N5S
16	TOK	and		and\CC
17	TOK	protein		protein\N5S
18	TOK	engineering		engineering\N5S
19	TOK	on		on\P
20	TOK	the		the\AT---6
21	TOK	treatment		treatment\N5S
22	TOK	of		of\P
23	TOK	genetic		genetic\JA
24	TOK	disease		disease\N5S
25	TOK	may		may\VOFDR66
26	TOK	be		be\VMI----
27	TOK	as		as\DGA7
28	TOK	great		great\JA
29	TOK	as		as\CS
30	TOK	that		that\RDS3N-
31	TOK	of		of\P
##	TAG	<name>
32	TOK	DNA		DNA\N46
##	TAG	</name>
33	TOK	polymorphisms		polymorphism\N5P
34	TOK	and		and\CC
35	TOK	positional		positional\JA
36	TOK	cloning		clone\VMG----
37	TOK	on		on\P
38	TOK	general		general\JA
39	TOK	medical		medical\JA
40	TOK	genetics		genetics\N56
41	TOK	in		in\P
42	TOK	the		the\AT---6
43	TOK	preceding		preceding\JA
44	TOK	decade		decade\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
45	TOK	In	BOS	in\P
46	TOK	this		this\AD---S
47	TOK	chapter		chapter\N5S
---	DLD	,		=\DELIM
48	TOK	therefore		therefore\DGA7
---	DLD	,		=\DELIM
49	TOK	we		we\RPP1NN
50	TOK	not		not\DGA7
51	TOK	only		only\DGA7
52	TOK	provide		provide\VMI----
53	TOK	an		an\AI---S
54	TOK	overview		overview\N5S
55	TOK	of		of\P
56	TOK	the		the\AT---6
57	TOK	standard		standard\JA
58	TOK	therapies		therapy\N5P
59	TOK	used		use\VMC----
60	TOK	in		in\P
61	TOK	the		the\AT---6
62	TOK	management		management\N5S
63	TOK	of		of\P
64	TOK	genetic		genetic\JA
65	TOK	disease		disease\N5S
66	TOK	but		but\CC
67	TOK	also		also\DGA7
68	TOK	outline		outline\VMI----
69	TOK	some		some\AG---6
70	TOK	of		of\P
71	TOK	the		the\AT---6
72	TOK	new		new\JA
73	TOK	strategies		strategy\N5P
74	TOK	that		that\RW63N6
75	TOK	may		may\VOFDR66
76	TOK	be		be\VMI----
77	TOK	used		use\VMC----
78	TOK	in		in\P
79	TOK	the		the\AT---6
80	TOK	future		future\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
81	TOK	In	BOS	in\P
82	TOK	particular		particular\JA
---	DLD	,		=\DELIM
83	TOK	we		we\RPP1NN
84	TOK	emphasize		emphasize\VMF6R66
85	TOK	therapies		therapy\N5P
86	TOK	that		that\RW63N6
87	TOK	reflect		reflect\VMF6R66
88	TOK	the		the\AT---6
89	TOK	genetic		genetic\JA
90	TOK	approach		approach\N5S
91	TOK	to		to\P
92	TOK	medicine		medicine\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
93	TOK	As	BOS	as\DGA7
94	TOK	with		with\P
95	TOK	all		all\AG---6
96	TOK	therapy		therapy\N5S
---	DLD	,		=\DELIM
97	TOK	the		the\AT---6
98	TOK	objective		objective\N5S
99	TOK	of		of\P
100	TOK	treating		treat\VMG----
101	TOK	genetic		genetic\JA
102	TOK	disease		disease\N5S
103	TOK	is		be\V6FDRS3
104	TOK	to		to\P
105	TOK	eliminate		eliminate\VMI----
106	TOK	or		or\CC
107	TOK	ameliorate		ameliorate\VMI----
108	TOK	the		the\AT---6
109	TOK	effects		effect\N5P
110	TOK	of		of\P
111	TOK	the		the\AT---6
112	TOK	disorder		disorder\N5S
113	TOK	on		on\P
114	TOK	not		not\DGA7
115	TOK	only		only\DGA7
116	TOK	the		the\AT---6
117	TOK	patient		patient\N5S
118	TOK	but		but\CC
119	TOK	also		also\DGA7
120	TOK	the		the\AT---6
121	TOK	family		family\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
122	TOK	In	BOS	in\P
123	TOK	addition		addition\N5S
---	DLD	,		=\DELIM
124	TOK	the		the\AT---6
125	TOK	family		family\N5S
126	TOK	must		must\VOFDR66
127	TOK	be		be\VMI----
128	TOK	informed		inform\VMC----
129	TOK	about		about\P
130	TOK	the		the\AT---6
131	TOK	risk		risk\N5S
132	TOK	that		that\CS
133	TOK	the		the\AT---6
134	TOK	disease		disease\N5S
135	TOK	may		may\VOFDR66
136	TOK	occur		occur\VMI----
137	TOK	in		in\P
138	TOK	other		other\JA
139	TOK	members		member\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
140	TOK	The	BOS	the\AT---6
141	TOK	latter		latter\JC
142	TOK	responsibility		responsibility\N5S
---	DLD	,		=\DELIM
143	TOK	genetic		genetic\JA
144	TOK	counseling		counsel\VMG----
---	DLD	,		=\DELIM
145	TOK	is		be\V6FDRS3
146	TOK	a		a\AI---S
147	TOK	major		major\JA
148	TOK	component		component\N5S
149	TOK	of		of\P
150	TOK	the		the\AT---6
151	TOK	management		management\N5S
152	TOK	of		of\P
153	TOK	hereditary		hereditary\JA
154	TOK	disorders		disorder\N5P
155	TOK	and		and\CC
156	TOK	is		be\V6FDRS3
157	TOK	dealt		deal\VMC----
158	TOK	with		with\P
159	TOK	separately		separately\DGA7
160	TOK	in		in\P
##	TAG	<name>
161	TOK	Chapter		Chapter\N46
##	TAG	</name>
##	TAG	<num>
162	TOK	18		18\X
##	TAG	</num>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
163	TOK	The	BOS	the\AT---6
164	TOK	preferred		prefer\VMC----
165	TOK	treatment		treatment\N5S
166	TOK	of		of\P
167	TOK	many		many\AI---P
168	TOK	single		single\JA
---	DLI	-		=\DELIM
169	TOK	gene		gene\N5S
170	TOK	diseases		disease\N5P
171	TOK	will		will\VOFDR66
172	TOK	eventually		eventually\DGA7
173	TOK	be		be\VMI----
174	TOK	gene		gene\N5S
175	TOK	transfer		transfer\N5S
176	TOK	therapy		therapy\N5S
---	DLD	,		=\DELIM
177	TOK	if		if\CS
178	TOK	the		the\AT---6
179	TOK	procedure		procedure\N5S
180	TOK	can		can\VOFDR66
181	TOK	be		be\VMI----
182	TOK	made		make\VMC----
183	TOK	safe		safe\JA
184	TOK	and		and\CC
185	TOK	effective		effective\JA
186	TOK	However		However\N5P
---	DLD	,		=\DELIM
187	TOK	even		even\DGA7
188	TOK	when		when\CS
189	TOK	copies		copy\N5P
190	TOK	of		of\P
191	TOK	a		a\AI---S
192	TOK	normal		normal\JA
193	TOK	gene		gene\N5S
194	TOK	can		can\VOFDR66
195	TOK	be		be\VMI----
196	TOK	transferred		transfer\VMC----
197	TOK	into		into\P
198	TOK	the		the\AT---6
199	TOK	patient		patient\N5S
200	TOK	to		to\P
201	TOK	effect		effect\VMI----
202	TOK	permanent		permanent\JA
203	TOK	cure		cure\N5S
---	DLD	,		=\DELIM
204	TOK	the		the\AT---6
205	TOK	family		family\N5S
206	TOK	will		will\VOFDR66
207	TOK	need		need\VMI----
208	TOK	ongoing		ongoing\JA
209	TOK	patient		patient\N5S
210	TOK	counseling		counsel\VMG----
---	DLD	,		=\DELIM
211	TOK	carrier		carrier\N5S
212	TOK	testing		test\VMG----
---	DLD	,		=\DELIM
213	TOK	and		and\CC
214	TOK	prenatal		prenatal\JA
215	TOK	diagnosis		diagnosis\N5S
---	DLD	,		=\DELIM
216	TOK	in		in\P
217	TOK	many		many\AI---P
218	TOK	cases		case\N5P
219	TOK	over		over\P
220	TOK	several		several\JA
221	TOK	generations		generation\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
222	TOK	For	BOS	for\P
223	TOK	the		the\AT---6
224	TOK	present		present\JA
---	DLD	,		=\DELIM
225	TOK	we		we\RPP1NN
226	TOK	are		be\V6FDR66
227	TOK	left		leave\VMC----
228	TOK	with		with\P
229	TOK	replacing		replace\VMG----
230	TOK	the		the\AT---6
231	TOK	defective		defective\JA
232	TOK	protein		protein\N5S
---	DLD	,		=\DELIM
233	TOK	improving		improve\VMG----
234	TOK	its		its\APS3N6
235	TOK	function		function\VMF6R66
---	DLD	,		=\DELIM
236	TOK	or		or\CC
237	TOK	minimizing		minimize\VMG----
238	TOK	the		the\AT---6
239	TOK	consequences		consequence\N5P
240	TOK	of		of\P
241	TOK	its		its\APS3N6
242	TOK	deficiency		deficiency\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
243	TOK	A	BOS	a\AI---S
244	TOK	number		number\N5S
245	TOK	of		of\P
246	TOK	excellent		excellent\JA
247	TOK	overviews		overview\N5P
248	TOK	of		of\P
249	TOK	the		the\AT---6
250	TOK	treatment		treatment\N5S
251	TOK	of		of\P
252	TOK	genetic		genetic\JA
253	TOK	disease		disease\N5S
254	TOK	have		have\V6F6R66
255	TOK	been		be\VMC----
256	TOK	published		publish\VMC----
---	DLD	,		=\DELIM
257	TOK	including		including\P
258	TOK	those		that\RDP3N-
259	TOK	by		by\P
##	TAG	<name>
260	TOK	Valle		Valle\N46
##	TAG	</name>
---	DLE	(		=\DELIM
##	TAG	<num>
261	TOK	1987		1987\X
##	TAG	</num>
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
##	TAG	<name>
262	TOK	Beaudet		Beaudet\N46
##	TAG	</name>
263	TOK	and		and\CC
264	TOK	colleagues		colleague\N5P
---	DLE	(		=\DELIM
##	TAG	<num>
265	TOK	1989		1989\X
##	TAG	</num>
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
##	TAG	<name>
266	TOK	Rosenberg		Rosenberg\N46
##	TAG	</name>
---	DLE	(		=\DELIM
##	TAG	<num>
267	TOK	1990		1990\X
##	TAG	</num>
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
268	TOK	and		and\CC
##	TAG	<name>
269	TOK	Desnick		Desnick\N46
##	TAG	</name>
---	DLE	(		=\DELIM
##	TAG	<num>
270	TOK	1991		1991\X
##	TAG	</num>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
271	TOK	THE	BOS	the\AT---6
272	TOK	PRESENT		present\N5S
273	TOK	STATE		state\N5S
274	TOK	OF		OF\N5S
275	TOK	TREATMENT		treatment\N5S
276	TOK	OF		OF\N5S
277	TOK	GENETIC		GENETIC\N5S
278	TOK	DISEASE	EOS	disease\N5S
##	TAG	</head>
##	TAG	<head>
280	TOK	Multifactorial	BOS	multifactorial\JA
##	TAG	<name>
281	TOK	Diseases	EOS	Diseases\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
283	TOK	For	BOS	for\P
284	TOK	most		most\AG---6
285	TOK	multifactorial		multifactorial\JA
286	TOK	diseases		disease\N5P
---	DLE	(		=\DELIM
287	TOK	see		see\VMF6R66
##	TAG	<name>
288	TOK	Chapter		Chapter\N46
##	TAG	</name>
##	TAG	<num>
289	TOK	15		15\X
##	TAG	</num>
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
290	TOK	both		both\RIP3N-
291	TOK	the		the\AT---6
292	TOK	genetic		genetic\JA
293	TOK	and		and\CC
294	TOK	environmental		environmental\JA
295	TOK	components		component\N5P
296	TOK	of		of\P
297	TOK	the		the\AT---6
298	TOK	etiology		etiology\N5S
299	TOK	are		be\V6FDR66
300	TOK	poorly		poorly\DGA7
301	TOK	understood		understand\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
302	TOK	However	BOS	however\DGA7
---	DLD	,		=\DELIM
303	TOK	when		when\CS
304	TOK	an		an\AI---S
305	TOK	environmental		environmental\JA
306	TOK	contribution		contribution\N5S
307	TOK	is		be\V6FDRS3
308	TOK	recognized		recognize\VMF6A66
---	DLD	,		=\DELIM
309	TOK	an		an\AI---S
310	TOK	opportunity		opportunity\N5S
311	TOK	for		for\P
312	TOK	effective		effective\JA
313	TOK	intervention		intervention\N5S
314	TOK	is		be\V6FDRS3
315	TOK	available		available\JA
316	TOK	because		because\CS
317	TOK	exposure		exposure\N5S
318	TOK	to		to\P
319	TOK	the		the\AT---6
320	TOK	environmental		environmental\JA
321	TOK	factor		factor\N5S
322	TOK	can		can\VOFDR66
323	TOK	often		often\DGA7
324	TOK	be		be\VMI----
325	TOK	modified		modify\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
326	TOK	Thus	BOS	thus\DGA7
327	TOK	cigarette		cigarette\N5S
328	TOK	smoking		smoke\VMG----
329	TOK	is		be\V6FDRS3
330	TOK	an		an\AI---S
331	TOK	environmental		environmental\JA
332	TOK	factor		factor\N5S
333	TOK	that		that\CS
334	TOK	all		all\AG---6
335	TOK	patients		patient\N5P
336	TOK	with		with\P
337	TOK	emphysema		emphysema\N5S
338	TOK	should		shall\VOFDA66
339	TOK	avoid		avoid\VMI----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<loc pos="DGA7">
340	TOK	At least	BOS	At_least\DGA7
##	TAG	</loc>
341	TOK	one		one\MCS
342	TOK	mechanism		mechanism\N5S
343	TOK	by		by\P
344	TOK	which		which\RW63N-
345	TOK	cigarette		cigarette\N5S
346	TOK	smoke		smoke\N5S
347	TOK	leads		lead\VMFDRS3
348	TOK	to		to\P
349	TOK	emphysema		emphysema\N5S
350	TOK	has		have\V6FDRS3
351	TOK	been		be\VMC----
352	TOK	disclosed		disclose\VMC----
353	TOK	by		by\P
354	TOK	the		the\AT---6
355	TOK	study		study\N5S
356	TOK	of		of\P
357	TOK	the		the\AT---6
358	TOK	single		single\JA
---	DLI	-		=\DELIM
359	TOK	gene		gene\N5S
360	TOK	disorder		disorder\N5S
361	TOK	xxx		noanat\W
362	TOK	deficiency		deficiency\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
363	TOK	As	BOS	as\DGA7
364	TOK	described		describe\VMC----
365	TOK	in		in\P
366	TOK	the		the\AT---6
367	TOK	preceding		preceding\JA
368	TOK	chapter		chapter\N5S
---	DLD	,		=\DELIM
369	TOK	cigarette		cigarette\N5S
370	TOK	smoke		smoke\N5S
371	TOK	oxidizes		oxidize\VMFDRS3
372	TOK	the		the\AT---6
373	TOK	critical		critical\JA
374	TOK	methionine		methionine\N5S
375	TOK	residue		residue\N5S
376	TOK	at		at\P
377	TOK	the		the\AT---6
378	TOK	active		active\JA
379	TOK	site		site\N5S
380	TOK	of		of\P
381	TOK	xxx		noanat\W
---	DLE	,		=\DELIM
382	TOK	which		which\RW63N-
383	TOK	reduces		reduce\VMFDRS3
384	TOK	by		by\P
##	TAG	<num>
385	TOK	2000		2000\X
##	TAG	</num>
---	DLE	-		=\DELIM
386	TOK	fold		fold\VMI----
387	TOK	its		its\APS3N6
388	TOK	ability		ability\N5S
389	TOK	to		to\P
390	TOK	inhibit		inhibit\VMI----
391	TOK	elastase		elastase\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
392	TOK	Thus	BOS	thus\DGA7
393	TOK	smoking		smoke\VMG----
394	TOK	produces		produce\VMFDRS3
395	TOK	a		a\AI---S
396	TOK	substantial		substantial\JA
397	TOK	acquired		acquire\VMC----
398	TOK	loss		loss\N5S
399	TOK	of		of\P
400	TOK	xxx		noanat\W
401	TOK	function		function\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
402	TOK	The	BOS	the\AT---6
403	TOK	general		general\JA
404	TOK	impression		impression\N5S
405	TOK	that		that\CS
406	TOK	genetic		genetic\JA
407	TOK	diseases		disease\N5P
408	TOK	are		be\V6FDR66
409	TOK	invariably		invariably\DGA7
410	TOK	difficult		difficult\JA
411	TOK	to		to\P
412	TOK	treat		treat\VMI----
413	TOK	is		be\V6FDRS3
414	TOK	contradicted		contradict\VMC----
415	TOK	by		by\P
416	TOK	data		data\N56
417	TOK	on		on\P
418	TOK	disorders		disorder\N5P
419	TOK	of		of\P
420	TOK	multifactorial		multifactorial\JA
421	TOK	inheritance		inheritance\N5S
422	TOK	in		in\P
423	TOK	newborns		newborn\N5P
424	TOK	that		that\RW63N6
425	TOK	may		may\VOFDR66
426	TOK	be		be\VMI----
427	TOK	cured		cure\VMC----
428	TOK	by		by\P
429	TOK	surgery		surgery\N5S
---	DLD	,		=\DELIM
430	TOK	a		a\AI---S
431	TOK	form		form\N5S
432	TOK	of		of\P
433	TOK	phenotypic		phenotypic\JA
434	TOK	modification		modification\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
435	TOK	These	BOS	this\AD---P
436	TOK	conditions		condition\N5P
437	TOK	include		include\VMF6R66
438	TOK	congenital		congenital\JA
439	TOK	heart		heart\N5S
440	TOK	defects		defect\N5P
---	DLD	,		=\DELIM
441	TOK	cleft		cleft\N5S
442	TOK	lip		lip\N5S
443	TOK	and		and\CC
444	TOK	palate		palate\N5S
---	DLD	,		=\DELIM
445	TOK	and		and\CC
446	TOK	pyloric		pyloric\JA
447	TOK	stenosis		stenosis\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
448	TOK	Remarkably	BOS	remarkably\DGA7
---	DLD	,		=\DELIM
449	TOK	these		this\AD---P
##	TAG	<num>
450	TOK	three		three\X
##	TAG	</num>
451	TOK	structural		structural\JA
452	TOK	abnormalities		abnormality\N5P
453	TOK	affect		affect\VMF6R66
454	TOK	nearly		nearly\DGA7
##	TAG	<num>
455	TOK	1.5		1.5\X
##	TAG	</num>
456	TOK	percent		percent\N56
457	TOK	of		of\P
458	TOK	all		all\AG---6
459	TOK	live		live\VMF6R66
---	DLI	-		=\DELIM
460	TOK	born		bear\VMC----
461	TOK	infants		infant\N5P
---	DLD	,		=\DELIM
462	TOK	who		who\RW63N-
463	TOK	make		make\VMF6R66
464	TOK	up		up\P
465	TOK	approximately		approximately\DGA7
##	TAG	<num>
466	TOK	30		30\X
##	TAG	</num>
467	TOK	percent		percent\N56
468	TOK	of		of\P
469	TOK	all		all\AG---6
470	TOK	newborns		newborn\N5P
471	TOK	with		with\P
472	TOK	genetic		genetic\JA
473	TOK	disease		disease\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
474	TOK	In	BOS	in\P
475	TOK	about		about\DGA7
476	TOK	half		half\N5S
477	TOK	of		of\P
478	TOK	these		this\AD---P
479	TOK	patients		patient\N5P
---	DLD	,		=\DELIM
480	TOK	the		the\AT---6
481	TOK	diseases		disease\N5P
482	TOK	are		be\V6FDR66
483	TOK	curable		curable\JA
484	TOK	by		by\P
485	TOK	a		a\AI---S
486	TOK	single		single\JA
487	TOK	operation		operation\N5S
---	DLD	;		=\DELIM
488	TOK	a		a\AI---S
489	TOK	cure		cure\N5S
490	TOK	is		be\V6FDRS3
491	TOK	therefore		therefore\DGA7
492	TOK	possible		possible\JA
493	TOK	in		in\P
##	TAG	<loc pos="DGA7">
494	TOK	at least		at_least\DGA7
##	TAG	</loc>
##	TAG	<num>
495	TOK	10		10\X
##	TAG	</num>
496	TOK	to		to\P
##	TAG	<num>
497	TOK	15		15\X
##	TAG	</num>
498	TOK	percent		percent\N56
499	TOK	of		of\P
500	TOK	infants		infant\N5P
501	TOK	with		with\P
502	TOK	a		a\AI---S
503	TOK	genetically		genetically\DGA7
504	TOK	determined		determine\VMC----
505	TOK	disorder		disorder\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
506	TOK	However	BOS	however\DGA7
---	DLD	,		=\DELIM
507	TOK	the		the\AT---6
508	TOK	treatment		treatment\N5S
509	TOK	of		of\P
510	TOK	inherited		inherit\VMC----
511	TOK	disease		disease\N5S
512	TOK	is		be\V6FDRS3
513	TOK	rarely		rarely\DGA7
514	TOK	so		so\DGA7
515	TOK	beneficial		beneficial\JA
---	DLD	,		=\DELIM
516	TOK	although		although\CS
517	TOK	it		it\RPS3N6
518	TOK	often		often\DGA7
519	TOK	improves		improve\VMFDRS3
520	TOK	the		the\AT---6
521	TOK	quality		quality\N5S
522	TOK	of		of\P
523	TOK	life		life\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
524	TOK	For	BOS	for\P
525	TOK	multifactorial		multifactorial\JA
526	TOK	disorders		disorder\N5P
527	TOK	that		that\RW63N6
528	TOK	typically		typically\DGA7
529	TOK	present		present\JA
530	TOK	in		in\P
531	TOK	adolescence		adolescence\N5S
532	TOK	or		or\CC
533	TOK	adult		adult\N5S
534	TOK	life		life\N5S
---	DLD	,		=\DELIM
535	TOK	such		such\JA
536	TOK	as		as\P
537	TOK	essential		essential\JA
538	TOK	hypertension		hypertension\N5S
---	DLD	,		=\DELIM
539	TOK	diabetes		diabetes\N56
---	DLD	,		=\DELIM
540	TOK	coronary		coronary\JA
541	TOK	artery		artery\N5S
542	TOK	disease		disease\N5S
---	DLD	,		=\DELIM
543	TOK	and		and\CC
544	TOK	schizophrenia		schizophrenia\N5S
545	TOK	and		and\CC
546	TOK	other		other\JA
547	TOK	major		major\JA
548	TOK	psychoses		psychosis\N5P
---	DLD	,		=\DELIM
549	TOK	the		the\AT---6
550	TOK	imperfections		imperfection\N5P
551	TOK	of		of\P
552	TOK	treatment		treatment\N5S
553	TOK	reflect		reflect\VMF6R66
554	TOK	ignorance		ignorance\N5S
555	TOK	of		of\P
556	TOK	the		the\AT---6
557	TOK	etiology		etiology\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
##	TAG	<name>
558	TOK	Single-Gene Diseases	BOS	Single-Gene_Diseases\N46
##	TAG	</name>
tf	TOK		EOS	=\DELS
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
560	TOK	The	BOS	the\AT---6
561	TOK	treatment		treatment\N5S
562	TOK	of		of\P
563	TOK	single		single\JA
---	DLI	-		=\DELIM
564	TOK	gene		gene\N5S
565	TOK	diseases		disease\N5P
566	TOK	is		be\V6FDRS3
567	TOK	sadly		sadly\DGA7
568	TOK	deficient		deficient\JA
569	TOK	at		at\P
570	TOK	present		present\VMI----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
571	TOK	A	BOS	a\AI---S
572	TOK	recent		recent\JA
573	TOK	survey		survey\N5S
574	TOK	of		of\P
##	TAG	<num>
575	TOK	351		351\X
##	TAG	</num>
576	TOK	disorders		disorder\N5P
577	TOK	showed		show\VMF6A66
578	TOK	that		that\CS
579	TOK	with		with\P
580	TOK	current		current\JA
581	TOK	therapy		therapy\N5S
---	DLD	,		=\DELIM
582	TOK	the		the\AT---6
583	TOK	life		life\N5S
584	TOK	span		span\N5S
585	TOK	can		can\VOFDR66
586	TOK	be		be\VMI----
587	TOK	restored		restore\VMC----
588	TOK	to		to\P
589	TOK	normal		normal\JA
590	TOK	in		in\P
591	TOK	only		only\DGA7
592	TOK	about		about\P
##	TAG	<num>
593	TOK	15		15\X
##	TAG	</num>
594	TOK	percent		percent\N56
595	TOK	of		of\P
596	TOK	single		single\JA
---	DLI	-		=\DELIM
597	TOK	gene		gene\N5S
598	TOK	conditions		condition\N5P
---	DLD	,		=\DELIM
599	TOK	reproductive		reproductive\JA
600	TOK	capability		capability\N5S
601	TOK	in		in\P
##	TAG	<num>
602	TOK	11		11\X
##	TAG	</num>
603	TOK	percent		percent\N56
---	DLD	,		=\DELIM
604	TOK	and		and\CC
605	TOK	social		social\JA
606	TOK	adaptation		adaptation\N5S
607	TOK	in		in\P
##	TAG	<num>
608	TOK	6		6\X
##	TAG	</num>
609	TOK	percent		percent\N56
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
610	TOK	However	BOS	however\DGA7
---	DLD	,		=\DELIM
611	TOK	one		one\RIS3N-
612	TOK	bright		bright\JA
613	TOK	note		note\N5S
614	TOK	was		be\V6F-A66
615	TOK	identified		identify\VMC----
616	TOK	by		by\P
617	TOK	the		the\AT---6
618	TOK	analysis		analysis\N5S
---	DLD	:		=\DELIM
619	TOK	the		the\AT---6
620	TOK	success		success\N5S
621	TOK	of		of\P
622	TOK	treatment		treatment\N5S
623	TOK	is		be\V6FDRS3
624	TOK	greatest		great\JS
625	TOK	for		for\P
626	TOK	disorders		disorder\N5P
627	TOK	in		in\P
628	TOK	which		which\RW63N-
629	TOK	the		the\AT---6
630	TOK	basic		basic\JA
631	TOK	biochemical		biochemical\JA
632	TOK	defect		defect\N5S
633	TOK	is		be\V6FDRS3
634	TOK	known		know\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
635	TOK	Even	BOS	even\DGA7
636	TOK	in		in\P
637	TOK	this		this\RDS3N-
638	TOK	favored		favor\VMC----
639	TOK	group		group\N5S
---	DLD	,		=\DELIM
640	TOK	however		however\DGA7
---	DLD	,		=\DELIM
641	TOK	the		the\AT---6
642	TOK	treatment		treatment\N5S
643	TOK	was		be\V6F-A66
644	TOK	completely		completely\DGA7
645	TOK	corrective		corrective\JA
646	TOK	for		for\P
647	TOK	phenotypic		phenotypic\JA
648	TOK	dysfunction		dysfunction\N5S
649	TOK	in		in\P
650	TOK	only		only\DGA7
##	TAG	<num>
651	TOK	12		12\X
##	TAG	</num>
652	TOK	percent		percent\N56
---	DLD	,		=\DELIM
653	TOK	partially		partially\DGA7
654	TOK	corrective		corrective\N5S
655	TOK	in		in\P
##	TAG	<num>
656	TOK	40		40\X
##	TAG	</num>
657	TOK	percent		percent\N56
---	DLD	,		=\DELIM
658	TOK	and		and\CC
659	TOK	of		of\P
660	TOK	no		no\AI---6
661	TOK	effect		effect\N5S
662	TOK	in		in\P
663	TOK	the		the\AT---6
664	TOK	remainder		remainder\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
665	TOK	Thus	BOS	thus\DGA7
666	TOK	research		research\N5S
667	TOK	to		to\P
668	TOK	elucidate		elucidate\VMI----
669	TOK	the		the\AT---6
670	TOK	genetic		genetic\JA
671	TOK	and		and\CC
672	TOK	biochemical		biochemical\JA
673	TOK	basis		basis\N5S
674	TOK	of		of\P
675	TOK	hereditary		hereditary\JA
676	TOK	disease		disease\N5S
677	TOK	does		do\V6FDRS3
678	TOK	have		have\VMI----
679	TOK	an		an\AI---S
680	TOK	impact		impact\N5S
681	TOK	on		on\P
682	TOK	the		the\AT---6
683	TOK	patient		patient\N5S
---	DLD	,		=\DELIM
684	TOK	although		although\CS
685	TOK	even		even\DGA7
686	TOK	in		in\P
687	TOK	biochemically		biochemically\DGA7
688	TOK	defined		define\VMC----
689	TOK	disorders		disorder\N5P
---	DLD	,		=\DELIM
690	TOK	current		current\JA
691	TOK	therapy		therapy\N5S
692	TOK	fails		fail\VMFDRS3
693	TOK	to		to\P
694	TOK	restore		restore\VMI----
695	TOK	normal		normal\JA
696	TOK	health		health\N5S
697	TOK	to		to\P
698	TOK	the		the\AT---6
699	TOK	great		great\JA
700	TOK	majority		majority\N5S
701	TOK	of		of\P
702	TOK	patients		patient\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
703	TOK	The	BOS	the\AT---6
704	TOK	present		present\JA
705	TOK	unsatisfactory		unsatisfactory\JA
706	TOK	state		state\N5S
707	TOK	of		of\P
708	TOK	treatment		treatment\N5S
709	TOK	of		of\P
710	TOK	genetic		genetic\JA
711	TOK	disease		disease\N5S
712	TOK	is		be\V6FDRS3
713	TOK	due		due\JA
714	TOK	to		to\P
715	TOK	numerous		numerous\JA
716	TOK	factors		factor\N5P
---	DLD	,		=\DELIM
717	TOK	including		including\P
718	TOK	the		the\AT---6
719	TOK	following		follow\VMG----
##	TAG	<num>
720	TOK	three		three\X
##	TAG	</num>
---	DLD	:		=\DELIM
##	TAG	<num>
721	TOK	1		1\X
##	TAG	</num>
722	TOK	The		The\N5S
723	TOK	mutant		mutant\N5S
##	TAG	<foreign lang="LA" pos="N5S">
724	TOK	locus		locus\N5S
##	TAG	</foreign>
725	TOK	in		in\P
726	TOK	more		more\DDC7
727	TOK	than		than\CS
##	TAG	<num>
728	TOK	80		80\X
##	TAG	</num>
729	TOK	percent		percent\N56
730	TOK	of		of\P
731	TOK	genetic		genetic\JA
732	TOK	diseases		disease\N5P
733	TOK	is		be\V6FDRS3
734	TOK	unknown		unknown\JA
---	DLD	,		=\DELIM
735	TOK	and		and\CC
736	TOK	knowledge		knowledge\N5S
737	TOK	of		of\P
738	TOK	the		the\AT---6
739	TOK	pathophysiology		pathophysiology\N5S
740	TOK	in		in\P
741	TOK	those		that\AD---P
742	TOK	diseases		disease\N5P
743	TOK	in		in\P
744	TOK	which		which\RW63N-
745	TOK	the		the\AT---6
746	TOK	affected		affect\VMC----
747	TOK	gene		gene\N5S
748	TOK	or		or\CC
749	TOK	biochemical		biochemical\JA
750	TOK	abnormality		abnormality\N5S
751	TOK	is		be\V6FDRS3
752	TOK	known		know\VMC----
753	TOK	is		be\V6FDRS3
754	TOK	inadequate		inadequate\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
755	TOK	In	BOS	in\P
756	TOK	phenylketonuria		phenylketonuria\N5S
---	DLE	(		=\DELIM
##	TAG	<name>
757	TOK	PKU		PKU\N46
##	TAG	</name>
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
##	TAG	<loc pos="DGA7">
758	TOK	for example		for_example\DGA7
##	TAG	</loc>
---	DLE	,		=\DELIM
759	TOK	despite		despite\P
760	TOK	years		year\N5P
761	TOK	of		of\P
762	TOK	study		study\VMI----
---	DLD	,		=\DELIM
763	TOK	the		the\AT---6
764	TOK	mechanisms		mechanism\N5P
765	TOK	by		by\P
766	TOK	which		which\RW63N-
767	TOK	the		the\AT---6
768	TOK	elevation		elevation\N5S
769	TOK	in		in\P
770	TOK	phenylalanine		phenylalanine\N5S
771	TOK	impairs		impair\VMFDRS3
772	TOK	brain		brain\N5S
773	TOK	development		development\N5S
774	TOK	and		and\CC
775	TOK	function		function\N5S
776	TOK	are		be\V6FDR66
777	TOK	still		still\DGA7
778	TOK	poorly		poorly\DGA7
779	TOK	understood		understand\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
780	TOK	For	BOS	for\P
781	TOK	diseases		disease\N5P
782	TOK	such		such\RIS3N-
783	TOK	as		as\P
784	TOK	cystic		cystic\JA
785	TOK	fibrosis		fibrosis\N5S
786	TOK	and		and\CC
##	TAG	<name>
787	TOK	Duchenne		Duchenne\N46
##	TAG	</name>
788	TOK	muscular		muscular\JA
789	TOK	dystrophy		dystrophy\N5S
---	DLD	,		=\DELIM
790	TOK	in		in\P
791	TOK	which		which\RW63N-
792	TOK	the		the\AT---6
793	TOK	affected		affect\VMC----
794	TOK	protein		protein\N5S
795	TOK	has		have\V6FDRS3
796	TOK	only		only\DGA7
797	TOK	recently		recently\DGA7
798	TOK	been		be\VMC----
799	TOK	identified		identify\VMF6A66
---	DLD	,		=\DELIM
800	TOK	much		much\JA
801	TOK	work		work\N5S
802	TOK	is		be\V6FDRS3
803	TOK	required		require\VMC----
804	TOK	before		before\P
805	TOK	the		the\AT---6
806	TOK	normal		normal\JA
807	TOK	function		function\N5S
808	TOK	of		of\P
809	TOK	the		the\AT---6
810	TOK	polypeptide		polypeptide\N5S
811	TOK	is		be\V6FDRS3
812	TOK	determined		determine\VMC----
813	TOK	and		and\CC
814	TOK	the		the\AT---6
815	TOK	disease		disease\N5S
816	TOK	process		process\N5S
817	TOK	fully		fully\DGA7
818	TOK	elucidated		elucidate\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<num>
819	TOK	2	BOS	2\X
##	TAG	</num>
820	TOK	Some		Some\N5S
821	TOK	mutations		mutation\N5P
822	TOK	act		act\VMF6R66
823	TOK	early		early\JA
824	TOK	in		in\P
825	TOK	development		development\N5S
826	TOK	or		or\CC
827	TOK	cause		cause\VMF6R66
828	TOK	irreversible		irreversible\JA
829	TOK	pathology		pathology\N5S
830	TOK	before		before\CS
831	TOK	they		they\RPP3NN
832	TOK	are		be\V6FDR66
833	TOK	diagnosed		diagnose\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
834	TOK	These	BOS	this\AD---P
835	TOK	problems		problem\N5P
836	TOK	can		can\VOFDR66
837	TOK	be		be\VMI----
838	TOK	anticipated		anticipate\VMC----
839	TOK	in		in\P
840	TOK	some		some\AG---6
841	TOK	cases		case\N5P
842	TOK	if		if\CS
843	TOK	there		there\DGA7
844	TOK	is		be\V6FDRS3
845	TOK	a		a\AI---S
846	TOK	family		family\N5S
847	TOK	history		history\N5S
848	TOK	of		of\P
849	TOK	a		a\AI---S
850	TOK	genetic		genetic\JA
851	TOK	disease		disease\N5S
852	TOK	or		or\CC
853	TOK	if		if\CS
854	TOK	carrier		carrier\N5S
855	TOK	screening		screening\N5S
856	TOK	identifies		identify\VMFDRS3
857	TOK	couples		couple\N5P
858	TOK	at		at\P
859	TOK	risk		risk\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
860	TOK	In	BOS	in\P
861	TOK	the		the\AT---6
862	TOK	latter		latter\JC
863	TOK	case		case\N5S
---	DLD	,		=\DELIM
864	TOK	prenatal		prenatal\JA
865	TOK	treatment		treatment\N5S
866	TOK	is		be\V6FDRS3
867	TOK	sometimes		sometimes\DGA7
868	TOK	possible		possible\JA
---	DLD	,		=\DELIM
869	TOK	for		for\P
870	TOK	both		both\RIP3N-
871	TOK	medical		medical\JA
872	TOK	and		and\CC
873	TOK	surgical		surgical\JA
874	TOK	conditions		condition\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<num>
875	TOK	3	BOS	3\X
##	TAG	</num>
876	TOK	The		The\N5P
877	TOK	initial		initial\JA
878	TOK	cases		case\N5P
879	TOK	of		of\P
880	TOK	a		a\AI---S
881	TOK	disease		disease\N5S
882	TOK	to		to\P
883	TOK	be		be\VMI----
884	TOK	recognized		recognize\VMC----
885	TOK	are		be\V6FDR66
886	TOK	usually		usually\DGA7
887	TOK	severely		severely\DGA7
888	TOK	affected		affect\VMC----
889	TOK	ones		one\RIP3N-
---	DLD	,		=\DELIM
890	TOK	which		which\RW63N-
891	TOK	are		be\V6FDR66
892	TOK	often		often\DGA7
893	TOK	less		less\DDC7
894	TOK	amenable		amenable\JA
895	TOK	to		to\P
896	TOK	treatment		treatment\N5S
897	TOK	than		than\CS
898	TOK	more		more\DDC7
899	TOK	mildly		mildly\DGA7
900	TOK	affected		affect\VMF6A66
901	TOK	ones		one\RIP3N-
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
902	TOK	In	BOS	in\P
903	TOK	the		the\AT---6
904	TOK	milder		mild\JC
905	TOK	cases		case\N5P
---	DLD	,		=\DELIM
906	TOK	the		the\AT---6
907	TOK	mutant		mutant\N5S
908	TOK	protein		protein\N5S
909	TOK	may		may\VOFDR66
910	TOK	retain		retain\VMI----
911	TOK	some		some\AG---6
912	TOK	residual		residual\JA
913	TOK	function		function\N5S
914	TOK	that		that\RW63N6
915	TOK	can		can\VOFDR66
916	TOK	be		be\VMI----
917	TOK	increased		increase\VMC----
918	TOK	by		by\P
919	TOK	one		one\MCS
920	TOK	of		of\P
921	TOK	several		several\JA
922	TOK	strategies		strategy\N5P
---	DLD	,		=\DELIM
923	TOK	as		as\DGA7
924	TOK	described		describe\VMC----
925	TOK	later		later\DGC7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
926	TOK	Figure	BOS	figure\N5S
##	TAG	<num>
927	TOK	1	EOS	1\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
929	TOK	The	BOS	the\AT---6
930	TOK	effect		effect\N5S
931	TOK	of		of\P
932	TOK	treatment		treatment\N5S
933	TOK	of		of\P
934	TOK	genetic		genetic\JA
935	TOK	diseases		disease\N5P
936	TOK	on		on\P
##	TAG	<num>
937	TOK	three		three\X
##	TAG	</num>
938	TOK	disease		disease\N5S
939	TOK	manifestations		manifestation\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
940	TOK	Although	BOS	although\CS
941	TOK	the		the\AT---6
942	TOK	response		response\N5S
943	TOK	to		to\P
944	TOK	treatment		treatment\N5S
945	TOK	is		be\V6FDRS3
946	TOK	poor		poor\JA
947	TOK	both		both\RIP3N-
948	TOK	for		for\P
949	TOK	diseases		disease\N5P
950	TOK	of		of\P
951	TOK	unknown		unknown\JA
952	TOK	cause		cause\N5S
953	TOK	and		and\CC
954	TOK	those		that\RDP3N-
955	TOK	in		in\P
956	TOK	which		which\RW63N-
957	TOK	the		the\AT---6
958	TOK	biochemical		biochemical\JA
959	TOK	defect		defect\N5S
960	TOK	is		be\V6FDRS3
961	TOK	known		know\VMC----
---	DLD	,		=\DELIM
962	TOK	the		the\AT---6
963	TOK	results		result\N5P
964	TOK	are		be\V6FDR66
965	TOK	better		better\DDC7
966	TOK	in		in\P
967	TOK	the		the\AT---6
968	TOK	latter		latter\JC
969	TOK	group		group\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
970	TOK	SPECIAL	BOS	special\JA
971	TOK	CONSIDERATIONS		consideration\N5P
972	TOK	IN		in\N5S
973	TOK	TREATING		TREATING\N5S
974	TOK	GENETIC		GENETIC\N5S
975	TOK	DISEASE	EOS	disease\N5S
##	TAG	</head>
##	TAG	<head>
977	TOK	The	BOS	the\AT---6
##	TAG	<name>
978	TOK	Need for Long-Term Assessment of Treatment	EOS	Need_for_Long-Term_Assessment_of_Treatment\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
980	TOK	In	BOS	in\P
981	TOK	genetic		genetic\JA
982	TOK	disease		disease\N5S
---	DLD	,		=\DELIM
983	TOK	perhaps		perhaps\DGA7
984	TOK	more		more\DDC7
985	TOK	than		than\CS
986	TOK	in		in\P
987	TOK	other		other\JA
988	TOK	areas		area\N5P
989	TOK	of		of\P
990	TOK	medicine		medicine\N5S
---	DLD	,		=\DELIM
991	TOK	treatment		treatment\N5S
992	TOK	initially		initially\DGA7
993	TOK	judged		judge\VMC----
994	TOK	as		as\P
995	TOK	successful		successful\JA
996	TOK	may		may\VOFDR66
997	TOK	eventually		eventually\DGA7
998	TOK	be		be\VMI----
999	TOK	shown		show\VMC----
1000	TOK	to		to\P
1001	TOK	be		be\VMI----
1002	TOK	imperfect		imperfect\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1003	TOK	There	BOS	there\DGA7
1004	TOK	are		be\V6FDR66
##	TAG	<loc pos="DGA7">
1005	TOK	at least		at_least\DGA7
##	TAG	</loc>
##	TAG	<num>
1006	TOK	three		three\X
##	TAG	</num>
1007	TOK	facets		facet\N5P
1008	TOK	to		to\P
1009	TOK	this		this\AD---S
1010	TOK	problem		problem\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1011	TOK	First	BOS	first\MOS
---	DLD	,		=\DELIM
1012	TOK	treatment		treatment\N5S
1013	TOK	may		may\VOFDR66
1014	TOK	initially		initially\DGA7
1015	TOK	appear		appear\VMI----
1016	TOK	to		to\P
1017	TOK	be		be\VMI----
1018	TOK	successful		successful\JA
---	DLD	,		=\DELIM
1019	TOK	only		only\DGA7
1020	TOK	to		to\P
1021	TOK	be		be\VMI----
1022	TOK	shown		show\VMC----
1023	TOK	by		by\P
1024	TOK	longer		long\JC
1025	TOK	observation		observation\N5S
1026	TOK	to		to\P
1027	TOK	have		have\VMI----
1028	TOK	subtle		subtle\JA
1029	TOK	inadequacies		inadequacy\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1030	TOK	Thus	BOS	thus\DGA7
1031	TOK	although		although\CS
1032	TOK	wellmanaged		wellmanaged\JA
1033	TOK	children		child\N5P
1034	TOK	with		with\P
##	TAG	<name>
1035	TOK	PKU		PKU\N46
##	TAG	</name>
1036	TOK	have		have\V6F6R66
1037	TOK	escaped		escape\VMC----
1038	TOK	severe		severe\JA
1039	TOK	retardation		retardation\N5S
1040	TOK	and		and\CC
1041	TOK	have		have\V6F6R66
1042	TOK	normal		normal\JA
1043	TOK	or		or\CC
1044	TOK	near		near\P
---	DLI	-		=\DELIM
1045	TOK	normal		normal\JA
##	TAG	<name>
1046	TOK	IQs		IQs\N46
##	TAG	</name>
---	DLE	(		=\DELIM
1047	TOK	see		see\VMF6R66
1048	TOK	below		below\P
---	DLD	)		=\DELIM
---	DLD	,		=\DELIM
1049	TOK	they		they\RPP3NN
1050	TOK	often		often\DGA7
1051	TOK	manifest		manifest\VMF6R66
1052	TOK	subtle		subtle\JA
1053	TOK	learning		learning\N5S
1054	TOK	disorders		disorder\N5P
1055	TOK	and		and\CC
1056	TOK	behavioral		behavioral\JA
1057	TOK	disturbances		disturbance\N5P
1058	TOK	that		that\RW63N6
1059	TOK	impair		impair\VMF6R66
1060	TOK	their		their\APP3N6
1061	TOK	academic		academic\JA
1062	TOK	performance		performance\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1063	TOK	Similarly	BOS	similarly\DGA7
---	DLD	,		=\DELIM
1064	TOK	in		in\P
1065	TOK	galactosemia		galactosemia\N5S
1066	TOK	patients		patient\N5P
---	DLD	,		=\DELIM
1067	TOK	learning		learning\N5S
1068	TOK	disabilities		disability\N5P
1069	TOK	like		like\P
1070	TOK	those		that\RDP3N-
1071	TOK	observed		observe\VMC----
1072	TOK	in		in\P
1073	TOK	treated		treat\VMC----
##	TAG	<name>
1074	TOK	PKU		PKU\N46
##	TAG	</name>
1075	TOK	patients		patient\N5P
1076	TOK	have		have\V6F6R66
1077	TOK	been		be\VMC----
1078	TOK	recognized		recognize\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1079	TOK	Second	BOS	second\MOS
---	DLD	,		=\DELIM
1080	TOK	successful		successful\JA
1081	TOK	treatment		treatment\N5S
1082	TOK	of		of\P
1083	TOK	the		the\AT---6
1084	TOK	pathological		pathological\JA
1085	TOK	changes		change\N5P
1086	TOK	in		in\P
1087	TOK	one		one\MCS
1088	TOK	organ		organ\N5S
1089	TOK	may		may\VOFDR66
1090	TOK	be		be\VMI----
1091	TOK	followed		follow\VMC----
1092	TOK	by		by\P
1093	TOK	unexpected		unexpected\JA
1094	TOK	problems		problem\N5P
1095	TOK	in		in\P
1096	TOK	tissues		tissue\N5P
1097	TOK	not		not\DGA7
1098	TOK	previously		previously\DGA7
1099	TOK	observed		observe\VMC----
1100	TOK	to		to\P
1101	TOK	be		be\VMI----
1102	TOK	clinically		clinically\DGA7
1103	TOK	involved		involve\VMF6A66
---	DLD	,		=\DELIM
1104	TOK	because		because\CS
1105	TOK	the		the\AT---6
1106	TOK	patients		patient\N5P
1107	TOK	did		do\V6FDA66
1108	TOK	not		not\DGA7
1109	TOK	survive		survive\VMI----
1110	TOK	long		long\JA
1111	TOK	enough		enough\RIP3N-
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<loc pos="DGA7">
1112	TOK	For example	BOS	For_example\DGA7
##	TAG	</loc>
---	DLE	,		=\DELIM
1113	TOK	despite		despite\P
1114	TOK	conscientious		conscientious\JA
1115	TOK	treatment		treatment\N5S
---	DLD	,		=\DELIM
1116	TOK	most		most\AG---6
1117	TOK	females		female\N5P
1118	TOK	with		with\P
1119	TOK	galactosemia		galactosemia\N5S
1120	TOK	have		have\V6F6R66
1121	TOK	ovarian		ovarian\JA
1122	TOK	failure		failure\N5S
1123	TOK	that		that\RW63N6
1124	TOK	appears		appear\VMFDRS3
1125	TOK	to		to\P
1126	TOK	result		result\N5S
1127	TOK	from		from\P
1128	TOK	continued		continue\VMC----
1129	TOK	galactose		galactose\N5S
1130	TOK	toxicity		toxicity\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1131	TOK	The	BOS	the\AT---6
1132	TOK	detection		detection\N5S
1133	TOK	of		of\P
1134	TOK	the		the\AT---6
1135	TOK	later		late\JC
1136	TOK	manifestations		manifestation\N5P
1137	TOK	may		may\VOFDR66
1138	TOK	require		require\VMI----
1139	TOK	many		many\AI---P
1140	TOK	years		year\N5P
1141	TOK	of		of\P
1142	TOK	observation		observation\N5S
1143	TOK	after		after\P
1144	TOK	the		the\AT---6
1145	TOK	initial		initial\JA
1146	TOK	therapy		therapy\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1147	TOK	Another	BOS	another\JA
1148	TOK	disease		disease\N5S
1149	TOK	that		that\RW63N6
1150	TOK	illustrates		illustrate\VMFDRS3
1151	TOK	this		this\AD---S
1152	TOK	phenomenon		phenomenon\N5S
1153	TOK	is		be\V6FDRS3
1154	TOK	cystinosis		cystinosis\N5S
---	DLE	,		=\DELIM
1155	TOK	which		which\RW63N-
1156	TOK	is		be\V6FDRS3
1157	TOK	caused		cause\VMC----
1158	TOK	by		by\P
1159	TOK	cystine		cystine\N5S
1160	TOK	accumulation		accumulation\N5S
1161	TOK	in		in\P
1162	TOK	the		the\AT---6
##	TAG	<name>
1163	TOK	Iysosome		Iysosome\N46
##	TAG	</name>
1164	TOK	due		due\JA
1165	TOK	to		to\P
1166	TOK	a		a\AI---S
1167	TOK	defect		defect\N5S
1168	TOK	in		in\P
1169	TOK	cystine		cystine\N5S
1170	TOK	efflux		efflux\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1171	TOK	The	BOS	the\AT---6
1172	TOK	cystine		cystine\N5S
1173	TOK	storage		storage\N5S
1174	TOK	initially		initially\DGA7
1175	TOK	leads		lead\VMFDRS3
1176	TOK	to		to\P
1177	TOK	renal		renal\JA
1178	TOK	failure		failure\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1179	TOK	As	BOS	as\P
1180	TOK	patients		patient\N5P
1181	TOK	who		who\RW63N-
1182	TOK	receive		receive\VMF6R66
1183	TOK	renal		renal\JA
1184	TOK	transplants		transplant\N5P
1185	TOK	grow		grow\VMF6R66
1186	TOK	older		old\JC
---	DLD	,		=\DELIM
1187	TOK	however		however\DGA7
---	DLD	,		=\DELIM
1188	TOK	morbidity		morbidity\N5S
1189	TOK	results		result\N5P
1190	TOK	from		from\P
1191	TOK	hypothyroidism		hypothyroidism\N5S
---	DLD	,		=\DELIM
1192	TOK	from		from\P
1193	TOK	islet		islet\N5S
1194	TOK	cell		cell\N5S
1195	TOK	disease		disease\N5S
1196	TOK	that		that\RW63N6
1197	TOK	causes		cause\VMFDRS3
1198	TOK	diabetes		diabetes\N56
---	DLD	,		=\DELIM
1199	TOK	and		and\CC
1200	TOK	from		from\P
1201	TOK	various		various\JA
1202	TOK	neurological		neurological\JA
1203	TOK	abnormalities		abnormality\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1204	TOK	A	BOS	a\AI---S
1205	TOK	final		final\JA
1206	TOK	example		example\N5S
1207	TOK	is		be\V6FDRS3
1208	TOK	provided		provide\VMC----
1209	TOK	by		by\P
1210	TOK	mutations		mutation\N5P
1211	TOK	in		in\P
1212	TOK	the		the\AT---6
1213	TOK	retinoblastoma		retinoblastoma\N5S
1214	TOK	gene		gene\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1216	TOK	Patients	BOS	patient\N5P
1217	TOK	successfully		successfully\DGA7
1218	TOK	treated		treat\VMC----
1219	TOK	for		for\P
1220	TOK	the		the\AT---6
1221	TOK	eye		eye\N5S
1222	TOK	tumor		tumor\N5S
1223	TOK	in		in\P
1224	TOK	the		the\AT---6
1225	TOK	first		first\MOS
1226	TOK	years		year\N5P
1227	TOK	of		of\P
1228	TOK	life		life\N5S
1229	TOK	are		be\V6FDR66
1230	TOK	at		at\P
1231	TOK	increased		increase\VMC----
1232	TOK	risk		risk\N5S
1233	TOK	of		of\P
1234	TOK	developing		develop\VMG----
1235	TOK	an		an\AI---S
1236	TOK	independent		independent\JA
1237	TOK	malignancy		malignancy\N5S
---	DLD	,		=\DELIM
1238	TOK	osteosarcoma		osteosarcoma\N5S
---	DLD	,		=\DELIM
1239	TOK	after		after\P
1240	TOK	the		the\AT---6
1241	TOK	first		first\MOS
1242	TOK	decade		decade\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1243	TOK	Ironically	BOS	ironically\DGA7
---	DLD	,		=\DELIM
1244	TOK	therefore		therefore\DGA7
---	DLD	,		=\DELIM
1245	TOK	treatment		treatment\N5S
1246	TOK	that		that\RW63N6
1247	TOK	successfully		successfully\DGA7
1248	TOK	prolongs		prolong\VMFDRS3
1249	TOK	life		life\N5S
1250	TOK	provides		provide\VMFDRS3
1251	TOK	a		a\AI---S
1252	TOK	new		new\JA
1253	TOK	opportunity		opportunity\N5S
1254	TOK	for		for\P
1255	TOK	the		the\AT---6
1256	TOK	clinical		clinical\JA
1257	TOK	expression		expression\N5S
1258	TOK	of		of\P
1259	TOK	the		the\AT---6
1260	TOK	basic		basic\JA
1261	TOK	defect		defect\N5S
---	DLD	,		=\DELIM
1262	TOK	particularly		particularly\DGA7
1263	TOK	in		in\P
1264	TOK	conditions		condition\N5P
1265	TOK	in		in\P
1266	TOK	which		which\RW63N-
1267	TOK	the		the\AT---6
1268	TOK	mutant		mutant\N5S
1269	TOK	gene		gene\N5S
1270	TOK	is		be\V6FDRS3
1271	TOK	normally		normally\DGA7
1272	TOK	expressed		express\VMC----
1273	TOK	in		in\P
1274	TOK	many		many\AI---P
1275	TOK	tissues		tissue\N5P
---	DLD	,		=\DELIM
1276	TOK	thus		thus\DGA7
1277	TOK	providing		provide\VMG----
1278	TOK	more		more\DDC7
1279	TOK	potential		potential\JA
1280	TOK	targets		target\N5P
1281	TOK	for		for\P
1282	TOK	the		the\AT---6
1283	TOK	development		development\N5S
1284	TOK	of		of\P
1285	TOK	pathology		pathology\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1286	TOK	Third	BOS	third\MOS
---	DLD	,		=\DELIM
1287	TOK	therapy		therapy\N5S
1288	TOK	that		that\RW63N6
1289	TOK	is		be\V6FDRS3
1290	TOK	problem		problem\N5S
1291	TOK	free		free\JA
1292	TOK	in		in\P
1293	TOK	the		the\AT---6
1294	TOK	short		short\JA
1295	TOK	term		term\N5S
1296	TOK	may		may\VOFDR66
1297	TOK	produce		produce\VMI----
1298	TOK	serious		serious\JA
1299	TOK	side		side\N5S
1300	TOK	effects		effect\N5P
1301	TOK	in		in\P
1302	TOK	the		the\AT---6
1303	TOK	long		long\JA
1304	TOK	term		term\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<loc pos="DGA7">
1305	TOK	For example	BOS	For_example\DGA7
##	TAG	</loc>
---	DLE	,		=\DELIM
1306	TOK	clotting		clot\VMG----
1307	TOK	factor		factor\N5S
1308	TOK	infusion		infusion\N5S
1309	TOK	in		in\P
1310	TOK	hemophilia		hemophilia\N5S
1311	TOK	sometimes		sometimes\DGA7
1312	TOK	results		result\VMFDRS3
1313	TOK	in		in\P
1314	TOK	the		the\AT---6
1315	TOK	formation		formation\N5S
1316	TOK	of		of\P
1317	TOK	antibodies		antibody\N5P
1318	TOK	to		to\P
1319	TOK	the		the\AT---6
1320	TOK	infused		infuse\VMC----
1321	TOK	protein		protein\N5S
---	DLD	,		=\DELIM
1322	TOK	and		and\CC
1323	TOK	blood		blood\N5S
1324	TOK	transfusion		transfusion\N5S
1325	TOK	in		in\P
1326	TOK	thalassemia		thalassemia\N5S
1327	TOK	invariably		invariably\DGA7
1328	TOK	produces		produce\VMFDRS3
1329	TOK	iron		iron\N5S
1330	TOK	overload		overload\N5S
---	DLD	,		=\DELIM
1331	TOK	which		which\RW63N-
1332	TOK	can		can\VOFDR66
1333	TOK	be		be\VMI----
1334	TOK	managed		manage\VMC----
1335	TOK	but		but\CC
1336	TOK	with		with\P
1337	TOK	difficulty		difficulty\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
1338	TOK	Genetic	BOS	genetic\JA
##	TAG	<name>
1339	TOK	Heterogeneity		Heterogeneity\N46
##	TAG	</name>
1340	TOK	and		and\CC
##	TAG	<name>
1341	TOK	Treatment	EOS	Treatment\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
1343	TOK	The	BOS	the\AT---6
1344	TOK	optimal		optimal\JA
1345	TOK	treatment		treatment\N5S
1346	TOK	of		of\P
1347	TOK	single		single\JA
---	DLI	-		=\DELIM
1348	TOK	gene		gene\N5S
1349	TOK	defects		defect\N5P
1350	TOK	often		often\DGA7
1351	TOK	requires		require\VMFDRS3
1352	TOK	an		an\AI---S
1353	TOK	unusual		unusual\JA
1354	TOK	degree		degree\N5S
1355	TOK	of		of\P
1356	TOK	diagnostic		diagnostic\JA
1357	TOK	precision		precision\N5S
---	DLD	,		=\DELIM
1358	TOK	at		at\P
1359	TOK	the		the\AT---6
1360	TOK	level		level\N5S
1361	TOK	of		of\P
1362	TOK	the		the\AT---6
1363	TOK	affected		affect\VMC----
1364	TOK	molecule		molecule\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1365	TOK	As	BOS	as\DGA7
1366	TOK	stated		state\VMC----
1367	TOK	repeatedly		repeatedly\DGA7
1368	TOK	in		in\P
1369	TOK	early		early\JA
1370	TOK	chapters		chapter\N5P
---	DLD	,		=\DELIM
1371	TOK	genetic		genetic\JA
1372	TOK	heterogeneity		heterogeneity\N5S
---	DLE	(		=\DELIM
1373	TOK	allelic		allelic\JA
1374	TOK	heterogeneity		heterogeneity\N5S
1375	TOK	or		or\CC
##	TAG	<foreign lang="LA" pos="N5S">
1376	TOK	locus		locus\N5S
##	TAG	</foreign>
1377	TOK	heterogeneity		heterogeneity\N5S
---	DLD	)		=\DELIM
1378	TOK	is		be\V6FDRS3
1379	TOK	a		a\AI---S
1380	TOK	common		common\JA
1381	TOK	characteristic		characteristic\JA
1382	TOK	of		of\P
1383	TOK	genetic		genetic\JA
1384	TOK	diseases		disease\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1385	TOK	For	BOS	for\P
1386	TOK	proper		proper\JA
1387	TOK	management		management\N5S
---	DLD	,		=\DELIM
1388	TOK	it		it\RPS3N6
1389	TOK	is		be\V6FDRS3
1390	TOK	often		often\DGA7
1391	TOK	critical		critical\JA
1392	TOK	not		not\DGA7
1393	TOK	simply		simply\DGA7
1394	TOK	to		to\P
1395	TOK	treat		treat\VMI----
1396	TOK	a		a\AI---S
1397	TOK	biochemical		biochemical\JA
1398	TOK	abnormality		abnormality\N5S
1399	TOK	but		but\CC
1400	TOK	to		to\P
1401	TOK	identify		identify\VMI----
1402	TOK	precisely		precisely\DGA7
1403	TOK	the		the\AT---6
1404	TOK	basic		basic\JA
1405	TOK	biochemical		biochemical\JA
1406	TOK	defect		defect\N5S
---	DLD	,		=\DELIM
##	TAG	<loc pos="JA">
1407	TOK	as opposed to		as_opposed_to\JA
##	TAG	</loc>
1408	TOK	a		a\AI---S
1409	TOK	secondary		secondary\JA
1410	TOK	defect		defect\N5S
1411	TOK	such		such\RIS3N-
1412	TOK	as		as\CS
1413	TOK	those		that\RDP3N-
1414	TOK	outlined		outline\VMC----
1415	TOK	in		in\P
##	TAG	<name>
1416	TOK	Table		Table\N46
##	TAG	</name>
##	TAG	<num>
1417	TOK	12-9		12-9\X
##	TAG	</num>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<loc pos="DGA7">
1418	TOK	For example	BOS	For_example\DGA7
##	TAG	</loc>
---	DLE	,		=\DELIM
1419	TOK	abnormalities		abnormality\N5P
1420	TOK	in		in\P
1421	TOK	phenylalanine		phenylalanine\N5S
1422	TOK	hydroxylase		hydroxylase\N5S
1423	TOK	and		and\CC
1424	TOK	in		in\P
1425	TOK	the		the\AT---6
1426	TOK	enzymes		enzyme\N5P
1427	TOK	of		of\P
1428	TOK	biopterin		biopterin\N5S
1429	TOK	metabolism		metabolism\N5S
1430	TOK	both		both\RIP3N-
1431	TOK	produce		produce\VMF6R66
1432	TOK	hyperphenylalaninemia		hyperphenylalaninemia\N5P
---	DLD	,		=\DELIM
1433	TOK	but		but\CC
1434	TOK	the		the\AT---6
1435	TOK	treatment		treatment\N5S
1436	TOK	of		of\P
1437	TOK	the		the\AT---6
##	TAG	<num>
1438	TOK	two		two\X
##	TAG	</num>
1439	TOK	types		type\N5P
1440	TOK	of		of\P
1441	TOK	defects		defect\N5P
1442	TOK	is		be\V6FDRS3
1443	TOK	quite		quite\DGA7
1444	TOK	different		different\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1445	TOK	Even	BOS	even\DGA7
1446	TOK	allelic		allelic\JA
1447	TOK	mutations		mutation\N5P
1448	TOK	may		may\VOFDR66
1449	TOK	require		require\VMI----
1450	TOK	different		different\JA
1451	TOK	management		management\N5S
---	DLD	:		=\DELIM
1452	TOK	the		the\AT---6
1453	TOK	clinically		clinically\DGA7
1454	TOK	distinct		distinct\JA
---	DLD	,		=\DELIM
1455	TOK	ß-globin		ß-globin\N5S
1456	TOK	disorders		disorder\N5P
---	DLD	,		=\DELIM
1457	TOK	thalassemia		thalassemia\N5S
---	DLD	,		=\DELIM
1458	TOK	and		and\CC
1459	TOK	sickle		sickle\N5S
1460	TOK	cell		cell\N5S
1461	TOK	disease		disease\N5S
---	DLD	,		=\DELIM
1462	TOK	illustrate		illustrate\VMI----
1463	TOK	this		this\AD---S
1464	TOK	concept		concept\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1465	TOK	The	BOS	the\AT---6
1466	TOK	study		study\N5S
1467	TOK	of		of\P
1468	TOK	allelic		allelic\JA
1469	TOK	variants		variant\N5P
1470	TOK	of		of\P
1471	TOK	enzyme		enzyme\N5S
1472	TOK	defects		defect\N5P
1473	TOK	has		have\V6FDRS3
1474	TOK	shown		show\VMC----
1475	TOK	that		that\CS
1476	TOK	alleles		allele\N5P
1477	TOK	that		that\RW63N6
1478	TOK	retain		retain\VMF6R66
1479	TOK	small		small\JA
1480	TOK	amounts		amount\N5P
1481	TOK	of		of\P
1482	TOK	residual		residual\JA
1483	TOK	enzyme		enzyme\N5S
1484	TOK	activity		activity\N5S
1485	TOK	often		often\DGA7
1486	TOK	cause		cause\VMF6R66
1487	TOK	much		much\DGA7
1488	TOK	less		less\DDC7
1489	TOK	severe		severe\JA
1490	TOK	disease		disease\N5S
1491	TOK	than		than\CS
1492	TOK	null		null\JA
1493	TOK	alleles		allele\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1494	TOK	The	BOS	the\AT---6
1495	TOK	contrast		contrast\N5S
1496	TOK	between		between\P
1497	TOK	patients		patient\N5P
1498	TOK	with		with\P
1499	TOK	classic		classic\JA
##	TAG	<name>
1500	TOK	PKU		PKU\N46
##	TAG	</name>
---	DLE	(		=\DELIM
1501	TOK	with		with\P
1502	TOK	virtually		virtually\DGA7
1503	TOK	no		no\AI---6
1504	TOK	residual		residual\JA
1505	TOK	enzyme		enzyme\N5S
1506	TOK	activity		activity\N5S
---	DLD	)		=\DELIM
1507	TOK	and		and\CC
1508	TOK	those		that\RDP3N-
1509	TOK	with		with\P
1510	TOK	benign		benign\JA
1511	TOK	hyperphenylalaninemia		hyperphenylalaninemia\N5P
---	DLE	(		=\DELIM
1512	TOK	with		with\P
1513	TOK	about		about\DGA7
##	TAG	<num>
1514	TOK	5		5\X
##	TAG	</num>
1515	TOK	percent		percent\N56
1516	TOK	activity		activity\N5S
---	DLD	)		=\DELIM
1517	TOK	illustrates		illustrate\VMFDRS3
1518	TOK	this		this\AD---S
1519	TOK	principle		principle\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1520	TOK	The	BOS	the\AT---6
1521	TOK	corollary		corollary\N5S
1522	TOK	of		of\P
1523	TOK	this		this\AD---S
1524	TOK	observation		observation\N5S
1525	TOK	is		be\V6FDRS3
1526	TOK	that		that\CS
1527	TOK	effective		effective\JA
1528	TOK	treatment		treatment\N5S
1529	TOK	of		of\P
1530	TOK	classic		classic\JA
##	TAG	<name>
1531	TOK	PKU		PKU\N46
##	TAG	</name>
1532	TOK	by		by\P
1533	TOK	gene		gene\N5S
1534	TOK	or		or\CC
1535	TOK	enzyme		enzyme\N5S
1536	TOK	transfer		transfer\N5S
1537	TOK	would		will\VOFDA66
1538	TOK	require		require\VMI----
1539	TOK	the		the\AT---6
1540	TOK	delivery		delivery\N5S
1541	TOK	of		of\P
1542	TOK	only		only\DGA7
1543	TOK	small		small\JA
1544	TOK	amounts		amount\N5P
1545	TOK	of		of\P
1546	TOK	phenylalanine		phenylalanine\N5S
1547	TOK	hydroxylase		hydroxylase\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
1548	TOK	Allelic	BOS	allelic\JA
1549	TOK	heterogeneity		heterogeneity\N5S
1550	TOK	has		have\V6FDRS3
1551	TOK	additional		additional\JA
1552	TOK	implications		implication\N5P
1553	TOK	for		for\P
1554	TOK	therapy		therapy\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1555	TOK	Some	BOS	some\AG---6
1556	TOK	alleles		allele\N5P
1557	TOK	produce		produce\VMF6R66
1558	TOK	a		a\AI---S
1559	TOK	protein		protein\N5S
1560	TOK	that		that\RW63N6
1561	TOK	is		be\V6FDRS3
1562	TOK	decreased		decrease\VMC----
1563	TOK	in		in\P
1564	TOK	abundance		abundance\N5S
1565	TOK	but		but\CC
1566	TOK	has		have\V6FDRS3
1567	TOK	residual		residual\JA
1568	TOK	function		function\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1569	TOK	Strategies	BOS	strategy\N5P
1570	TOK	designed		design\VMC----
1571	TOK	to		to\P
1572	TOK	increase		increase\VMI----
1573	TOK	the		the\AT---6
1574	TOK	expression		expression\N5S
1575	TOK	or		or\CC
1576	TOK	stability		stability\N5S
1577	TOK	of		of\P
1578	TOK	the		the\AT---6
1579	TOK	partially		partially\DGA7
1580	TOK	functional		functional\JA
1581	TOK	protein		protein\N5S
1582	TOK	may		may\VOFDR66
1583	TOK	be		be\VMI----
1584	TOK	effective		effective\JA
1585	TOK	in		in\P
1586	TOK	correcting		correct\VMG----
1587	TOK	the		the\AT---6
1588	TOK	biochemical		biochemical\JA
1589	TOK	defect		defect\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1590	TOK	In	BOS	in\P
1591	TOK	contrast		contrast\VMI----
---	DLD	,		=\DELIM
1592	TOK	nothing		nothing\RIS3N-
1593	TOK	is		be\V6FDRS3
1594	TOK	to		to\P
1595	TOK	be		be\VMI----
1596	TOK	gained		gain\VMC----
1597	TOK	by		by\P
1598	TOK	increasing		increase\VMG----
1599	TOK	the		the\AT---6
1600	TOK	abundance		abundance\N5S
1601	TOK	of		of\P
1602	TOK	a		a\AI---S
1603	TOK	mutant		mutant\N5S
1604	TOK	protein		protein\N5S
1605	TOK	with		with\P
1606	TOK	no		no\AI---6
1607	TOK	residual		residual\JA
1608	TOK	function		function\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1609	TOK	In	BOS	in\P
1610	TOK	fact		fact\N5S
---	DLD	,		=\DELIM
1611	TOK	increased		increase\VMC----
1612	TOK	expression		expression\N5S
1613	TOK	of		of\P
1614	TOK	a		a\AI---S
1615	TOK	functionless		functionless\JA
1616	TOK	mutant		mutant\N5S
1617	TOK	protein		protein\N5S
1618	TOK	may		may\VOFDR66
1619	TOK	be		be\VMI----
1620	TOK	detrimental		detrimental\JA
1621	TOK	because		because\CS
1622	TOK	it		it\RPS3N6
1623	TOK	may		may\VOFDR66
1624	TOK	exert		exert\VMI----
1625	TOK	a		a\AI---S
1626	TOK	dominant		dominant\JA
1627	TOK	negative		negative\JA
1628	TOK	effect		effect\N5S
1629	TOK	if		if\CS
1630	TOK	it		it\RPS3N6
1631	TOK	interacts		interact\VMFDRS3
1632	TOK	with		with\P
1633	TOK	the		the\AT---6
1634	TOK	product		product\N5S
1635	TOK	of		of\P
1636	TOK	the		the\AT---6
1637	TOK	normal		normal\JA
1638	TOK	allele		allele\N5S
---	DLD	,		=\DELIM
1639	TOK	or		or\CC
1640	TOK	with		with\P
1641	TOK	other		other\JA
1642	TOK	proteins		protein\N5P
---	DLD	,		=\DELIM
1643	TOK	to		to\P
1644	TOK	impair		impair\VMI----
1645	TOK	their		their\APP3N6
1646	TOK	function		function\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1647	TOK	This	BOS	this\AD---S
1648	TOK	consideration		consideration\N5S
1649	TOK	is		be\V6FDRS3
1650	TOK	also		also\DGA7
1651	TOK	relevant		relevant\JA
1652	TOK	to		to\P
1653	TOK	efforts		effort\N5P
1654	TOK	to		to\P
1655	TOK	transfer		transfer\VMI----
1656	TOK	a		a\AI---S
1657	TOK	normal		normal\JA
1658	TOK	gene		gene\N5S
1659	TOK	into		into\P
1660	TOK	a		a\AI---S
1661	TOK	patient		patient\N5S
1662	TOK	with		with\P
1663	TOK	a		a\AI---S
1664	TOK	genetic		genetic\JA
1665	TOK	disease		disease\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<loc pos="DGA7">
1666	TOK	For example	BOS	For_example\DGA7
##	TAG	</loc>
---	DLE	,		=\DELIM
1667	TOK	in		in\P
1668	TOK	osteogenesis		osteogenesis\N5S
1669	TOK	imperfecta		imperfecta\N5P
---	DLD	,		=\DELIM
1670	TOK	patients		patient\N5P
1671	TOK	with		with\P
1672	TOK	null		null\JA
1673	TOK	alleles		allele\N5P
1674	TOK	may		may\VOFDR66
1675	TOK	be		be\VMI----
1676	TOK	easier		easy\JC
1677	TOK	to		to\P
1678	TOK	treat		treat\VMI----
1679	TOK	by		by\P
1680	TOK	gene		gene\N5S
1681	TOK	transfer		transfer\N5S
1682	TOK	than		than\CS
1683	TOK	those		that\RDP3N-
1684	TOK	with		with\P
1685	TOK	qualitatively		qualitatively\DGA7
1686	TOK	abnormal		abnormal\JA
1687	TOK	collagen		collagen\N5S
1688	TOK	chains		chain\N5P
1689	TOK	that		that\RW63N6
1690	TOK	reduce		reduce\VMF6R66
1691	TOK	the		the\AT---6
1692	TOK	effective		effective\JA
1693	TOK	contribution		contribution\N5S
1694	TOK	of		of\P
1695	TOK	the		the\AT---6
1696	TOK	transferred		transfer\VMC----
1697	TOK	gene		gene\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
1698	TOK	TREATMENT	BOS	treatment\N5S
1699	TOK	STRATEGIES	EOS	strategy\N5P
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
1701	TOK	Genetic	BOS	genetic\JA
1702	TOK	disease		disease\N5S
1703	TOK	can		can\VOFDR66
1704	TOK	be		be\VMI----
1705	TOK	treated		treat\VMC----
1706	TOK	at		at\P
1707	TOK	many		many\AI---P
1708	TOK	levels		level\N5P
---	DLD	,		=\DELIM
1709	TOK	at		at\P
1710	TOK	various		various\JA
1711	TOK	steps		step\N5P
1712	TOK	away		away\DGA7
1713	TOK	from		from\P
1714	TOK	the		the\AT---6
1715	TOK	mutant		mutant\N5S
1716	TOK	gene		gene\N5S
---	DLE	(		=\DELIM
##	TAG	<abbr pos="N5S" expansion="figure">
1717	TOK	Fig.		Fig.\N5S
##	TAG	</abbr>
##	TAG	<na type="function">
1718	TOK	13-2		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1719	TOK	In	BOS	in\P
1720	TOK	the		the\AT---6
1721	TOK	remainder		remainder\N5S
1722	TOK	of		of\P
1723	TOK	this		this\AD---S
1724	TOK	chapter		chapter\N5S
---	DLD	,		=\DELIM
1725	TOK	we		we\RPP1NN
1726	TOK	describe		describe\VMF6R66
1727	TOK	the		the\AT---6
1728	TOK	rationale		rationale\N5S
1729	TOK	used		use\VMC----
1730	TOK	or		or\CC
1731	TOK	proposed		propose\VMC----
1732	TOK	for		for\P
1733	TOK	treatment		treatment\N5S
1734	TOK	at		at\P
1735	TOK	each		each\RIS3N-
1736	TOK	of		of\P
1737	TOK	these		this\AD---P
1738	TOK	levels		level\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1739	TOK	In	BOS	in\P
1740	TOK	general		general\JA
---	DLD	,		=\DELIM
1741	TOK	diseases		disease\N5P
1742	TOK	described		describe\VMF6A66
1743	TOK	earlier		early\JC
1744	TOK	in		in\P
1745	TOK	the		the\AT---6
1746	TOK	book		book\N5S
1747	TOK	are		be\V6FDR66
1748	TOK	used		use\VMC----
1749	TOK	as		as\P
1750	TOK	examples		example\N5P
---	DLD	,		=\DELIM
1751	TOK	although		although\CS
1752	TOK	new		new\JA
1753	TOK	disorders		disorder\N5P
1754	TOK	are		be\V6FDR66
1755	TOK	presented		present\VMC----
1756	TOK	when		when\CS
1757	TOK	necessary		necessary\JA
1758	TOK	to		to\P
1759	TOK	illustrate		illustrate\VMI----
1760	TOK	a		a\AI---S
1761	TOK	specific		specific\JA
1762	TOK	approach		approach\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1763	TOK	None	BOS	none\RIS3N-
1764	TOK	of		of\P
1765	TOK	the		the\AT---6
1766	TOK	current		current\JA
1767	TOK	treatments		treatment\N5P
1768	TOK	are		be\V6FDR66
1769	TOK	necessarily		necessarily\DGA7
1770	TOK	mutually		mutually\DGA7
1771	TOK	exclusive		exclusive\JA
---	DLD	,		=\DELIM
1772	TOK	although		although\CS
1773	TOK	successful		successful\JA
1774	TOK	gene		gene\N5S
1775	TOK	transfer		transfer\N5S
1776	TOK	therapy		therapy\N5S
1777	TOK	would		will\VOFDA66
1778	TOK	render		render\VMI----
1779	TOK	other		other\JA
1780	TOK	therapies		therapy\N5P
1781	TOK	superfluous		superfluous\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1782	TOK	Treatment	BOS	treatment\N5S
---	DLE	"		=\DELIM
1783	TOK	at		at\P
1784	TOK	the		the\AT---6
1785	TOK	level		level\N5S
1786	TOK	of		of\P
1787	TOK	the		the\AT---6
1788	TOK	clinical		clinical\JA
1789	TOK	phenotype		phenotype\N5S
---	DLD	"		=\DELIM
---	DLE	(		=\DELIM
##	TAG	<abbr pos="N5S" expansion="figure">
1790	TOK	Fig.		Fig.\N5S
##	TAG	</abbr>
##	TAG	<na type="function">
1791	TOK	13 - 2		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
1792	TOK	is		be\V6FDRS3
1793	TOK	a		a\AI---S
1794	TOK	category		category\N5S
1795	TOK	meant		mean\VMC----
1796	TOK	to		to\P
1797	TOK	include		include\VMI----
1798	TOK	all		all\AG---6
1799	TOK	the		the\AT---6
1800	TOK	types		type\N5P
1801	TOK	of		of\P
1802	TOK	medical		medical\JA
1803	TOK	or		or\CC
1804	TOK	surgical		surgical\JA
1805	TOK	intervention		intervention\N5S
1806	TOK	that		that\RW63N6
1807	TOK	are		be\V6FDR66
1808	TOK	not		not\DGA7
1809	TOK	unique		unique\JA
1810	TOK	to		to\P
1811	TOK	the		the\AT---6
1812	TOK	management		management\N5S
1813	TOK	of		of\P
1814	TOK	genetic		genetic\JA
1815	TOK	disease		disease\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1816	TOK	Often	BOS	often\DGA7
1817	TOK	this		this\RDS3N-
1818	TOK	is		be\V6FDRS3
1819	TOK	the		the\AT---6
1820	TOK	only		only\JA
1821	TOK	therapy		therapy\N5S
1822	TOK	available		available\JA
1823	TOK	and		and\CC
---	DLD	,		=\DELIM
1824	TOK	in		in\P
1825	TOK	some		some\AG---6
1826	TOK	cases		case\N5P
---	DLD	,		=\DELIM
1827	TOK	may		may\VOFDR66
1828	TOK	be		be\VMI----
1829	TOK	all		all\AG---6
1830	TOK	that		that\RDS3N-
1831	TOK	is		be\V6FDRS3
1832	TOK	necessary		necessary\JA
---	DLD	,		=\DELIM
1833	TOK	as		as\DGA7
1834	TOK	is		be\V6FDRS3
1835	TOK	the		the\AT---6
1836	TOK	case		case\N5S
---	DLD	,		=\DELIM
##	TAG	<loc pos="DGA7">
1837	TOK	for example		for_example\DGA7
##	TAG	</loc>
---	DLE	,		=\DELIM
1838	TOK	with		with\P
1839	TOK	some		some\AG---6
1840	TOK	surgically		surgically\DGA7
1841	TOK	correctable		correctable\JA
1842	TOK	malformations		malformation\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1843	TOK	Finally	BOS	finally\DGA7
---	DLD	,		=\DELIM
1844	TOK	the		the\AT---6
1845	TOK	importance		importance\N5S
1846	TOK	of		of\P
1847	TOK	educating		educate\VMG----
1848	TOK	the		the\AT---6
1849	TOK	patient		patient\N5S
---	DLI	-		=\DELIM
1850	TOK	not		not\DGA7
1851	TOK	only		only\DGA7
1852	TOK	to		to\P
1853	TOK	achieve		achieve\VMI----
1854	TOK	understanding		understanding\N5S
1855	TOK	of		of\P
1856	TOK	the		the\AT---6
1857	TOK	disease		disease\N5S
---	DLD	,		=\DELIM
1858	TOK	its		its\APS3N6
1859	TOK	genetic		genetic\JA
1860	TOK	implications		implication\N5P
---	DLD	,		=\DELIM
1861	TOK	and		and\CC
1862	TOK	the		the\AT---6
1863	TOK	treatment		treatment\N5S
1864	TOK	but		but\CC
1865	TOK	also		also\DGA7
1866	TOK	to		to\P
1867	TOK	ensure		ensure\VMI----
1868	TOK	compliance		compliance\N5S
1869	TOK	with		with\P
1870	TOK	therapy		therapy\N5S
1871	TOK	that		that\RW63N6
1872	TOK	may		may\VOFDR66
1873	TOK	be		be\VMI----
1874	TOK	inconvenient		inconvenient\JA
1875	TOK	and		and\CC
1876	TOK	lifelong		lifelong\JA
---	DLI	-		=\DELIM
1877	TOK	can		can\V6FDR66
1878	PGR	not		not\DGA7
1879	TOK	be		be\VMI----
1880	TOK	overemphasized		overemphasize\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
1881	TOK	Treatment	BOS	treatment\N5S
1882	TOK	of		of\P
##	TAG	<name>
1883	TOK	Metabolic Abnormalities	EOS	Metabolic_Abnormalities\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
1885	TOK	The	BOS	the\AT---6
1886	TOK	most		most\DDS7
1887	TOK	successful		successful\JA
1888	TOK	disease		disease\N5S
---	DLI	-		=\DELIM
1889	TOK	specific		specific\JA
1890	TOK	approach		approach\N5S
1891	TOK	to		to\P
1892	TOK	the		the\AT---6
1893	TOK	treatment		treatment\N5S
1894	TOK	of		of\P
1895	TOK	genetic		genetic\JA
1896	TOK	disease		disease\N5S
1897	TOK	has		have\V6FDRS3
1898	TOK	been		be\VMC----
1899	TOK	at		at\P
1900	TOK	the		the\AT---6
1901	TOK	level		level\N5S
1902	TOK	of		of\P
1903	TOK	the		the\AT---6
1904	TOK	metabolic		metabolic\JA
1905	TOK	abnormality		abnormality\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1906	TOK	In	BOS	in\P
1907	TOK	fact		fact\N5S
---	DLD	,		=\DELIM
1908	TOK	this		this\AD---S
1909	TOK	concept		concept\N5S
1910	TOK	is		be\V6FDRS3
1911	TOK	familiar		familiar\JA
1912	TOK	to		to\P
1913	TOK	those		that\RDP3N-
1914	TOK	who		who\RW63N-
1915	TOK	are		be\V6FDR66
1916	TOK	aware		aware\JA
1917	TOK	of		of\P
1918	TOK	the		the\AT---6
1919	TOK	need		need\N5S
1920	TOK	for		for\P
1921	TOK	dietary		dietary\JA
1922	TOK	compensation		compensation\N5S
1923	TOK	for		for\P
1924	TOK	the		the\AT---6
1925	TOK	inability		inability\N5S
1926	TOK	of		of\P
1927	TOK	humans		human\N5P
1928	TOK	and		and\CC
1929	TOK	other		other\JA
1930	TOK	higher		high\JC
1931	TOK	primates		primate\N5P
1932	TOK	to		to\P
1933	TOK	synthesize		synthesize\VMI----
1934	TOK	ascorbic		ascorbic\N5S
1935	TOK	acid		acid\N5S
---	DLE	(		=\DELIM
1936	TOK	vitamin		vitamin\N5S
1937	TOK	C		C\N5P
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1938	TOK	The	BOS	the\AT---6
1939	TOK	principal		principal\JA
1940	TOK	strategies		strategy\N5P
1941	TOK	used		use\VMC----
1942	TOK	to		to\P
1943	TOK	manipulate		manipulate\VMI----
1944	TOK	metabolism		metabolism\N5S
1945	TOK	in		in\P
1946	TOK	the		the\AT---6
1947	TOK	treatment		treatment\N5S
1948	TOK	of		of\P
1949	TOK	inborn		inborn\JA
1950	TOK	errors		error\N5P
1951	TOK	are		be\V6FDR66
1952	TOK	listed		list\VMC----
1953	TOK	in		in\P
##	TAG	<name>
1954	TOK	Table		Table\N46
##	TAG	</name>
##	TAG	<num>
1955	TOK	1		1\X
##	TAG	</num>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1956	TOK	The	BOS	the\AT---6
1957	TOK	necessity		necessity\N5S
1958	TOK	for		for\P
1959	TOK	patients		patient\N5P
1960	TOK	with		with\P
1961	TOK	pharmacogenetic		pharmacogenetic\JA
1962	TOK	diseases		disease\N5P
---	DLD	,		=\DELIM
1963	TOK	such		such\JA
1964	TOK	as		as\P
1965	TOK	glucose		glucose\N5S
---	DLD	-		=\DELIM
##	TAG	<num>
1966	TOK	6		6\X
##	TAG	</num>
---	DLE	-		=\DELIM
1967	TOK	phosphate		phosphate\N5S
1968	TOK	dehydrogenase		dehydrogenase\N5S
1969	TOK	deficiency		deficiency\N5S
---	DLD	,		=\DELIM
1970	TOK	to		to\P
1971	TOK	avoid		avoid\VMI----
1972	TOK	certain		certain\JA
1973	TOK	drugs		drug\N5P
1974	TOK	and		and\CC
1975	TOK	chemicals		chemical\N5P
1976	TOK	is		be\V6FDRS3
1977	TOK	described		describe\VMC----
1978	TOK	in		in\P
##	TAG	<name>
1979	TOK	Chapter		Chapter\N46
##	TAG	</name>
##	TAG	<num>
1980	TOK	12		12\X
##	TAG	</num>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
1981	TOK	Dietary	BOS	dietary\JA
##	TAG	<name>
1982	TOK	Restriction	EOS	Restriction\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
1984	TOK	Dietary	BOS	dietary\JA
1985	TOK	restriction		restriction\N5S
1986	TOK	is		be\V6FDRS3
1987	TOK	one		one\MCS
1988	TOK	of		of\P
1989	TOK	the		the\AT---6
1990	TOK	oldest		old\JS
1991	TOK	and		and\CC
1992	TOK	most		most\AG---6
1993	TOK	effective		effective\JA
1994	TOK	methods		method\N5P
1995	TOK	of		of\P
1996	TOK	managing		manage\VMG----
1997	TOK	genetic		genetic\JA
1998	TOK	disease		disease\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
1999	TOK	Its	BOS	its\APS3N6
2000	TOK	advantage		advantage\N5S
2001	TOK	is		be\V6FDRS3
2002	TOK	that		that\CS
2003	TOK	it		it\RPS3N6
2004	TOK	can		can\VOFDR66
2005	TOK	be		be\VMI----
2006	TOK	highly		highly\DGA7
2007	TOK	effective		effective\JA
---	DLD	;		=\DELIM
2008	TOK	its		its\APS3N6
2009	TOK	drawback		drawback\N5S
2010	TOK	is		be\V6FDRS3
2011	TOK	that		that\CS
2012	TOK	it		it\RPS3N6
2013	TOK	usually		usually\DGA7
2014	TOK	requires		require\VMFDRS3
2015	TOK	lifelong		lifelong\JA
2016	TOK	compliance		compliance\N5S
2017	TOK	with		with\P
2018	TOK	a		a\AI---S
2019	TOK	restricted		restrict\VMC----
2020	TOK	and		and\CC
2021	TOK	often		often\DGA7
2022	TOK	artificial		artificial\JA
2023	TOK	diet		diet\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2024	TOK	This	BOS	this\AD---S
2025	TOK	dietary		dietary\JA
2026	TOK	constraint		constraint\N5S
2027	TOK	is		be\V6FDRS3
2028	TOK	onerous		onerous\JA
2029	TOK	for		for\P
2030	TOK	the		the\AT---6
2031	TOK	family		family\N5S
##	TAG	<loc pos="DGA7">
2032	TOK	as well as		as_well_as\DGA7
##	TAG	</loc>
2033	TOK	the		the\AT---6
2034	TOK	patient		patient\N5S
---	DLD	,		=\DELIM
2035	TOK	especially		especially\DGA7
2036	TOK	in		in\P
2037	TOK	adolescence		adolescence\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2038	TOK	Many	BOS	many\AI---P
2039	TOK	of		of\P
2040	TOK	the		the\AT---6
2041	TOK	diseases		disease\N5P
2042	TOK	treatable		treatable\JA
2043	TOK	in		in\P
2044	TOK	this		this\AD---S
2045	TOK	manner		manner\N5S
2046	TOK	involve		involve\VMF6R66
2047	TOK	amino		amino\N5S
2048	TOK	acid		acid\N5S
2049	TOK	catabolic		catabolic\JA
2050	TOK	pathways		pathway\N5P
---	DLD	,		=\DELIM
2051	TOK	and		and\CC
2052	TOK	therefore		therefore\DGA7
2053	TOK	severe		severe\JA
2054	TOK	restriction		restriction\N5S
2055	TOK	of		of\P
2056	TOK	normal		normal\JA
2057	TOK	dietary		dietary\JA
2058	TOK	protein		protein\N5S
2059	TOK	is		be\V6FDRS3
2060	TOK	usually		usually\DGA7
2061	TOK	necessary		necessary\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2062	TOK	Essential	BOS	essential\JA
2063	TOK	nutrients		nutrient\N5P
2064	TOK	such		such\RIS3N-
2065	TOK	as		as\P
2066	TOK	amino		amino\N5S
2067	TOK	acids		acid\N5P
---	DLD	,		=\DELIM
2068	TOK	however		however\DGA7
---	DLD	,		=\DELIM
2069	TOK	can		can\V6FDR66
2070	PGR	not		not\DGA7
2071	TOK	be		be\VMI----
2072	TOK	withheld		withhold\VMC----
2073	TOK	entirely		entirely\DGA7
---	DLD	;		=\DELIM
2074	TOK	their		their\APP3N6
2075	TOK	intake		intake\N5S
2076	TOK	must		must\VOFDR66
2077	TOK	be		be\VMI----
2078	TOK	sufficient		sufficient\JA
2079	TOK	for		for\P
2080	TOK	anabolic		anabolic\JA
2081	TOK	needs		need\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2082	TOK	Patients	BOS	patient\N5P
2083	TOK	with		with\P
2084	TOK	mild		mild\JA
2085	TOK	enzymatic		enzymatic\JA
2086	TOK	defects		defect\N5P
---	DLE	(		=\DELIM
##	TAG	<abbr>
2087	TOK	i.e.		i.e.\N5P
##	TAG	</abbr>
---	DLE	,		=\DELIM
---	DLE	"		=\DELIM
2088	TOK	leaky		leaky\JA
---	DLD	"		=\DELIM
2089	TOK	mutant		mutant\N5S
2090	TOK	alleles		allele\N5P
---	DLD	)		=\DELIM
2091	TOK	can		can\VOFDR66
2092	TOK	tolerate		tolerate\VMI----
2093	TOK	more		more\DDC7
2094	TOK	of		of\P
2095	TOK	the		the\AT---6
2096	TOK	offending		offend\VMG----
2097	TOK	compound		compound\N5S
---	DLD	;		=\DELIM
2098	TOK	consequently		consequently\DGA7
---	DLD	,		=\DELIM
2099	TOK	the		the\AT---6
2100	TOK	diet		diet\N5S
2101	TOK	is		be\V6FDRS3
2102	TOK	less		less\DDC7
2103	TOK	restrictive		restrictive\JA
---	DLD	,		=\DELIM
2104	TOK	and		and\CC
2105	TOK	compliance		compliance\N5S
2106	TOK	may		may\VOFDR66
2107	TOK	be		be\VMI----
2108	TOK	better		good\JC
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2109	TOK	In	BOS	in\P
2110	TOK	other		other\JA
2111	TOK	cases		case\N5P
---	DLD	,		=\DELIM
2112	TOK	the		the\AT---6
2113	TOK	dietary		dietary\JA
2114	TOK	precursor		precursor\N5S
2115	TOK	to		to\P
2116	TOK	the		the\AT---6
2117	TOK	offending		offend\VMG----
2118	TOK	substrate		substrate\N5S
2119	TOK	is		be\V6FDRS3
2120	TOK	not		not\DGA7
2121	TOK	an		an\AI---S
2122	TOK	essential		essential\JA
2123	TOK	nutrient		nutrient\JA
---	DLE	(		=\DELIM
##	TAG	<abbr>
2124	TOK	e.g.		e.g.\N5P
##	TAG	</abbr>
---	DLE	,		=\DELIM
2125	TOK	galactose		galactose\N5S
---	DLD	)		=\DELIM
---	DLD	,		=\DELIM
2126	TOK	and		and\CC
2127	TOK	it		it\RPS3N6
2128	TOK	can		can\VOFDR66
2129	TOK	be		be\VMI----
2130	TOK	eliminated		eliminate\VMC----
2131	TOK	from		from\P
2132	TOK	the		the\AT---6
2133	TOK	diet		diet\N5S
2134	TOK	altogether		altogether\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2135	TOK	Diseases	BOS	disease\N5P
2136	TOK	involving		involve\VMG----
2137	TOK	more		more\DDC7
2138	TOK	than		than\CS
##	TAG	<num>
2139	TOK	two		two\X
##	TAG	</num>
2140	TOK	dozen		dozen\N56
2141	TOK	loci		locus\N5P
2142	TOK	are		be\V6FDR66
2143	TOK	presently		presently\DGA7
2144	TOK	managed		manage\VMC----
2145	TOK	in		in\P
2146	TOK	this		this\AD---S
2147	TOK	way		way\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2148	TOK	A	BOS	a\AI---S
2149	TOK	diet		diet\N5S
2150	TOK	restricted		restrict\VMC----
2151	TOK	in		in\P
2152	TOK	phenylalanine		phenylalanine\N5S
2153	TOK	largely		largely\DGA7
2154	TOK	circumvents		circumvent\VMFDRS3
2155	TOK	the		the\AT---6
2156	TOK	neurological		neurological\JA
2157	TOK	damage		damage\N5S
2158	TOK	in		in\P
2159	TOK	classic		classic\JA
##	TAG	<name>
2160	TOK	PKU		PKU\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2161	TOK	Phenylketonuric	BOS	phenylketonuric\JA
2162	TOK	children		child\N5P
2163	TOK	are		be\V6FDR66
2164	TOK	normal		normal\JA
2165	TOK	at		at\P
2166	TOK	birth		birth\N5S
2167	TOK	because		because\CS
2168	TOK	the		the\AT---6
2169	TOK	maternal		maternal\JA
2170	TOK	enzyme		enzyme\N5S
2171	TOK	protects		protect\VMFDRS3
2172	TOK	them		them\RPP3NA
2173	TOK	during		during\P
2174	TOK	prenatal		prenatal\JA
2175	TOK	life		life\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2176	TOK	The	BOS	the\AT---6
2177	TOK	results		result\N5P
2178	TOK	of		of\P
2179	TOK	treatment		treatment\N5S
2180	TOK	are		be\V6FDR66
2181	TOK	best		good\DDS7
2182	TOK	when		when\CS
2183	TOK	the		the\AT---6
2184	TOK	diagnosis		diagnosis\N5S
2185	TOK	is		be\V6FDRS3
2186	TOK	made		make\VMC----
2187	TOK	soon		soon\DGA7
2188	TOK	after		after\P
2189	TOK	birth		birth\N5S
2190	TOK	and		and\CC
2191	TOK	treatment		treatment\N5S
2192	TOK	is		be\V6FDRS3
2193	TOK	begun		begin\VMC----
2194	TOK	promptly		promptly\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2195	TOK	If	BOS	if\CS
2196	TOK	the		the\AT---6
2197	TOK	child		child\N5S
2198	TOK	is		be\V6FDRS3
2199	TOK	fed		feed\VMC----
2200	TOK	a		a\AI---S
2201	TOK	normal		normal\JA
2202	TOK	diet		diet\N5S
2203	TOK	in		in\P
2204	TOK	the		the\AT---6
2205	TOK	first		first\MOS
2206	TOK	months		month\N5P
2207	TOK	of		of\P
2208	TOK	life		life\N5S
---	DLD	,		=\DELIM
2209	TOK	irreversible		irreversible\JA
2210	TOK	mental		mental\JA
2211	TOK	retardation		retardation\N5S
2212	TOK	occurs		occur\VMFDRS3
---	DLD	;		=\DELIM
2213	TOK	the		the\AT---6
2214	TOK	degree		degree\N5S
2215	TOK	of		of\P
2216	TOK	intellectual		intellectual\JA
2217	TOK	deficit		deficit\N5S
2218	TOK	is		be\V6FDRS3
2219	TOK	directly		directly\DGA7
2220	TOK	related		relate\VMC----
2221	TOK	to		to\P
2222	TOK	the		the\AT---6
2223	TOK	delay		delay\N5S
2224	TOK	in		in\P
2225	TOK	the		the\AT---6
2226	TOK	institution		institution\N5S
2227	TOK	of		of\P
2228	TOK	the		the\AT---6
2229	TOK	low		low\JA
---	DLI	-		=\DELIM
2230	TOK	phenylalanine		phenylalanine\N5S
2231	TOK	diet		diet\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2232	TOK	The	BOS	the\AT---6
2233	TOK	normal		normal\JA
2234	TOK	mental		mental\JA
2235	TOK	status		status\N5S
2236	TOK	of		of\P
2237	TOK	patients		patient\N5P
2238	TOK	with		with\P
2239	TOK	benign		benign\JA
2240	TOK	hyperphenylalaninemia		hyperphenylalaninemia\N5S
2241	TOK	demonstrates		demonstrate\VMFDRS3
2242	TOK	that		that\CS
2243	TOK	effective		effective\JA
2244	TOK	treatment		treatment\N5S
2245	TOK	of		of\P
2246	TOK	classic		classic\JA
##	TAG	<name>
2247	TOK	PKU		PKU\N46
##	TAG	</name>
2248	TOK	can		can\VOFDR66
2249	TOK	be		be\VMI----
2250	TOK	achieved		achieve\VMC----
2251	TOK	if		if\CS
2252	TOK	the		the\AT---6
2253	TOK	phenylalanine		phenylalanine\N5S
2254	TOK	levels		level\N5P
2255	TOK	can		can\VOFDR66
2256	TOK	be		be\VMI----
2257	TOK	kept		keep\VMC----
2258	TOK	below		below\DGA7
2259	TOK	about		about\P
##	TAG	<num>
2260	TOK	0.7		0.7\X
##	TAG	</num>
2261	TOK	mM		mM\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2262	TOK	Without	BOS	without\P
2263	TOK	this		this\AD---S
2264	TOK	guidance		guidance\N5S
2265	TOK	from		from\P
2266	TOK	nature		nature\N5S
---	DLD	,		=\DELIM
2267	TOK	many		many\AI---P
2268	TOK	clinical		clinical\JA
2269	TOK	trials		trial\N5P
2270	TOK	would		will\VOFDA66
2271	TOK	have		have\VMI----
2272	TOK	been		be\VMC----
2273	TOK	required		require\VMC----
2274	TOK	to		to\P
2275	TOK	establish		establish\VMI----
2276	TOK	a		a\AI---S
---	DLE	"		=\DELIM
2277	TOK	safe		safe\JA
---	DLD	"		=\DELIM
2278	TOK	plasma		plasma\N5S
2279	TOK	phenylalanine		phenylalanine\N5S
2280	TOK	level		level\N5S
2281	TOK	in		in\P
2282	TOK	the		the\AT---6
2283	TOK	classic		classic\JA
2284	TOK	disease		disease\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2285	TOK	It	BOS	it\RPS3N6
2286	TOK	is		be\V6FDRS3
2287	TOK	now		now\DGA7
2288	TOK	recommended		recommend\VMC----
2289	TOK	that		that\CS
2290	TOK	patients		patient\N5P
2291	TOK	with		with\P
##	TAG	<name>
2292	TOK	PKU		PKU\N46
##	TAG	</name>
2293	TOK	remain		remain\VMF6R66
2294	TOK	on		on\P
2295	TOK	a		a\AI---S
2296	TOK	low		low\JA
2297	TOK	phenylalanine		phenylalanine\N5S
2298	TOK	diet		diet\N5S
2299	TOK	for		for\P
2300	TOK	life		life\N5S
2301	TOK	because		because\CS
2302	TOK	neurological		neurological\JA
2303	TOK	and		and\CC
2304	TOK	behavioral		behavioral\JA
2305	TOK	abnormalities		abnormality\N5P
2306	TOK	develop		develop\VMF6R66
2307	TOK	in		in\P
2308	TOK	many		many\AI---P
---	DLE	(		=\DELIM
2309	TOK	though		though\DGA7
2310	TOK	not		not\DGA7
2311	TOK	all		all\AG---6
---	DLD	)		=\DELIM
2312	TOK	patients		patient\N5P
2313	TOK	if		if\CS
2314	TOK	the		the\AT---6
2315	TOK	diet		diet\N5S
2316	TOK	is		be\V6FDRS3
2317	TOK	stopped		stop\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2318	TOK	However	BOS	however\DGA7
---	DLD	,		=\DELIM
2319	TOK	even		even\DGA7
2320	TOK	in		in\P
2321	TOK	patients		patient\N5P
2322	TOK	who		who\RW63N-
2323	TOK	have		have\V6F6R66
2324	TOK	been		be\VMC----
2325	TOK	treated		treat\VMC----
2326	TOK	throughout		throughout\P
2327	TOK	life		life\N5S
---	DLD	,		=\DELIM
2328	TOK	it		it\RPS3N6
2329	TOK	is		be\V6FDRS3
2330	TOK	now		now\DGA7
2331	TOK	clear		clear\JA
2332	TOK	that		that\CS
2333	TOK	even		even\DGA7
2334	TOK	when		when\CS
2335	TOK	the		the\AT---6
##	TAG	<name>
2336	TOK	IQ		IQ\N46
##	TAG	</name>
2337	TOK	is		be\V6FDRS3
2338	TOK	normal		normal\JA
2339	TOK	or		or\CC
2340	TOK	near		near\JA
2341	TOK	normal		normal\JA
---	DLD	,		=\DELIM
2342	TOK	there		there\DGA7
2343	TOK	are		be\V6FDR66
2344	TOK	neuropsychological		neuropsychological\JA
2345	TOK	deficits		deficit\N5P
---	DLE	(		=\DELIM
##	TAG	<abbr>
2346	TOK	e.g.		e.g.\N5P
##	TAG	</abbr>
---	DLE	,		=\DELIM
2347	TOK	in		in\P
2348	TOK	conceptual		conceptual\JA
---	DLD	,		=\DELIM
2349	TOK	visuospatial		visuospatial\JA
---	DLD	,		=\DELIM
2350	TOK	and		and\CC
2351	TOK	language		language\N5S
2352	TOK	skills		skill\N5P
---	DLD	)		=\DELIM
---	DLD	,		=\DELIM
2353	TOK	although		although\CS
2354	TOK	treatment		treatment\N5S
2355	TOK	produces		produce\VMFDRS3
2356	TOK	results		result\N5P
2357	TOK	vastly		vastly\DGA7
2358	TOK	superior		superior\JA
2359	TOK	to		to\P
2360	TOK	the		the\AT---6
2361	TOK	outcome		outcome\N5S
2362	TOK	without		without\P
2363	TOK	treatment		treatment\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
2364	TOK	Figure	BOS	figure\N5S
##	TAG	<num>
2365	TOK	2	EOS	2\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
2367	TOK	The	BOS	the\AT---6
2368	TOK	various		various\JA
2369	TOK	levels		level\N5P
2370	TOK	of		of\P
2371	TOK	treatment		treatment\N5S
2372	TOK	that		that\RW63N6
2373	TOK	are		be\V6FDR66
2374	TOK	relevant		relevant\JA
2375	TOK	to		to\P
2376	TOK	genetic		genetic\JA
2377	TOK	disease		disease\N5S
---	DLD	,		=\DELIM
2378	TOK	with		with\P
2379	TOK	the		the\AT---6
2380	TOK	corresponding		corresponding\JA
2381	TOK	strategies		strategy\N5P
2382	TOK	used		use\VMC----
2383	TOK	at		at\P
2384	TOK	each		each\AG---S
2385	TOK	level	EOS	level\N5S
##	TAG	</head>
##	TAG	<head>
2386	TOK	Table	BOS	table\N5S
tf	TOK		EOS	=\DELS
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
2388	TOK	Level	BOS	level\N5S
2389	TOK	of		of\P
2390	TOK	intervention		intervention\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2391	TOK	Mutant	BOS	mutant\N5S
2392	TOK	gene		gene\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2393	TOK	Mutant	BOS	mutant\N5S
2394	TOK	mRNA		mRNA\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2395	TOK	Mutant	BOS	mutant\N5S
2396	TOK	protein		protein\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2397	TOK	Metabolic	BOS	metabolic\JA
2398	TOK	or		or\CC
2399	TOK	other		other\JA
2400	TOK	biochemical		biochemical\JA
2401	TOK	dysfunction		dysfunction\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2403	TOK	Clinical	BOS	clinical\JA
2404	TOK	phenotype		phenotype\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2405	TOK	The	BOS	the\AT---6
2406	TOK	family		family\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2408	TOK	Treatment	BOS	treatment\N5S
2409	TOK	strategy		strategy\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2410	TOK	Modification	BOS	modification\N5S
2411	TOK	of		of\P
2412	TOK	the		the\AT---6
2413	TOK	somatic		somatic\JA
2414	TOK	genotype		genotype\N5S
---	DLE	(		=\DELIM
2415	TOK	transplantation		transplantation\N5S
---	DLD	;		=\DELIM
2416	TOK	gene		gene\N5S
2417	TOK	transfer		transfer\N5S
2418	TOK	therapy		therapy\N5S
2419	TOK	in		in\P
2420	TOK	near		near\JA
2421	TOK	future		future\N5S
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2422	TOK	Pharmacologic	BOS	pharmacologic\JA
2423	TOK	modulation		modulation\N5S
2424	TOK	of		of\P
2425	TOK	gene		gene\N5S
2426	TOK	expression		expression\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2427	TOK	Protein	BOS	protein\N5S
2428	TOK	replacement		replacement\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2429	TOK	Enhancement	BOS	enhancement\N5S
2430	TOK	of		of\P
2431	TOK	residual		residual\JA
2432	TOK	protein		protein\N5S
2433	TOK	function		function\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2434	TOK	Disease	BOS	disease\N5S
---	DLI	-		=\DELIM
2435	TOK	specific		specific\JA
2436	TOK	compensation		compensation\N5S
---	DLE	(		=\DELIM
2437	TOK	dietary		dietary\JA
2438	TOK	or		or\CC
2439	TOK	pharmacologic		pharmacologic\JA
---	DLD	)		=\DELIM
2440	TOK	in		in\P
2441	TOK	selected		select\VMC----
2442	TOK	patients		patient\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2443	TOK	Medical	BOS	medical\JA
2444	TOK	or		or\CC
2445	TOK	surgical		surgical\JA
2446	TOK	intervention		intervention\N5S
---	DLD	;		=\DELIM
2447	TOK	patient		patient\N5S
2448	TOK	education		education\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2449	TOK	Genetic	BOS	genetic\JA
2450	TOK	counseling		counsel\VMG----
---	DLD	;		=\DELIM
2451	TOK	carrier		carrier\N5S
2452	TOK	screening		screen\VMG----
---	DLD	;		=\DELIM
2453	TOK	presymptomatic		presymptomatic\JA
2454	TOK	diagnosis		diagnosis\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
2455	TOK	Table	BOS	table\VMF6R66
##	TAG	<num>
2456	TOK	1	EOS	1\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
2458	TOK	Treatment	BOS	treatment\N5S
2459	TOK	of		of\P
##	TAG	<name pos="N46" type="other">
2460	TOK	Genetic Disease		Genetic_Disease\N46
##	TAG	</name>
2461	TOK	by		by\P
##	TAG	<name>
2462	TOK	Metabolic Manipulation	EOS	Metabolic_Manipulation\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
2464	TOK	Type	BOS	type\N5S
2465	TOK	of		of\P
##	TAG	<name>
2466	TOK	Metabolic Intervention		Metabolic_Intervention\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2467	TOK	Avoidance	BOS	avoidance\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2469	TOK	Dietary	BOS	dietary\JA
2470	TOK	restriction		restriction\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2471	TOK	Replacement	BOS	replacement\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2472	TOK	Diversion	BOS	diversion\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2473	TOK	Inhibition	BOS	inhibition\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2474	TOK	Depletion	BOS	depletion\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2475	TOK	Substance	BOS	substance\N5S
2476	TOK	or		or\CC
##	TAG	<name>
2477	TOK	Technique		Technique\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2478	TOK	Antimalarial	BOS	antimalarial\JA
2479	TOK	drugs		drug\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2480	TOK	Isoniazid	BOS	isoniazid\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2481	TOK	Phenylalanine	BOS	phenylalanine\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2482	TOK	Galactose	BOS	galactose\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2483	TOK	Thyroxine	BOS	thyroxine\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2484	TOK	Biotin	BOS	biotin\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2485	TOK	Sodium	BOS	sodium\N5S
2486	TOK	benzoate		benzoate\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2487	TOK	Oral	BOS	oral\JA
2488	TOK	resins		resin\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2489	TOK	Lovastatin	BOS	lovastatin\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2490	TOK	Plasma	BOS	plasma\N5S
2491	TOK	exchange		exchange\N5S
2492	TOK	therapy		therapy\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2493	TOK	Example	BOS	example\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
2494	TOK	G6PD	BOS	G6PD\N46
##	TAG	</name>
2495	TOK	deficiency		deficiency\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2496	TOK	Slow	BOS	slow\JA
2497	TOK	acetylators		acetylator\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
2498	TOK	PKU	BOS	PKU\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2499	TOK	Galactosemia	BOS	galactosemia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2501	TOK	Congenital	BOS	congenital\JA
2502	TOK	hypothyroidism		hypothyroidism\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
2503	TOK	Biotinidase	BOS	Biotinidase\N46
##	TAG	</name>
2504	TOK	deficiency		deficiency\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2505	TOK	Urea	BOS	urea\N5S
2506	TOK	cycle		cycle\N5S
2507	TOK	disorders		disorder\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2508	TOK	Familial	BOS	familial\JA
2509	TOK	hypercholesterolemia		hypercholesterolemia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2510	TOK	Familial	BOS	familial\JA
2511	TOK	hypercholesterolemia		hypercholesterolemia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2513	TOK	Familial	BOS	familial\JA
2514	TOK	hypercholesterolemia		hypercholesterolemia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
2515	TOK	Replacement	BOS	replacement\N5S
tf	TOK		EOS	=\DELS
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
2517	TOK	The	BOS	the\AT---6
2518	TOK	provision		provision\N5S
2519	TOK	of		of\P
2520	TOK	essential		essential\JA
2521	TOK	metabolites		metabolite\N5P
---	DLD	,		=\DELIM
2522	TOK	cofactors		cofactor\N5P
---	DLD	,		=\DELIM
2523	TOK	or		or\CC
2524	TOK	hormones		hormone\N5P
2525	TOK	whose		whose\AW---6
2526	TOK	deficiency		deficiency\N5S
2527	TOK	is		be\V6FDRS3
2528	TOK	due		due\JA
2529	TOK	to		to\P
2530	TOK	a		a\AI---S
2531	TOK	genetic		genetic\JA
2532	TOK	disease		disease\N5S
2533	TOK	is		be\V6FDRS3
2534	TOK	simple		simple\JA
2535	TOK	in		in\P
2536	TOK	concept		concept\N5S
2537	TOK	and		and\CC
2538	TOK	often		often\DGA7
2539	TOK	in		in\P
2540	TOK	application		application\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2541	TOK	Some	BOS	some\AG---6
2542	TOK	of		of\P
2543	TOK	the		the\AT---6
2544	TOK	most		most\DDS7
2545	TOK	successfully		successfully\DGA7
2546	TOK	treated		treat\VMC----
2547	TOK	singlegene		singlegene\JA
2548	TOK	defects		defect\N5P
2549	TOK	belong		belong\VMF6R66
2550	TOK	to		to\P
2551	TOK	this		this\AD---S
2552	TOK	category		category\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2553	TOK	An	BOS	an\AI---S
2554	TOK	important		important\JA
2555	TOK	example		example\N5S
2556	TOK	is		be\V6FDRS3
2557	TOK	congenital		congenital\JA
2558	TOK	hypothyroidism		hypothyroidism\N5S
---	DLE	,		=\DELIM
2559	TOK	which		which\RW63N-
2560	TOK	results		result\VMFDRS3
2561	TOK	from		from\P
2562	TOK	a		a\AI---S
2563	TOK	variety		variety\N5S
2564	TOK	of		of\P
2565	TOK	defects		defect\N5P
---	DLE	(		=\DELIM
##	TAG	<num>
2566	TOK	10		10\X
##	TAG	</num>
2567	TOK	to		to\P
##	TAG	<num>
2568	TOK	15		15\X
##	TAG	</num>
2569	TOK	percent		percent\N56
2570	TOK	of		of\P
2571	TOK	which		which\RW63N-
2572	TOK	are		be\V6FDR66
2573	TOK	genetic		genetic\JA
---	DLD	)		=\DELIM
2574	TOK	in		in\P
2575	TOK	the		the\AT---6
2576	TOK	formation		formation\N5S
2577	TOK	of		of\P
2578	TOK	the		the\AT---6
2579	TOK	thyroid		thyroid\N5S
2580	TOK	gland		gland\N5S
2581	TOK	or		or\CC
2582	TOK	of		of\P
2583	TOK	its		its\APS3N6
2584	TOK	major		major\JA
2585	TOK	product		product\N5S
---	DLD	,		=\DELIM
2586	TOK	thyroxine		thyroxine\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2587	TOK	Because	BOS	because\CS
2588	TOK	congenital		congenital\JA
2589	TOK	hypothyroidism		hypothyroidism\N5S
2590	TOK	is		be\V6FDRS3
2591	TOK	common		common\JA
---	DLE	(		=\DELIM
2592	TOK	about		about\P
##	TAG	<na type="function">
2593	TOK	1/4000		noanat\W
##	TAG	</na>
2594	TOK	neonates		neonate\N5P
---	DLD	)		=\DELIM
2595	TOK	and		and\CC
2596	TOK	treatment		treatment\N5S
2597	TOK	can		can\VOFDR66
2598	TOK	prevent		prevent\VMI----
2599	TOK	the		the\AT---6
2600	TOK	associated		associate\VMC----
2601	TOK	mental		mental\JA
2602	TOK	retardation		retardation\N5S
---	DLD	,		=\DELIM
2603	TOK	neonatal		neonatal\JA
2604	TOK	screening		screening\N5S
2605	TOK	is		be\V6FDRS3
2606	TOK	conducted		conduct\VMC----
2607	TOK	in		in\P
2608	TOK	many		many\AI---P
2609	TOK	countries		country\N5P
---	DLD	,		=\DELIM
2610	TOK	so		so\CC
2611	TOK	that		that\CS
2612	TOK	thyroxine		thyroxine\N5S
2613	TOK	administration		administration\N5S
2614	TOK	may		may\VOFDR66
2615	TOK	be		be\VMI----
2616	TOK	initiated		initiate\VMC----
2617	TOK	as		as\DGA7
2618	TOK	soon		soon\DGA7
2619	TOK	as		as\CS
2620	TOK	possible		possible\JA
2621	TOK	after		after\P
2622	TOK	birth		birth\N5S
2623	TOK	to		to\P
2624	TOK	prevent		prevent\VMI----
2625	TOK	the		the\AT---6
2626	TOK	severe		severe\JA
2627	TOK	intellectual		intellectual\JA
2628	TOK	defects		defect\N5P
2629	TOK	that		that\RW63N6
2630	TOK	are		be\V6FDR66
2631	TOK	otherwise		otherwise\DGA7
2632	TOK	inevitable		inevitable\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2633	TOK	In	BOS	in\P
2634	TOK	biotinidase		biotinidase\N5S
2635	TOK	deficiency		deficiency\N5S
---	DLE	,		=\DELIM
2636	TOK	the		the\AT---6
2637	TOK	enzymopathy		enzymopathy\N5S
2638	TOK	prevents		prevent\VMFDRS3
2639	TOK	the		the\AT---6
2640	TOK	recovery		recovery\N5S
2641	TOK	of		of\P
2642	TOK	biotin		biotin\N5S
2643	TOK	from		from\P
2644	TOK	biotinylated		biotinylated\JA
2645	TOK	proteins		protein\N5P
2646	TOK	and		and\CC
2647	TOK	thus		thus\DGA7
2648	TOK	prevents		prevent\VMFDRS3
2649	TOK	recycling		recycle\VMG----
2650	TOK	of		of\P
2651	TOK	this		this\AD---S
2652	TOK	enzyme		enzyme\N5S
2653	TOK	cofactor		cofactor\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2654	TOK	The	BOS	the\AT---6
2655	TOK	administration		administration\N5S
2656	TOK	of		of\P
2657	TOK	large		large\JA
2658	TOK	amounts		amount\N5P
2659	TOK	of		of\P
2660	TOK	biotin		biotin\N5S
2661	TOK	is		be\V6FDRS3
2662	TOK	completely		completely\DGA7
2663	TOK	corrective		corrective\JA
2664	TOK	if		if\CS
2665	TOK	given		give\VMC----
2666	TOK	before		before\P
2667	TOK	serious		serious\JA
2668	TOK	neurological		neurological\JA
2669	TOK	sequelae		sequela\N5P
2670	TOK	develop		develop\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
2671	TOK	GENETICS	BOS	genetics\N56
2672	TOK	OF		OF\N5S
2673	TOK	CANCER	EOS	cancer\N5S
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
2675	TOK	Cancer	BOS	cancer\N5S
2676	TOK	is		be\V6FDRS3
2677	TOK	one		one\MCS
2678	TOK	of		of\P
2679	TOK	the		the\AT---6
2680	TOK	most		most\DDS7
2681	TOK	common		common\JA
2682	TOK	and		and\CC
2683	TOK	severe		severe\JA
2684	TOK	problems		problem\N5P
2685	TOK	of		of\P
2686	TOK	clinical		clinical\JA
2687	TOK	medicine		medicine\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2688	TOK	Statistics	BOS	statistic\N5P
2689	TOK	show		show\VMF6R66
2690	TOK	that		that\CS
2691	TOK	cancer		cancer\N5S
2692	TOK	in		in\P
2693	TOK	some		some\AG---6
2694	TOK	form		form\N5S
2695	TOK	strikes		strike\VMFDRS3
2696	TOK	more		more\DDC7
2697	TOK	than		than\CS
2698	TOK	one		one\MCS
2699	TOK	third		third\MOS
2700	TOK	of		of\P
2701	TOK	the		the\AT---6
2702	TOK	population		population\N5S
---	DLD	,		=\DELIM
2703	TOK	accounts		account\N5P
2704	TOK	for		for\P
2705	TOK	more		more\DDC7
2706	TOK	than		than\CS
##	TAG	<num>
2707	TOK	20		20\X
##	TAG	</num>
2708	TOK	percent		percent\N56
2709	TOK	of		of\P
2710	TOK	all		all\AG---6
2711	TOK	deaths		death\N5P
---	DLD	,		=\DELIM
2712	TOK	and		and\CC
---	DLD	,		=\DELIM
2713	TOK	in		in\P
2714	TOK	developed		develop\VMC----
2715	TOK	countries		country\N5P
---	DLD	,		=\DELIM
2716	TOK	is		be\V6FDRS3
2717	TOK	responsible		responsible\JA
2718	TOK	for		for\P
2719	TOK	more		more\DDC7
2720	TOK	than		than\CS
##	TAG	<num>
2721	TOK	10		10\X
##	TAG	</num>
2722	TOK	percent		percent\N56
2723	TOK	of		of\P
2724	TOK	the		the\AT---6
2725	TOK	total		total\JA
2726	TOK	cost		cost\N5S
2727	TOK	of		of\P
2728	TOK	medical		medical\JA
2729	TOK	care		care\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2730	TOK	Cancer	BOS	cancer\N5S
2731	TOK	is		be\V6FDRS3
2732	TOK	not		not\DGA7
2733	TOK	a		a\AI---S
2734	TOK	single		single\JA
2735	TOK	disease		disease\N5S
2736	TOK	but		but\CC
2737	TOK	rather		rather\DGA7
2738	TOK	a		a\AI---S
2739	TOK	name		name\N5S
2740	TOK	applied		apply\VMC----
2741	TOK	to		to\P
2742	TOK	a		a\AI---S
2743	TOK	great		great\JA
2744	TOK	variety		variety\N5S
2745	TOK	of		of\P
2746	TOK	malignant		malignant\JA
2747	TOK	tumors		tumor\N5P
2748	TOK	that		that\RW63N6
2749	TOK	are		be\V6FDR66
2750	TOK	formed		form\VMC----
2751	TOK	by		by\P
2752	TOK	the		the\AT---6
2753	TOK	same		same\JA
2754	TOK	basic		basic\JA
2755	TOK	process		process\N5S
2756	TOK	of		of\P
2757	TOK	uncontrolled		uncontrolled\JA
2758	TOK	growth		growth\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2759	TOK	Cell	BOS	cell\N5S
2760	TOK	proliferation		proliferation\N5S
2761	TOK	results		result\N5P
2762	TOK	in		in\P
2763	TOK	a		a\AI---S
2764	TOK	mass		mass\N5S
---	DLE	(		=\DELIM
2765	TOK	neoplasm		neoplasm\N5S
2766	TOK	or		or\CC
2767	TOK	tumor		tumor\N5S
---	DLD	)		=\DELIM
2768	TOK	that		that\CS
2769	TOK	invades		invade\VMFDRS3
2770	TOK	neighboring		neighbor\VMG----
2771	TOK	tissues		tissue\N5P
---	DLE	(		=\DELIM
2772	TOK	hence		hence\DGA7
2773	TOK	the		the\AT---6
2774	TOK	name		name\N5S
2775	TOK	cancer		cancer\N5S
---	DLE	,		=\DELIM
2776	TOK	meaning		meaning\N5S
2777	TOK	crab		crab\VMF6R66
---	DLD	)		=\DELIM
2778	TOK	and		and\CC
2779	TOK	may		may\VOFDR66
2780	TOK	also		also\DGA7
2781	TOK	metastasize		metastasize\VMI----
2782	TOK	to		to\P
2783	TOK	more		more\DDC7
2784	TOK	distant		distant\JA
2785	TOK	sites		site\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2786	TOK	The	BOS	the\AT---6
2787	TOK	growth		growth\N5S
2788	TOK	is		be\V6FDRS3
2789	TOK	autonomous		autonomous\JA
---	DLD	,		=\DELIM
2790	TOK	increasingly		increasingly\DGA7
2791	TOK	malignant		malignant\JA
---	DLD	,		=\DELIM
2792	TOK	and		and\CC
---	DLD	,		=\DELIM
2793	TOK	if		if\CS
2794	TOK	untreated		untreated\JA
---	DLD	,		=\DELIM
2795	TOK	invariably		invariably\DGA7
2796	TOK	fatal		fatal\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2797	TOK	Early	BOS	early\JA
2798	TOK	diagnosis		diagnosis\N5S
2799	TOK	and		and\CC
2800	TOK	early		early\JA
2801	TOK	treatment		treatment\N5S
2802	TOK	are		be\V6FDR66
2803	TOK	vital		vital\JA
---	DLD	,		=\DELIM
2804	TOK	and		and\CC
2805	TOK	identification		identification\N5S
2806	TOK	of		of\P
2807	TOK	persons		person\N5P
2808	TOK	at		at\P
2809	TOK	increased		increase\VMC----
2810	TOK	risk		risk\N5S
2811	TOK	of		of\P
2812	TOK	cancer		cancer\N5S
2813	TOK	before		before\P
2814	TOK	its		its\APS3N6
2815	TOK	development		development\N5S
2816	TOK	is		be\V6FDRS3
2817	TOK	an		an\AI---S
2818	TOK	important		important\JA
2819	TOK	objective		objective\N5S
2820	TOK	of		of\P
2821	TOK	cancer		cancer\N5S
2822	TOK	research		research\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
2823	TOK	A	BOS	a\AI---S
2824	TOK	tumor		tumor\N5S
2825	TOK	is		be\V6FDRS3
2826	TOK	composed		compose\VMC----
2827	TOK	of		of\P
2828	TOK	a		a\AI---S
2829	TOK	parenchyma		parenchyma\N5S
2830	TOK	of		of\P
2831	TOK	proliferating		proliferate\VMG----
2832	TOK	cells		cell\N5P
---	DLD	,		=\DELIM
2833	TOK	with		with\P
2834	TOK	a		a\AI---S
2835	TOK	stroma		stroma\N5S
2836	TOK	of		of\P
2837	TOK	connective		connective\JA
2838	TOK	tissue		tissue\N5S
2839	TOK	and		and\CC
2840	TOK	blood		blood\N5S
2841	TOK	vessels		vessel\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2842	TOK	There	BOS	there\DGA7
2843	TOK	are		be\V6FDR66
##	TAG	<num>
2844	TOK	three		three\X
##	TAG	</num>
2845	TOK	main		main\JA
2846	TOK	forms		form\N5P
---	DLD	:		=\DELIM
2847	TOK	sarcomas		sarcoma\N5P
---	DLE	,		=\DELIM
2848	TOK	in		in\P
2849	TOK	which		which\RW63N-
2850	TOK	the		the\AT---6
2851	TOK	tumor		tumor\N5S
2852	TOK	has		have\V6FDRS3
2853	TOK	arisen		arise\VMC----
2854	TOK	in		in\P
2855	TOK	mesenchymal		mesenchymal\JA
2856	TOK	tissue		tissue\N5S
---	DLD	;		=\DELIM
2857	TOK	carcinomas		carcinoma\N5P
---	DLE	,		=\DELIM
2858	TOK	which		which\RW63N-
2859	TOK	originate		originate\VMF6R66
2860	TOK	in		in\P
2861	TOK	epithelial		epithelial\JA
2862	TOK	tissue		tissue\N5S
---	DLD	;		=\DELIM
2863	TOK	and		and\CC
2864	TOK	hematopoietic		hematopoietic\JA
2865	TOK	and		and\CC
2866	TOK	lymphoid		lymphoid\JA
2867	TOK	malignancies		malignancy\N5P
2868	TOK	such		such\RIS3N-
2869	TOK	as		as\P
2870	TOK	leukemias		leukemia\N5P
2871	TOK	and		and\CC
2872	TOK	lymphomas		lymphoma\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2873	TOK	Within	BOS	within\P
2874	TOK	the		the\AT---6
2875	TOK	major		major\JA
2876	TOK	groups		group\N5P
---	DLD	,		=\DELIM
2877	TOK	tumors		tumor\N5P
2878	TOK	are		be\V6FDR66
2879	TOK	classified		classify\VMC----
2880	TOK	by		by\P
2881	TOK	site		site\N5S
---	DLD	,		=\DELIM
2882	TOK	tissue		tissue\N5S
2883	TOK	type		type\VMF6R66
---	DLD	,		=\DELIM
2884	TOK	and		and\CC
2885	TOK	degree		degree\N5S
2886	TOK	of		of\P
2887	TOK	malignancy		malignancy\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2888	TOK	Most	BOS	most\AG---6
2889	TOK	cancers		cancer\N5P
2890	TOK	are		be\V6FDR66
2891	TOK	disorders		disorder\N5P
2892	TOK	of		of\P
2893	TOK	later		late\JC
2894	TOK	life		life\N5S
---	DLD	,		=\DELIM
2895	TOK	but		but\CC
2896	TOK	some		some\DGA7
2897	TOK	are		be\V6FDR66
2898	TOK	characteristic		characteristic\JA
2899	TOK	of		of\P
2900	TOK	childhood		childhood\N5S
2901	TOK	or		or\CC
2902	TOK	may		may\VOFDR66
2903	TOK	exhibit		exhibit\VMI----
2904	TOK	a		a\AI---S
2905	TOK	greater		great\JC
2906	TOK	degree		degree\N5S
2907	TOK	of		of\P
2908	TOK	malignancy		malignancy\N5S
2909	TOK	if		if\CS
2910	TOK	they		they\RPP3NN
2911	TOK	occur		occur\VMF6R66
2912	TOK	in		in\P
2913	TOK	younger		young\JC
2914	TOK	persons		person\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
2915	TOK	THE	BOS	the\AT---6
2916	TOK	GENETIC		GENETIC\N5S
2917	TOK	NATURE		nature\N5S
2918	TOK	OF		OF\N5S
2919	TOK	CANCER	EOS	cancer\N5S
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
2921	TOK	The	BOS	the\AT---6
2922	TOK	concept		concept\N5S
2923	TOK	of		of\P
2924	TOK	cancer		cancer\N5S
2925	TOK	as		as\P
2926	TOK	a		a\AI---S
2927	TOK	genetic		genetic\JA
2928	TOK	disease		disease\N5S
2929	TOK	is		be\V6FDRS3
2930	TOK	relatively		relatively\DGA7
2931	TOK	new		new\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2932	TOK	Perhaps	BOS	perhaps\DGA7
##	TAG	<num>
2933	TOK	5		5\X
##	TAG	</num>
2934	TOK	percent		percent\N56
2935	TOK	of		of\P
2936	TOK	all		all\AG---6
2937	TOK	cancers		cancer\N5P
2938	TOK	appear		appear\VMF6R66
2939	TOK	to		to\P
2940	TOK	follow		follow\VMI----
2941	TOK	a		a\AI---S
2942	TOK	familial		familial\JA
2943	TOK	pattern		pattern\N5S
---	DLD	;		=\DELIM
2944	TOK	in		in\P
2945	TOK	the		the\AT---6
2946	TOK	great		great\JA
2947	TOK	majority		majority\N5S
---	DLD	,		=\DELIM
2948	TOK	however		however\DGA7
---	DLD	,		=\DELIM
2949	TOK	inheritance		inheritance\N5S
2950	TOK	seems		seem\VMFDRS3
2951	TOK	to		to\P
2952	TOK	play		play\VMI----
##	TAG	<loc pos="DGA7">
2953	TOK	little or no		little_or_no\DGA7
##	TAG	</loc>
2954	TOK	part		part\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2955	TOK	Nevertheless	BOS	nevertheless\DGA7
---	DLD	,		=\DELIM
2956	TOK	many		many\AI---P
2957	TOK	cancers		cancer\N5P
---	DLD	,		=\DELIM
2958	TOK	like		like\P
2959	TOK	other		other\JA
2960	TOK	diseases		disease\N5P
2961	TOK	that		that\RW63N6
2962	TOK	show		show\VMF6R66
2963	TOK	features		feature\N5P
2964	TOK	of		of\P
2965	TOK	multifactorial		multifactorial\JA
2966	TOK	inheritance		inheritance\N5S
---	DLD	,		=\DELIM
2967	TOK	have		have\VMI----
2968	TOK	a		a\AI---S
2969	TOK	significant		significant\JA
2970	TOK	genetic		genetic\JA
2971	TOK	component		component\N5S
2972	TOK	in		in\P
2973	TOK	that		that\AD---S
2974	TOK	certain		certain\JA
2975	TOK	people		people\N56
2976	TOK	are		be\V6FDR66
2977	TOK	more		more\DDC7
2978	TOK	susceptible		susceptible\JA
2979	TOK	to		to\P
2980	TOK	developing		develop\VMG----
2981	TOK	a		a\AI---S
2982	TOK	particular		particular\JA
2983	TOK	malignancy		malignancy\N5S
2984	TOK	as		as\P
2985	TOK	a		a\AI---S
2986	TOK	result		result\N5S
2987	TOK	of		of\P
2988	TOK	genetic		genetic\JA
2989	TOK	defects		defect\N5P
2990	TOK	that		that\RW63N6
2991	TOK	predispose		predispose\VMF6R66
2992	TOK	to		to\P
2993	TOK	cancer		cancer\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
2994	TOK	Furthermore	BOS	furthermore\DGA7
---	DLD	,		=\DELIM
2995	TOK	it		it\RPS3N6
2996	TOK	has		have\V6FDRS3
2997	TOK	become		become\VMC----
2998	TOK	apparent		apparent\JA
2999	TOK	that		that\CS
3000	TOK	essentially		essentially\DGA7
3001	TOK	all		all\AG---6
3002	TOK	cancer		cancer\N5S
---	DLI	-		=\DELIM
3003	TOK	even		even\DGA7
3004	TOK	in		in\P
3005	TOK	the		the\AT---6
3006	TOK	absence		absence\N5S
3007	TOK	of		of\P
3008	TOK	any		any\AG---6
3009	TOK	apparent		apparent\JA
3010	TOK	inherited		inherit\VMC----
3011	TOK	component		component\N5S
---	DLI	-		=\DELIM
3012	TOK	is		be\V6FDRS3
3013	TOK	the		the\AT---6
3014	TOK	result		result\N5S
3015	TOK	of		of\P
3016	TOK	mutations		mutation\N5P
3017	TOK	in		in\P
3018	TOK	somatic		somatic\JA
3019	TOK	cells		cell\N5P
3020	TOK	and		and\CC
3021	TOK	that		that\CS
3022	TOK	its		its\APS3N6
3023	TOK	progression		progression\N5S
3024	TOK	also		also\DGA7
3025	TOK	involves		involve\VMFDRS3
3026	TOK	the		the\AT---6
3027	TOK	expression		expression\N5S
3028	TOK	of		of\P
3029	TOK	a		a\AI---S
3030	TOK	series		series\N56
3031	TOK	of		of\P
3032	TOK	genes		gene\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3033	TOK	In	BOS	in\P
3034	TOK	the		the\AT---6
3035	TOK	past		past\JA
---	DLD	,		=\DELIM
3036	TOK	viruses		virus\N5P
3037	TOK	and		and\CC
3038	TOK	exposure		exposure\N5S
3039	TOK	to		to\P
3040	TOK	environmental		environmental\JA
3041	TOK	agents		agent\N5P
3042	TOK	such		such\RIS3N-
3043	TOK	as		as\P
3044	TOK	ionizing		ionize\VMG----
3045	TOK	radiation		radiation\N5S
3046	TOK	were		be\V6F-A66
3047	TOK	blamed		blame\VMC----
3048	TOK	for		for\P
3049	TOK	most		most\AG---6
3050	TOK	cancers		cancer\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3051	TOK	It	BOS	it\RPS3N6
3052	TOK	is		be\V6FDRS3
3053	TOK	now		now\DGA7
3054	TOK	recognized		recognize\VMC----
3055	TOK	that		that\CS
3056	TOK	the		the\AT---6
3057	TOK	underlying		underlying\JA
3058	TOK	cause		cause\N5S
3059	TOK	is		be\V6FDRS3
3060	TOK	gene		gene\N5S
3061	TOK	mutation		mutation\N5S
3062	TOK	and		and\CC
3063	TOK	that		that\CS
3064	TOK	when		when\CS
3065	TOK	carcinogenic		carcinogenic\JA
3066	TOK	agents		agent\N5P
3067	TOK	are		be\V6FDR66
3068	TOK	involved		involve\VMC----
---	DLD	,		=\DELIM
3069	TOK	they		they\RPP3NN
3070	TOK	operate		operate\VMF6R66
3071	TOK	by		by\P
3072	TOK	causing		cause\VMG----
3073	TOK	mutation		mutation\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3074	TOK	The	BOS	the\AT---6
3075	TOK	mutations		mutation\N5P
3076	TOK	that		that\RW63N6
3077	TOK	lead		lead\VMF6R66
3078	TOK	to		to\P
3079	TOK	cancer		cancer\N5S
3080	TOK	affect		affect\VMF6R66
3081	TOK	genes		gene\N5P
3082	TOK	responsible		responsible\JA
3083	TOK	for		for\P
3084	TOK	cell		cell\N5S
3085	TOK	proliferation		proliferation\N5S
---	DLD	,		=\DELIM
3086	TOK	cell		cell\N5S
3087	TOK	development		development\N5S
---	DLD	,		=\DELIM
3088	TOK	and		and\CC
3089	TOK	other		other\JA
3090	TOK	fundamental		fundamental\JA
3091	TOK	cellular		cellular\JA
3092	TOK	activities		activity\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3093	TOK	When	BOS	when\CS
3094	TOK	normal		normal\JA
3095	TOK	regulation		regulation\N5S
3096	TOK	is		be\V6FDRS3
3097	TOK	altered		alter\VMC----
---	DLD	,		=\DELIM
3098	TOK	uncontrolled		uncontrolled\JA
3099	TOK	growth		growth\N5S
3100	TOK	is		be\V6FDRS3
3101	TOK	initiated		initiate\VMC----
3102	TOK	and		and\CC
3103	TOK	a		a\AI---S
3104	TOK	malignant		malignant\JA
3105	TOK	tumor		tumor\N5S
3106	TOK	develops		develop\VMFDRS3
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3107	TOK	The	BOS	the\AT---6
3108	TOK	understanding		understanding\N5S
3109	TOK	of		of\P
3110	TOK	the		the\AT---6
3111	TOK	genetic		genetic\JA
3112	TOK	basis		basis\N5S
3113	TOK	of		of\P
3114	TOK	cancer		cancer\N5S
3115	TOK	that		that\RW63N6
3116	TOK	has		have\V6FDRS3
3117	TOK	begun		begin\VMC----
3118	TOK	to		to\P
3119	TOK	emerge		emerge\VMI----
3120	TOK	after		after\P
3121	TOK	many		many\AI---P
3122	TOK	decades		decade\N5P
3123	TOK	of		of\P
3124	TOK	investigation		investigation\N5S
3125	TOK	has		have\V6FDRS3
3126	TOK	come		come\VMC----
3127	TOK	about		about\DGA7
3128	TOK	largely		largely\DGA7
3129	TOK	through		through\P
3130	TOK	the		the\AT---6
3131	TOK	application		application\N5S
3132	TOK	of		of\P
3133	TOK	molecular		molecular\JA
3134	TOK	genetics		genetics\N56
3135	TOK	to		to\P
3136	TOK	the		the\AT---6
3137	TOK	analysis		analysis\N5S
3138	TOK	of		of\P
3139	TOK	various		various\JA
3140	TOK	forms		form\N5P
3141	TOK	of		of\P
3142	TOK	malignant		malignant\JA
3143	TOK	disease		disease\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3144	TOK	As	BOS	as\DGA7
3145	TOK	so		so\CC
3146	TOK	often		often\DGA7
3147	TOK	happens		happen\VMFDRS3
3148	TOK	in		in\P
3149	TOK	medical		medical\JA
3150	TOK	genetics		genetics\N56
---	DLD	,		=\DELIM
3151	TOK	the		the\AT---6
3152	TOK	abnormal		abnormal\JA
3153	TOK	has		have\V6FDRS3
3154	TOK	provided		provide\VMC----
3155	TOK	insight		insight\N5S
3156	TOK	into		into\P
3157	TOK	the		the\AT---6
3158	TOK	normal		normal\JA
---	DLD	:		=\DELIM
3159	TOK	learning		learning\N5S
3160	TOK	what		what\RW63N-
3161	TOK	goes		go\VMFDRS3
3162	TOK	wrong		wrong\JA
3163	TOK	in		in\P
3164	TOK	cancer		cancer\N5S
3165	TOK	has		have\V6FDRS3
3166	TOK	also		also\DGA7
3167	TOK	helped		help\VMC----
3168	TOK	to		to\P
3169	TOK	clarify		clarify\VMI----
3170	TOK	the		the\AT---6
3171	TOK	genetic		genetic\JA
3172	TOK	control		control\N5S
3173	TOK	of		of\P
3174	TOK	many		many\AI---P
3175	TOK	aspects		aspect\N5P
3176	TOK	of		of\P
3177	TOK	normal		normal\JA
3178	TOK	cell		cell\N5S
3179	TOK	growth		growth\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3180	TOK	The	BOS	the\AT---6
3181	TOK	field		field\N5S
3182	TOK	of		of\P
3183	TOK	cancer		cancer\N5S
3184	TOK	genetics		genetics\N56
3185	TOK	is		be\V6FDRS3
3186	TOK	one		one\MCS
3187	TOK	of		of\P
3188	TOK	the		the\AT---6
3189	TOK	fastest		fast\JS
3190	TOK	moving		move\VMG----
3191	TOK	in		in\P
3192	TOK	biology		biology\N5S
3193	TOK	and		and\CC
3194	TOK	medicine		medicine\N5S
3195	TOK	today		today\DGA7
---	DLD	,		=\DELIM
3196	TOK	and		and\CC
3197	TOK	our		our\APP1N6
3198	TOK	understanding		understanding\N5S
3199	TOK	of		of\P
3200	TOK	cancer		cancer\N5S
3201	TOK	mechanisms		mechanism\N5P
3202	TOK	is		be\V6FDRS3
3203	TOK	increasing		increase\VMG----
3204	TOK	rapidly		rapidly\DGA7
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3205	TOK	Although	BOS	although\CS
3206	TOK	much		much\DGA7
3207	TOK	remains		remain\VMFDRS3
3208	TOK	to		to\P
3209	TOK	be		be\VMI----
3210	TOK	learned		learn\VMF6A66
---	DLD	,		=\DELIM
3211	TOK	the		the\AT---6
3212	TOK	outlines		outline\N5P
3213	TOK	of		of\P
3214	TOK	a		a\AI---S
3215	TOK	unifying		unify\VMG----
3216	TOK	hypothesis		hypothesis\N5S
3217	TOK	are		be\V6FDR66
3218	TOK	beginning		begin\VMG----
3219	TOK	to		to\P
3220	TOK	emerge		emerge\VMI----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3221	TOK	In	BOS	in\P
3222	TOK	this		this\AD---S
3223	TOK	chapter		chapter\N5S
3224	TOK	we		we\RPP1NN
3225	TOK	consider		consider\VMF6R66
3226	TOK	the		the\AT---6
3227	TOK	current		current\JA
3228	TOK	state		state\N5S
3229	TOK	of		of\P
3230	TOK	knowledge		knowledge\N5S
3231	TOK	of		of\P
3232	TOK	the		the\AT---6
3233	TOK	genetic		genetic\JA
3234	TOK	basis		basis\N5S
3235	TOK	of		of\P
3236	TOK	cancer		cancer\N5S
---	DLD	,		=\DELIM
3237	TOK	including		including\P
3238	TOK	the		the\AT---6
3239	TOK	role		role\N5S
3240	TOK	of		of\P
3241	TOK	specific		specific\JA
3242	TOK	genes		gene\N5P
3243	TOK	in		in\P
3244	TOK	causing		cause\VMG----
3245	TOK	both		both\RIP3N-
3246	TOK	inherited		inherit\VMC----
3247	TOK	and		and\CC
3248	TOK	sporadic		sporadic\JA
3249	TOK	cancers		cancer\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
3250	TOK	The	BOS	the\AT---6
##	TAG	<name>
3251	TOK	Clonal Nature of Cancer	EOS	Clonal_Nature_of_Cancer\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
3253	TOK	There	BOS	there\DGA7
3254	TOK	is		be\V6FDRS3
3255	TOK	strong		strong\JA
3256	TOK	evidence		evidence\N5S
3257	TOK	that		that\CS
3258	TOK	a		a\AI---S
3259	TOK	tumor		tumor\N5S
3260	TOK	is		be\V6FDRS3
3261	TOK	a		a\AI---S
3262	TOK	clone		clone\N5S
3263	TOK	of		of\P
3264	TOK	cells		cell\N5P
3265	TOK	derived		derive\VMC----
3266	TOK	from		from\P
3267	TOK	a		a\AI---S
3268	TOK	single		single\JA
3269	TOK	ancestral		ancestral\JA
3270	TOK	cell		cell\N5S
3271	TOK	in		in\P
3272	TOK	which		which\RW63N-
3273	TOK	the		the\AT---6
3274	TOK	initiating		initiate\VMG----
3275	TOK	event		event\N5S
---	DLE	(		=\DELIM
3276	TOK	a		a\AI---S
3277	TOK	somatic		somatic\JA
3278	TOK	mutation		mutation\N5S
---	DLD	)		=\DELIM
3279	TOK	has		have\V6FDRS3
3280	TOK	taken		take\VMC----
3281	TOK	place		place\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3282	TOK	The	BOS	the\AT---6
3283	TOK	clonal		clonal\JA
3284	TOK	nature		nature\N5S
3285	TOK	of		of\P
3286	TOK	tumors		tumor\N5P
3287	TOK	has		have\V6FDRS3
3288	TOK	been		be\VMC----
3289	TOK	recognized		recognize\VMC----
3290	TOK	for		for\P
3291	TOK	many		many\AI---P
3292	TOK	years		year\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3293	TOK	The	BOS	the\AT---6
3294	TOK	original		original\JA
3295	TOK	evidence		evidence\N5S
3296	TOK	came		come\VMF6A66
3297	TOK	from		from\P
3298	TOK	the		the\AT---6
3299	TOK	study		study\N5S
3300	TOK	of		of\P
3301	TOK	tumors		tumor\N5P
3302	TOK	in		in\P
3303	TOK	women		woman\N5P
3304	TOK	heterozygous		heterozygous\JA
3305	TOK	for		for\P
3306	TOK	the		the\AT---6
##	TAG	<name>
3307	TOK	X-linked		X-linked\N46
##	TAG	</name>
3308	TOK	enzyme		enzyme\N5S
3309	TOK	glucose		glucose\N5S
---	DLD	-		=\DELIM
##	TAG	<num>
3310	TOK	6		6\X
##	TAG	</num>
---	DLE	-		=\DELIM
3311	TOK	phosphate		phosphate\N5S
3312	TOK	dehydrogenase		dehydrogenase\N5S
---	DLE	(		=\DELIM
##	TAG	<name>
3313	TOK	G6PD		G6PD\N46
##	TAG	</name>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3314	TOK	As	BOS	as\CS
3315	TOK	previously		previously\DGA7
3316	TOK	discussed		discuss\VMF6A66
---	DLD	,		=\DELIM
##	TAG	<loc pos="P">
3317	TOK	because of		because_of\P
##	TAG	</loc>
3318	TOK	X		x\N5S
3319	TOK	inactivation		inactivation\N5S
---	DLD	,		=\DELIM
3320	TOK	only		only\DGA7
3321	TOK	one		one\MCS
3322	TOK	of		of\P
3323	TOK	a		a\AI---S
3324	TOK	pair		pair\N56
3325	TOK	of		of\P
##	TAG	<name>
3326	TOK	X-linked		X-linked\N46
##	TAG	</name>
3327	TOK	alleles		allele\N5P
3328	TOK	in		in\P
3329	TOK	a		a\AI---S
3330	TOK	female		female\N5S
3331	TOK	heterozygote		heterozygote\N5S
3332	TOK	is		be\V6FDRS3
3333	TOK	expressed		express\VMC----
3334	TOK	in		in\P
3335	TOK	a		a\AI---S
3336	TOK	somatic		somatic\JA
3337	TOK	cell		cell\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3338	TOK	Cell	BOS	cell\N5S
3339	TOK	lines		line\N5P
3340	TOK	derived		derive\VMC----
3341	TOK	from		from\P
3342	TOK	tumors		tumor\N5P
3343	TOK	in		in\P
3344	TOK	these		this\AD---P
3345	TOK	women		woman\N5P
3346	TOK	expressed		express\VMF6A66
3347	TOK	one		one\MCS
3348	TOK	or		or\CC
3349	TOK	the		the\AT---6
3350	TOK	other		other\JA
##	TAG	<name>
3351	TOK	G6PD		G6PD\N46
##	TAG	</name>
3352	TOK	allele		allele\N5S
3353	TOK	but		but\CC
3354	TOK	not		not\DGA7
3355	TOK	both		both\RIP3N-
---	DLD	,		=\DELIM
3356	TOK	indicating		indicate\VMG----
3357	TOK	that		that\CS
3358	TOK	each		each\AG---S
3359	TOK	tumor		tumor\N5S
3360	TOK	had		have\V6F6A66
3361	TOK	grown		grow\VMC----
3362	TOK	from		from\P
3363	TOK	a		a\AI---S
3364	TOK	single		single\JA
3365	TOK	cell		cell\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3366	TOK	The	BOS	the\AT---6
3367	TOK	characteristic		characteristic\JA
3368	TOK	chromosomal		chromosomal\JA
3369	TOK	rearrangements		rearrangement\N5P
3370	TOK	in		in\P
3371	TOK	many		many\AI---P
3372	TOK	types		type\N5P
3373	TOK	of		of\P
3374	TOK	cancer		cancer\N5S
---	DLD	,		=\DELIM
3375	TOK	such		such\JA
3376	TOK	as		as\P
3377	TOK	the		the\AT---6
3378	TOK	translocations		translocation\N5P
3379	TOK	seen		see\VMC----
3380	TOK	in		in\P
##	TAG	<name>
3381	TOK	Burkitt		Burkitt\N46
##	TAG	</name>
3382	TOK	lymphoma		lymphoma\N5S
3383	TOK	and		and\CC
3384	TOK	in		in\P
3385	TOK	chronic		chronic\JA
3386	TOK	myelogenous		myelogenous\JA
3387	TOK	leukemia		leukemia\N5S
---	DLE	(		=\DELIM
3388	TOK	to		to\P
3389	TOK	be		be\VMI----
3390	TOK	described		describe\VMC----
3391	TOK	later		later\DGC7
---	DLD	)		=\DELIM
---	DLD	,		=\DELIM
3392	TOK	also		also\DGA7
3393	TOK	indicate		indicate\VMF6R66
3394	TOK	that		that\CS
3395	TOK	these		this\AD---P
3396	TOK	malignancies		malignancy\N5P
3397	TOK	are		be\V6FDR66
3398	TOK	of		of\P
3399	TOK	single		single\JA
---	DLI	-		=\DELIM
3400	TOK	cell		cell\N5S
3401	TOK	origin		origin\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
##	TAG	<num>
3402	TOK	TWO	BOS	TWO\X
##	TAG	</num>
3403	TOK	KINDS		kind\N5P
3404	TOK	OF		OF\N5S
3405	TOK	CANCER		cancer\N5S
3406	TOK	GENES	EOS	gene\N5P
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
3408	TOK	Genes	BOS	gene\N5P
3409	TOK	that		that\RW63N6
3410	TOK	cause		cause\VMF6R66
3411	TOK	cancer		cancer\N5S
3412	TOK	are		be\V6FDR66
3413	TOK	of		of\P
##	TAG	<num>
3414	TOK	two		two\X
##	TAG	</num>
3415	TOK	distinct		distinct\JA
3416	TOK	types		type\N5P
---	DLD	:		=\DELIM
3417	TOK	oncogenes		oncogene\N5P
3418	TOK	and		and\CC
3419	TOK	tumor		tumor\N5S
---	DLI	-		=\DELIM
3420	TOK	suppressor		suppressor\N5S
3421	TOK	genes		gene\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3422	TOK	The	BOS	the\AT---6
##	TAG	<num>
3423	TOK	two		two\X
##	TAG	</num>
3424	TOK	types		type\N5P
3425	TOK	have		have\V6F6R66
3426	TOK	opposite		opposite\JA
3427	TOK	effects		effect\N5P
3428	TOK	in		in\P
3429	TOK	carcinogenesis		carcinogenesis\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3430	TOK	Oncogenes	BOS	oncogene\N5P
3431	TOK	facilitate		facilitate\VMF6R66
3432	TOK	malignant		malignant\JA
3433	TOK	transformation		transformation\N5S
---	DLD	,		=\DELIM
3434	TOK	whereas		whereas\CS
3435	TOK	tumor		tumor\N5S
---	DLI	-		=\DELIM
3436	TOK	suppressor		suppressor\N5S
3437	TOK	genes		gene\N5P
---	DLD	,		=\DELIM
3438	TOK	as		as\P
3439	TOK	the		the\AT---6
3440	TOK	name		name\N5S
3441	TOK	implies		imply\VMFDRS3
---	DLD	,		=\DELIM
3442	TOK	block		block\N5S
3443	TOK	tumor		tumor\N5S
3444	TOK	development		development\N5S
3445	TOK	by		by\P
3446	TOK	regulating		regulate\VMG----
3447	TOK	genes		gene\N5P
3448	TOK	involved		involve\VMC----
3449	TOK	in		in\P
3450	TOK	cell		cell\N5S
3451	TOK	growth		growth\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
3452	TOK	Figure	BOS	figure\N5S
##	TAG	<num>
3453	TOK	1	EOS	1\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
3455	TOK	General	BOS	general\JA
3456	TOK	scheme		scheme\N5S
3457	TOK	for		for\P
3458	TOK	mechanisms		mechanism\N5P
3459	TOK	of		of\P
3460	TOK	oncogenesis		oncogenesis\N5S
3461	TOK	by		by\P
3462	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
3463	TOK	oncogene		oncogene\N5S
3464	TOK	activation		activation\N5S
3465	TOK	and		and\CC
3466	TOK	mutation		mutation\N5S
3467	TOK	or		or\CC
3468	TOK	loss		loss\N5S
3469	TOK	of		of\P
3470	TOK	tumor		tumor\N5S
3471	TOK	suppressor		suppressor\N5S
3472	TOK	genes		gene\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3473	TOK	Cell	BOS	cell\N5S
3474	TOK	growth		growth\N5S
3475	TOK	and		and\CC
3476	TOK	proliferation		proliferation\N5S
3477	TOK	is		be\V6FDRS3
3478	TOK	stimulated		stimulate\VMC----
3479	TOK	by		by\P
3480	TOK	the		the\AT---6
3481	TOK	products		product\N5P
3482	TOK	of		of\P
3483	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
3484	TOK	oncogenes		oncogene\N5P
3485	TOK	and		and\CC
3486	TOK	is		be\V6FDRS3
3487	TOK	under		under\P
3488	TOK	the		the\AT---6
3489	TOK	negative		negative\JA
3490	TOK	control		control\N5S
3491	TOK	of		of\P
3492	TOK	tumor		tumor\N5S
---	DLI	-		=\DELIM
3493	TOK	suppressor		suppressor\N5S
3494	TOK	genes		gene\N5P
3495	TOK	that		that\RW63N6
3496	TOK	prevent		prevent\VMF6R66
3497	TOK	overgrowth		overgrowth\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3498	TOK	Action	BOS	action\N5S
3499	TOK	of		of\P
3500	TOK	oncogenes		oncogene\N5P
3501	TOK	is		be\V6FDRS3
3502	TOK	dominant		dominant\JA
3503	TOK	and		and\CC
3504	TOK	requires		require\VMFDRS3
3505	TOK	only		only\DGA7
3506	TOK	a		a\AI---S
3507	TOK	single		single\JA
3508	TOK	mutation		mutation\N5S
---	DLD	,		=\DELIM
3509	TOK	leading		leading\JA
3510	TOK	to		to\P
3511	TOK	uncontrolled		uncontrolled\JA
3512	TOK	cell		cell\N5S
3513	TOK	growth		growth\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3514	TOK	Action	BOS	action\N5S
3515	TOK	of		of\P
3516	TOK	tumor		tumor\N5S
---	DLI	-		=\DELIM
3517	TOK	suppressor		suppressor\N5S
3518	TOK	genes		gene\N5P
3519	TOK	is		be\V6FDRS3
3520	TOK	recessive		recessive\JA
---	DLD	;		=\DELIM
3521	TOK	when		when\CS
3522	TOK	bath		bath\N5S
3523	TOK	alleles		allele\N5P
3524	TOK	are		be\V6FDR66
3525	TOK	mutated		mutate\VMC----
3526	TOK	or		or\CC
3527	TOK	lost		lose\VMF6A66
---	DLD	,		=\DELIM
3528	TOK	cell		cell\N5S
3529	TOK	growth		growth\N5S
3530	TOK	is		be\V6FDRS3
3531	TOK	unregulated		unregulated\JA
3532	TOK	and		and\CC
3533	TOK	leads		lead\VMFDRS3
3534	TOK	to		to\P
3535	TOK	tumor		tumor\N5S
3536	TOK	formation		formation\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3537	TOK	See	BOS	see\VMF6R66
3538	TOK	text		text\N5S
3539	TOK	for		for\P
3540	TOK	discussion		discussion\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
3541	TOK	Oncogenes	BOS	oncogene\N5P
tf	TOK		EOS	=\DELS
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
3543	TOK	Oncogenes	BOS	oncogene\N5P
3544	TOK	are		be\V6FDR66
3545	TOK	genes		gene\N5P
3546	TOK	that		that\RW63N6
3547	TOK	affect		affect\VMF6R66
3548	TOK	normal		normal\JA
3549	TOK	cell		cell\N5S
3550	TOK	growth		growth\N5S
3551	TOK	and		and\CC
3552	TOK	development		development\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3553	TOK	If	BOS	if\CS
3554	TOK	an		an\AI---S
3555	TOK	oncogene		oncogene\N5S
3556	TOK	is		be\V6FDRS3
3557	TOK	altered		alter\VMC----
3558	TOK	or		or\CC
3559	TOK	overexpressed		overexpressed\JA
---	DLD	,		=\DELIM
3560	TOK	either		either\CC
3561	TOK	as		as\CS
3562	TOK	a		a\AI---S
3563	TOK	result		result\N5S
3564	TOK	of		of\P
3565	TOK	a		a\AI---S
3566	TOK	mutation		mutation\N5S
3567	TOK	in		in\P
3568	TOK	the		the\AT---6
3569	TOK	gene		gene\N5S
3570	TOK	itself		itself\RXS3N-
3571	TOK	or		or\CC
3572	TOK	by		by\P
3573	TOK	altered		alter\VMC----
3574	TOK	external		external\JA
3575	TOK	control		control\N5S
---	DLD	,		=\DELIM
3576	TOK	the		the\AT---6
3577	TOK	cell		cell\N5S
3578	TOK	in		in\P
3579	TOK	which		which\RW63N-
3580	TOK	the		the\AT---6
3581	TOK	change		change\N5S
3582	TOK	occurred		occur\VMC----
3583	TOK	can		can\VOFDR66
3584	TOK	undergo		undergo\VMI----
3585	TOK	uncontrolled		uncontrolled\JA
3586	TOK	growth		growth\N5S
---	DLD	,		=\DELIM
3587	TOK	eventually		eventually\DGA7
3588	TOK	becoming		become\VMG----
3589	TOK	malignant		malignant\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3590	TOK	Most	BOS	most\AG---6
3591	TOK	oncogenes		oncogene\N5P
3592	TOK	are		be\V6FDR66
3593	TOK	mutated		mutate\VMC----
---	DLE	(		=\DELIM
---	DLE	"		=\DELIM
3594	TOK	activated		activate\VMF6A66
---	DLD	"		=\DELIM
---	DLD	)		=\DELIM
3595	TOK	forms		form\N5P
3596	TOK	of		of\P
3597	TOK	normal		normal\JA
3598	TOK	genes		gene\N5P
---	DLD	,		=\DELIM
3599	TOK	called		call\VMC----
3600	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
3601	TOK	oncogenes		oncogene\N5P
---	DLE	,		=\DELIM
3602	TOK	that		that\RW63N6
3603	TOK	are		be\V6FDR66
3604	TOK	involved		involve\VMC----
3605	TOK	in		in\P
3606	TOK	the		the\AT---6
3607	TOK	control		control\N5S
3608	TOK	of		of\P
3609	TOK	cell		cell\N5S
3610	TOK	proliferation		proliferation\N5S
3611	TOK	and		and\CC
3612	TOK	differentiation		differentiation\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3613	TOK	Oncogenes	BOS	oncogene\N5P
3614	TOK	can		can\VOFDR66
3615	TOK	be		be\VMI----
3616	TOK	identified		identify\VMC----
3617	TOK	experimentally		experimentally\DGA7
3618	TOK	in		in\P
##	TAG	<name>
3619	TOK	DNA		DNA\N46
##	TAG	</name>
3620	TOK	transfer		transfer\N5S
3621	TOK	studies		study\N5P
3622	TOK	by		by\P
3623	TOK	their		their\APP3N6
3624	TOK	ability		ability\N5S
3625	TOK	to		to\P
3626	TOK	transform		transform\VMI----
3627	TOK	a		a\AI---S
3628	TOK	nontumorigenic		nontumorigenic\JA
3629	TOK	mouse		mouse\N5S
3630	TOK	cell		cell\N5S
3631	TOK	line		line\N5S
3632	TOK	in		in\P
3633	TOK	culture		culture\N5S
3634	TOK	to		to\P
3635	TOK	generate		generate\VMI----
3636	TOK	foci		focus\N5P
3637	TOK	of		of\P
3638	TOK	cells		cell\N5P
3639	TOK	with		with\P
3640	TOK	tumorigenic		tumorigenic\JA
3641	TOK	properties		property\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3642	TOK	To	BOS	to\P
3643	TOK	date		date\VMI----
---	DLD	,		=\DELIM
3644	TOK	more		more\DDC7
3645	TOK	than		than\CS
##	TAG	<num>
3646	TOK	50		50\X
##	TAG	</num>
3647	TOK	human		human\JA
3648	TOK	oncogenes		oncogene\N5P
---	DLE	(		=\DELIM
3649	TOK	and		and\CC
3650	TOK	thus		thus\DGA7
3651	TOK	their		their\APP3N6
3652	TOK	normal		normal\JA
3653	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
3654	TOK	oncogenes		oncogene\N5P
---	DLD	)		=\DELIM
3655	TOK	have		have\VMI----
3656	TOK	been		be\VMC----
3657	TOK	identified		identify\VMF6A66
---	DLD	,		=\DELIM
3658	TOK	largely		largely\DGA7
3659	TOK	on		on\P
3660	TOK	the		the\AT---6
3661	TOK	basis		basis\N5S
3662	TOK	of		of\P
##	TAG	<name>
3663	TOK	DNA		DNA\N46
##	TAG	</name>
3664	TOK	transfection		transfection\N5S
3665	TOK	studies		study\N5P
3666	TOK	with		with\P
3667	TOK	genomic		genomic\JA
##	TAG	<name>
3668	TOK	DNA		DNA\N46
##	TAG	</name>
3669	TOK	from		from\P
3670	TOK	human		human\JA
3671	TOK	tumors		tumor\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3672	TOK	Examples	BOS	example\N5P
3673	TOK	of		of\P
3674	TOK	some		some\AG---6
3675	TOK	of		of\P
3676	TOK	these		this\AD---P
3677	TOK	oncogenes		oncogene\N5P
3678	TOK	are		be\V6FDR66
3679	TOK	given		give\VMC----
3680	TOK	in		in\P
##	TAG	<name>
3681	TOK	Table		Table\N46
##	TAG	</name>
##	TAG	<num>
3682	TOK	1		1\X
##	TAG	</num>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3683	TOK	It	BOS	it\RPS3N6
3684	TOK	is		be\V6FDRS3
3685	TOK	noteworthy		noteworthy\JA
3686	TOK	that		that\CS
3687	TOK	many		many\AI---P
---	DLE	(		=\DELIM
3688	TOK	but		but\CC
3689	TOK	not		not\DGA7
3690	TOK	all		all\AG---6
---	DLD	)		=\DELIM
3691	TOK	of		of\P
3692	TOK	the		the\AT---6
3693	TOK	oncogenes		oncogene\N5P
3694	TOK	identified		identify\VMC----
3695	TOK	in		in\P
3696	TOK	human		human\JA
3697	TOK	tumors		tumor\N5P
3698	TOK	have		have\V6F6R66
3699	TOK	turned		turn\VMC----
3700	TOK	out		out\DGA7
3701	TOK	to		to\P
3702	TOK	be		be\VMI----
3703	TOK	related		relate\VMC----
3704	TOK	to		to\P
3705	TOK	viral		viral\JA
3706	TOK	oncogenes		oncogene\N5P
3707	TOK	previously		previously\DGA7
3708	TOK	isolated		isolate\VMC----
3709	TOK	from		from\P
##	TAG	<name>
3710	TOK	RNA		RNA\N46
##	TAG	</name>
3711	TOK	tumor		tumor\N5S
3712	TOK	viruses		virus\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3713	TOK	The	BOS	the\AT---6
3714	TOK	demonstration		demonstration\N5S
3715	TOK	that		that\CS
3716	TOK	genetic		genetic\JA
3717	TOK	information		information\N5S
3718	TOK	from		from\P
3719	TOK	a		a\AI---S
3720	TOK	virus		virus\N5S
3721	TOK	could		can\VOFDA66
3722	TOK	change		change\VMI----
3723	TOK	a		a\AI---S
3724	TOK	normal		normal\JA
3725	TOK	cell		cell\N5S
3726	TOK	into		into\P
3727	TOK	a		a\AI---S
3728	TOK	malignant		malignant\JA
3729	TOK	one		one\RIS3N-
3730	TOK	established		establish\VMC----
3731	TOK	that		that\CS
3732	TOK	genes		gene\N5P
3733	TOK	could		can\VOFDA66
3734	TOK	act		act\VMI----
3735	TOK	as		as\P
3736	TOK	central		central\JA
3737	TOK	controllers		controller\N5P
3738	TOK	of		of\P
3739	TOK	malignant		malignant\JA
3740	TOK	conversion		conversion\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
3741	TOK	RNA	BOS	RNA\N46
##	TAG	</name>
3742	TOK	viruses		virus\N5P
3743	TOK	known		know\VMC----
3744	TOK	as		as\P
3745	TOK	retroviruses		retrovirus\N5P
3746	TOK	have		have\V6F6R66
3747	TOK	the		the\AT---6
3748	TOK	unique		unique\JA
3749	TOK	property		property\N5S
3750	TOK	of		of\P
3751	TOK	transcribing		transcribe\VMG----
##	TAG	<name>
3752	TOK	RNA		RNA\N46
##	TAG	</name>
3753	TOK	into		into\P
##	TAG	<name>
3754	TOK	DNA		DNA\N46
##	TAG	</name>
---	DLE	,		=\DELIM
3755	TOK	using		use\VMG----
3756	TOK	the		the\AT---6
3757	TOK	enzyme		enzyme\N5S
3758	TOK	reverse		reverse\JA
3759	TOK	transcriptase		transcriptase\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3760	TOK	The	BOS	the\AT---6
3761	TOK	viral		viral\JA
##	TAG	<name>
3762	TOK	DNA		DNA\N46
##	TAG	</name>
3763	TOK	can		can\VOFDR66
3764	TOK	then		then\DGA7
3765	TOK	be		be\VMI----
3766	TOK	integrated		integrate\VMC----
3767	TOK	into		into\P
3768	TOK	the		the\AT---6
3769	TOK	chromosomal		chromosomal\JA
##	TAG	<name>
3770	TOK	DNA		DNA\N46
##	TAG	</name>
3771	TOK	of		of\P
3772	TOK	the		the\AT---6
3773	TOK	host		host\N5S
3774	TOK	and		and\CC
3775	TOK	expressed		express\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3776	TOK	When	BOS	when\CS
3777	TOK	the		the\AT---6
3778	TOK	so		so\DGA7
---	DLI	-		=\DELIM
3779	TOK	called		call\VMC----
3780	TOK	src		src\N5S
3781	TOK	oncogene		oncogene\N5S
---	DLE	(		=\DELIM
3782	TOK	transforming		transform\VMG----
3783	TOK	sequences		sequence\N5P
3784	TOK	from		from\P
3785	TOK	the		the\AT---6
##	TAG	<name>
3786	TOK	Rous		Rous\N46
##	TAG	</name>
3787	TOK	sarcoma		sarcoma\N5S
3788	TOK	virus		virus\N5S
---	DLD	)		=\DELIM
3789	TOK	was		be\V6F-A66
3790	TOK	characterized		characterize\VMC----
---	DLD	,		=\DELIM
3791	TOK	it		it\RPS3N6
3792	TOK	was		be\V6F-A66
3793	TOK	found		find\VMC----
3794	TOK	to		to\P
3795	TOK	be		be\VMI----
3796	TOK	not		not\DGA7
3797	TOK	a		a\AI---S
3798	TOK	true		true\JA
3799	TOK	viral		viral\JA
3800	TOK	gene		gene\N5S
3801	TOK	but		but\CC
---	DLD	'		=\DELIM
3802	TOK	a		a\AI---S
3803	TOK	host		host\N5S
3804	TOK	gene		gene\N5S
3805	TOK	that		that\RW63N6
3806	TOK	had		have\V6F6A66
3807	TOK	been		be\VMC----
3808	TOK	picked		pick\VMC----
3809	TOK	up		up\P
3810	TOK	by		by\P
3811	TOK	an		an\AI---S
3812	TOK	ancestor		ancestor\N5S
3813	TOK	of		of\P
3814	TOK	the		the\AT---6
3815	TOK	virus		virus\N5S
3816	TOK	through		through\P
3817	TOK	a		a\AI---S
3818	TOK	process		process\N5S
3819	TOK	termed		term\VMC----
3820	TOK	transduction		transduction\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3821	TOK	The	BOS	the\AT---6
3822	TOK	equivalent		equivalent\JA
3823	TOK	host		host\N5S
3824	TOK	gene		gene\N5S
3825	TOK	was		be\V6F-A66
3826	TOK	the		the\AT---6
3827	TOK	first		first\MOS
3828	TOK	proto		proto\N5S
---	DLI	-		=\DELIM
3829	TOK	oncogene		oncogene\N5S
3830	TOK	to		to\P
3831	TOK	be		be\VMI----
3832	TOK	recognized		recognize\VMF6A66
---	DLD	;		=\DELIM
3833	TOK	now		now\DGA7
---	DLD	,		=\DELIM
3834	TOK	as		as\DGA7
3835	TOK	mentioned		mention\VMC----
3836	TOK	before		before\P
---	DLD	,		=\DELIM
3837	TOK	it		it\RPS3N6
3838	TOK	is		be\V6FDRS3
3839	TOK	recognized		recognize\VMC----
3840	TOK	that		that\CS
3841	TOK	many		many\AI---P
3842	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
3843	TOK	oncogenes		oncogene\N5P
3844	TOK	are		be\V6FDR66
3845	TOK	related		relate\VMC----
3846	TOK	to		to\P
3847	TOK	specific		specific\JA
##	TAG	<name>
3848	TOK	RNA		RNA\N46
##	TAG	</name>
3849	TOK	tumor		tumor\N5S
3850	TOK	viruses		virus\N5P
---	DLE	(		=\DELIM
##	TAG	<name>
3851	TOK	Table		Table\N46
##	TAG	</name>
##	TAG	<na type="function">
3852	TOK	16-1		noanat\W
##	TAG	</na>
---	DLE	)		=\DELIM
---	DLD	.		=\DELIM
---	DLE	(		=\DELIM
##	TAG	<name>
3853	TOK	Unlike		Unlike\N46
##	TAG	</name>
3854	TOK	the		the\AT---6
3855	TOK	oncogenes		oncogene\N5P
3856	TOK	of		of\P
3857	TOK	retroviruses		retrovirus\N5P
---	DLD	,		=\DELIM
3858	TOK	the		the\AT---6
3859	TOK	oncogenes		oncogene\N5P
3860	TOK	of		of\P
##	TAG	<name>
3861	TOK	DNA		DNA\N46
##	TAG	</name>
3862	TOK	tumor		tumor\N5S
3863	TOK	viruses		virus\N5P
---	DLD	,		=\DELIM
3864	TOK	such		such\JA
3865	TOK	as		as\P
##	TAG	<name>
3866	TOK	Simian		Simian\N46
##	TAG	</name>
3867	TOK	virus		virus\N5S
##	TAG	<num>
3868	TOK	40		40\X
##	TAG	</num>
---	DLE	[		=\DELIM
##	TAG	<name>
3869	TOK	SV40		SV40\N46
##	TAG	</name>
---	DLD	]		=\DELIM
3870	TOK	and		and\CC
3871	TOK	polyoma		polyoma\N5S
3872	TOK	virus		virus\N5S
---	DLD	,		=\DELIM
3873	TOK	are		be\V6FDR66
3874	TOK	not		not\DGA7
3875	TOK	transduced		transduce\VMC----
3876	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
3877	TOK	oncogenes		oncogene\N5P
3878	TOK	but		but\CC
3879	TOK	are		be\V6FDR66
3880	TOK	viral		viral\JA
##	TAG	<abbr>
3881	TOK	genes.		genes.\N5P
##	TAG	</abbr>
---	DLE	)		=\DELIM
##	TAG	<name>
3882	TOK	Proto		Proto\N46
##	TAG	</name>
---	DLE	-		=\DELIM
3883	TOK	oncogenes		oncogene\N5P
3884	TOK	have		have\V6F6R66
3885	TOK	remained		remain\VMC----
3886	TOK	highly		highly\DGA7
3887	TOK	conserved		conserve\VMC----
3888	TOK	in		in\P
3889	TOK	evolution		evolution\N5S
---	DLD	;		=\DELIM
##	TAG	<loc pos="DGA7">
3890	TOK	for example		for_example\DGA7
##	TAG	</loc>
---	DLE	,		=\DELIM
3891	TOK	the		the\AT---6
3892	TOK	proto		proto\N5S
---	DLI	-		=\DELIM
3893	TOK	oncogene		oncogene\N5S
3894	TOK	H		H\N5P
---	DLD	-		=\DELIM
3895	TOK	ras		ras\N5S
---	DLE	(		=\DELIM
3896	TOK	so		so\DGA7
3897	TOK	named		name\VMC----
3898	TOK	because		because\CS
3899	TOK	it		it\RPS3N6
3900	TOK	was		be\V6F-A66
3901	TOK	originally		originally\DGA7
3902	TOK	identified		identify\VMC----
3903	TOK	in		in\P
3904	TOK	the		the\AT---6
##	TAG	<name>
3905	TOK	Harvey		Harvey\N46
##	TAG	</name>
3906	TOK	rat		rat\N5S
3907	TOK	sarcoma		sarcoma\N5S
3908	TOK	virus		virus\N5S
---	DLD	)		=\DELIM
3909	TOK	and		and\CC
3910	TOK	its		its\APS3N6
3911	TOK	corresponding		corresponding\JA
3912	TOK	protein		protein\N5S
3913	TOK	have		have\V6F6R66
3914	TOK	been		be\VMC----
3915	TOK	found		find\VMC----
3916	TOK	in		in\P
3917	TOK	organisms		organism\N5P
3918	TOK	as		as\P
3919	TOK	far		far\DGA7
3920	TOK	apart		apart\JA
3921	TOK	in		in\P
3922	TOK	the		the\AT---6
3923	TOK	evolutionary		evolutionary\JA
3924	TOK	scale		scale\N5S
3925	TOK	as		as\P
3926	TOK	humans		human\N5P
3927	TOK	and		and\CC
3928	TOK	yeast		yeast\N5S
---	DLD	,		=\DELIM
3929	TOK	suggesting		suggest\VMG----
3930	TOK	that		that\CS
3931	TOK	these		this\AD---P
3932	TOK	proteins		protein\N5P
3933	TOK	have		have\V6F6R66
3934	TOK	essential		essential\JA
3935	TOK	biological		biological\JA
3936	TOK	roles		role\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3937	TOK	The	BOS	the\AT---6
3938	TOK	various		various\JA
3939	TOK	roles		role\N5P
3940	TOK	of		of\P
3941	TOK	several		several\JA
3942	TOK	classes		class\N5P
3943	TOK	of		of\P
3944	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
3945	TOK	oncogene		oncogene\N5S
3946	TOK	in		in\P
3947	TOK	growth		growth\N5S
3948	TOK	regulation		regulation\N5S
3949	TOK	are		be\V6FDR66
3950	TOK	illustrated		illustrate\VMC----
3951	TOK	in		in\P
##	TAG	<name>
3952	TOK	Figure		Figure\N46
##	TAG	</name>
##	TAG	<num>
3953	TOK	2		2\X
##	TAG	</num>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
3954	TOK	Table	BOS	table\VMF6R66
##	TAG	<num>
3955	TOK	1	EOS	1\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
3957	TOK	Selected	BOS	select\VMC----
##	TAG	<name>
3958	TOK	Examples of Oncogenes	EOS	Examples_of_Oncogenes\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
3960	TOK	Oncogene	BOS	oncogene\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3961	TOK	Source	BOS	source\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3962	TOK	Map	BOS	map\N5S
##	TAG	<name>
3963	TOK	Location of Proto-Oncogene		Location_of_Proto-Oncogene\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
3964	TOK	Biochemical	BOS	biochemical\JA
##	TAG	<name>
3965	TOK	Property		Property\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3966	TOK	Signal	BOS	signal\N5S
##	TAG	<name>
3967	TOK	Transduction Proteins		Transduction_Proteins\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3968	TOK	Abelson	BOS	Abelson\N46
##	TAG	</name>
3969	TOK	murine		murine\JA
3970	TOK	leakemia		leakemia\N5S
3971	TOK	virus		virus\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3972	TOK	Rous	BOS	Rous\N46
##	TAG	</name>
3973	TOK	sarcoma		sarcoma\N5S
3974	TOK	virus		virus\N5S
---	DLE	(		=\DELIM
3975	TOK	chicken		chicken\N5S
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3976	TOK	Human	BOS	human\JA
3977	TOK	colon		colon\N5S
3978	TOK	carcinoma		carcinoma\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3979	TOK	Harvey	BOS	Harvey\N46
##	TAG	</name>
3980	TOK	rat		rat\N5S
3981	TOK	sarcoma		sarcoma\N5S
3982	TOK	virus		virus\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3983	TOK	Various	BOS	various\JA
3984	TOK	human		human\JA
3985	TOK	tumors		tumor\N5P
---	DLE	(		=\DELIM
3986	TOK	neuroblastomas		neuroblastoma\N5P
---	DLD	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
3987	TOK	Nucleur DNA-Binding Proteins	BOS	Nucleur_DNA-Binding_Proteins\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3988	TOK	xxx	BOS	noanat\W
##	TAG	<name>
3989	TOK	Chicken		Chicken\N46
##	TAG	</name>
3990	TOK	sarcoma		sarcoma\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3991	TOK	xxx	BOS	noanat\W
##	TAG	<name>
3992	TOK	Human		Human\N46
##	TAG	</name>
3993	TOK	neuroblastoma		neuroblastoma\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3994	TOK	Secreted	BOS	secrete\VMC----
##	TAG	<name>
3995	TOK	Growth Factors		Growth_Factors\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
3996	TOK	sis	BOS	si\N56
##	TAG	<name>
3997	TOK	Simian		Simian\N46
##	TAG	</name>
3998	TOK	sarcoma		sarcoma\N5S
3999	TOK	virus		virus\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4000	TOK	Growth	BOS	growth\N5S
##	TAG	<name>
4001	TOK	Factor Cell Surface Receptors		Factor_Cell_Surface_Receptors\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4002	TOK	xxx	BOS	noanat\W
##	TAG	<name>
4003	TOK	Avian		Avian\N46
##	TAG	</name>
4004	TOK	erythroblastosis		erythroblastosis\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4005	TOK	Binds	BOS	bind\VMFDRS3
##	TAG	<name>
4006	TOK	DNA		DNA\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4007	TOK	Unknown	BOS	unknown\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4008	TOK	ß-chain	BOS	ß-chain\N5S
4009	TOK	of		of\P
4010	TOK	platelet		platelet\N5S
---	DLI	-		=\DELIM
4011	TOK	derived		derive\VMC----
4012	TOK	growth		growth\N5S
4013	TOK	factor		factor\N5S
---	DLE	(		=\DELIM
##	TAG	<name>
4014	TOK	PDGF		PDGF\N46
##	TAG	</name>
---	DLE	)		=\DELIM
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4016	TOK	Steroid	BOS	steroid\N5S
4017	TOK	receptor		receptor\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
4018	TOK	Figure	BOS	figure\N5S
##	TAG	<num>
4019	TOK	2	EOS	2\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
4021	TOK	Signal	BOS	signal\N5S
4022	TOK	transduction		transduction\N5S
4023	TOK	and		and\CC
4024	TOK	growth		growth\N5S
4025	TOK	regulation		regulation\N5S
4026	TOK	by		by\P
4027	TOK	products		product\N5P
4028	TOK	of		of\P
4029	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
4030	TOK	oncogenes		oncogene\N5P
---	DLD	,		=\DELIM
4031	TOK	classified		classify\VMC----
4032	TOK	by		by\P
4033	TOK	their		their\APP3N6
4034	TOK	location		location\N5S
4035	TOK	and		and\CC
4036	TOK	function		function\N5S
4037	TOK	in		in\P
4038	TOK	the		the\AT---6
4039	TOK	cell		cell\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4040	TOK	Deregulation	BOS	deregulation\N5S
4041	TOK	of		of\P
4042	TOK	a		a\AI---S
4043	TOK	proto		proto\JA
---	DLI	-		=\DELIM
4044	TOK	oncogene		oncogene\N5S
4045	TOK	can		can\VOFDR66
4046	TOK	lead		lead\VMI----
4047	TOK	to		to\P
4048	TOK	malignant		malignant\JA
4049	TOK	transformation		transformation\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<num>
4050	TOK	1	BOS	1\X
##	TAG	</num>
4051	TOK	Secreted		Secreted\JA
4052	TOK	growth		growth\N5S
4053	TOK	factors		factor\N5P
---	DLD	,		=\DELIM
4054	TOK	such		such\JA
4055	TOK	as		as\P
##	TAG	<name>
4056	TOK	EGF		EGF\N46
##	TAG	</name>
---	DLE	(		=\DELIM
4057	TOK	embryonic		embryonic\JA
4058	TOK	growth		growth\N5S
4059	TOK	factor		factor\N5S
---	DLD	)		=\DELIM
4060	TOK	and		and\CC
##	TAG	<name>
4061	TOK	PDGF		PDGF\N46
##	TAG	</name>
---	DLE	(		=\DELIM
4062	TOK	platelet		platelet\N5S
---	DLI	-		=\DELIM
4063	TOK	derived		derive\VMC----
4064	TOK	growth		growth\N5S
4065	TOK	factor		factor\N5S
---	DLD	)		=\DELIM
##	TAG	<num>
4066	TOK	2		2\X
##	TAG	</num>
##	TAG	<name>
4067	TOK	Specific		Specific\N46
##	TAG	</name>
4068	TOK	receptors		receptor\N5P
4069	TOK	for		for\P
4070	TOK	the		the\AT---6
4071	TOK	secreted		secrete\VMC----
4072	TOK	growth		growth\N5S
4073	TOK	factors		factor\N5P
##	TAG	<num>
4074	TOK	3		3\X
##	TAG	</num>
##	TAG	<name>
4075	TOK	Cytoplasmic		Cytoplasmic\N46
##	TAG	</name>
4076	TOK	signal		signal\N5S
4077	TOK	transduction		transduction\N5S
4078	TOK	proteins		protein\N5P
4079	TOK	such		such\RIS3N-
4080	TOK	as		as\P
4081	TOK	ras		ras\N5S
---	DLE	,		=\DELIM
4082	TOK	src		src\N5P
---	DLE	,		=\DELIM
4083	TOK	and		and\CC
4084	TOK	abl		abl\N5P
---	DLE	,		=\DELIM
4085	TOK	which		which\RW63N-
4086	TOK	are		be\V6FDR66
4087	TOK	protein		protein\N5S
4088	TOK	kinases		kinase\N5P
4089	TOK	and		and\CC
##	TAG	<name>
4090	TOK	GTP		GTP\N46
##	TAG	</name>
---	DLE	-		=\DELIM
4091	TOK	binding		binding\N5S
4092	TOK	proteins		protein\N5P
##	TAG	<num>
4093	TOK	4		4\X
##	TAG	</num>
##	TAG	<name>
4094	TOK	Nuclear		Nuclear\N46
##	TAG	</name>
4095	TOK	proteins		protein\N5P
4096	TOK	such		such\RIS3N-
4097	TOK	as		as\P
4098	TOK	myc		myc\N5S
4099	TOK	interact		interact\VMF6R66
4100	TOK	with		with\P
4101	TOK	genes		gene\N5P
4102	TOK	by		by\P
##	TAG	<name>
4103	TOK	DNA		DNA\N46
##	TAG	</name>
4104	TOK	binding	EOS	binding\N5S
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
##	TAG	<name>
4105	TOK	Proto-Oncogene Activation	BOS	Proto-Oncogene_Activation\N46
##	TAG	</name>
tf	TOK		EOS	=\DELS
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
4107	TOK	An	BOS	an\AI---S
4108	TOK	important		important\JA
4109	TOK	early		early\JA
4110	TOK	finding		finding\N5S
4111	TOK	related		relate\VMC----
4112	TOK	to		to\P
4113	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
4114	TOK	oncogenes		oncogene\N5P
4115	TOK	came		come\VMF6A66
4116	TOK	from		from\P
4117	TOK	the		the\AT---6
4118	TOK	molecular		molecular\JA
4119	TOK	analysis		analysis\N5S
4120	TOK	of		of\P
4121	TOK	a		a\AI---S
4122	TOK	ras		ras\N5S
4123	TOK	oncogene		oncogene\N5S
4124	TOK	derived		derive\VMC----
4125	TOK	from		from\P
4126	TOK	a		a\AI---S
4127	TOK	bladder		bladder\N5S
4128	TOK	carcinoma		carcinoma\N5S
4129	TOK	cell		cell\N5S
4130	TOK	line		line\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4131	TOK	The	BOS	the\AT---6
4132	TOK	oncogene		oncogene\N5S
4133	TOK	and		and\CC
4134	TOK	its		its\APS3N6
4135	TOK	counterpart		counterpart\N5S
4136	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
4137	TOK	oncogene		oncogene\N5S
4138	TOK	differed		differ\VMF6A66
4139	TOK	in		in\P
4140	TOK	only		only\DGA7
4141	TOK	a		a\AI---S
4142	TOK	single		single\JA
4143	TOK	base		base\N5S
4144	TOK	pair		pair\N56
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4145	TOK	The	BOS	the\AT---6
4146	TOK	alteration		alteration\N5S
---	DLD	,		=\DELIM
4147	TOK	a		a\AI---S
4148	TOK	point		point\N5S
4149	TOK	mutation		mutation\N5S
4150	TOK	in		in\P
4151	TOK	a		a\AI---S
4152	TOK	somatic		somatic\JA
4153	TOK	cell		cell\N5S
4154	TOK	of		of\P
4155	TOK	the		the\AT---6
4156	TOK	tumor		tumor\N5S
---	DLD	,		=\DELIM
4157	TOK	led		lead\VMC----
4158	TOK	to		to\P
4159	TOK	synthesis		synthesis\N5S
4160	TOK	of		of\P
4161	TOK	an		an\AI---S
4162	TOK	abnormal		abnormal\JA
4163	TOK	gene		gene\N5S
4164	TOK	product		product\N5S
---	DLD	,		=\DELIM
4165	TOK	which		which\RW63N-
4166	TOK	was		be\V6F-A66
4167	TOK	able		able\JA
4168	TOK	to		to\P
4169	TOK	stimulate		stimulate\VMI----
4170	TOK	the		the\AT---6
4171	TOK	growth		growth\N5S
4172	TOK	of		of\P
4173	TOK	the		the\AT---6
4174	TOK	cell		cell\N5S
4175	TOK	line		line\N5S
---	DLD	,		=\DELIM
4176	TOK	changing		change\VMG----
4177	TOK	it		it\RPS3N6
4178	TOK	into		into\P
4179	TOK	a		a\AI---S
4180	TOK	tumor		tumor\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4181	TOK	Oncogenes	BOS	oncogene\N5P
4182	TOK	have		have\V6F6R66
4183	TOK	a		a\AI---S
4184	TOK	dominant		dominant\JA
4185	TOK	effect		effect\N5S
4186	TOK	at		at\P
4187	TOK	the		the\AT---6
4188	TOK	cellular		cellular\JA
4189	TOK	level		level\VMF6R66
---	DLD	;		=\DELIM
4190	TOK	that		that\CS
4191	TOK	is		be\V6FDRS3
---	DLD	,		=\DELIM
4192	TOK	when		when\CS
4193	TOK	activated		activate\VMC----
---	DLD	,		=\DELIM
4194	TOK	a		a\AI---S
4195	TOK	single		single\JA
4196	TOK	mutant		mutant\N5S
4197	TOK	allele		allele\N5S
4198	TOK	is		be\V6FDRS3
4199	TOK	sufficient		sufficient\JA
4200	TOK	to		to\P
4201	TOK	change		change\VMI----
4202	TOK	the		the\AT---6
4203	TOK	phenotype		phenotype\N5S
4204	TOK	of		of\P
4205	TOK	a		a\AI---S
4206	TOK	cell		cell\N5S
4207	TOK	from		from\P
4208	TOK	normal		normal\JA
4209	TOK	to		to\P
4210	TOK	malignant		malignant\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4211	TOK	Ras	BOS	ras\N5S
4212	TOK	point		point\N5S
4213	TOK	mutations		mutation\N5P
4214	TOK	are		be\V6FDR66
4215	TOK	observed		observe\VMC----
4216	TOK	in		in\P
4217	TOK	many		many\AI---P
4218	TOK	tumors		tumor\N5P
---	DLD	,		=\DELIM
4219	TOK	and		and\CC
4220	TOK	the		the\AT---6
4221	TOK	ras		ras\N5S
4222	TOK	genes		gene\N5P
4223	TOK	have		have\V6F6R66
4224	TOK	been		be\VMC----
4225	TOK	shown		show\VMC----
4226	TOK	experimentally		experimentally\DGA7
4227	TOK	to		to\P
4228	TOK	be		be\VMI----
4229	TOK	the		the\AT---6
4230	TOK	target		target\N5S
4231	TOK	of		of\P
4232	TOK	known		know\VMC----
4233	TOK	carcinogens		carcinogen\N5P
---	DLD	,		=\DELIM
4234	TOK	a		a\AI---S
4235	TOK	finding		finding\N5S
4236	TOK	that		that\RW63N6
4237	TOK	supports		support\VMFDRS3
4238	TOK	a		a\AI---S
4239	TOK	role		role\N5S
4240	TOK	for		for\P
4241	TOK	mutated		mutate\VMC----
4242	TOK	ras		ras\N5S
4243	TOK	genes		gene\N5P
4244	TOK	in		in\P
4245	TOK	the		the\AT---6
4246	TOK	development		development\N5S
4247	TOK	of		of\P
4248	TOK	many		many\AI---P
4249	TOK	cancers		cancer\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4250	TOK	Structural	BOS	structural\JA
4251	TOK	mutation		mutation\N5S
4252	TOK	is		be\V6FDRS3
4253	TOK	only		only\DGA7
4254	TOK	one		one\MCS
4255	TOK	of		of\P
4256	TOK	several		several\JA
4257	TOK	mechanisms		mechanism\N5P
4258	TOK	that		that\RW63N6
4259	TOK	can		can\VOFDR66
4260	TOK	induce		induce\VMI----
4261	TOK	activation		activation\N5S
4262	TOK	of		of\P
4263	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
4264	TOK	oncogenes		oncogene\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4265	TOK	Chromosomal	BOS	chromosomal\JA
4266	TOK	translocations		translocation\N5P
4267	TOK	are		be\V6FDR66
4268	TOK	a		a\AI---S
4269	TOK	common		common\JA
4270	TOK	mechanism		mechanism\N5S
4271	TOK	for		for\P
4272	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
4273	TOK	oncogene		oncogene\N5S
4274	TOK	activation		activation\N5S
4275	TOK	in		in\P
4276	TOK	a		a\AI---S
4277	TOK	variety		variety\N5S
4278	TOK	of		of\P
4279	TOK	cancers		cancer\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4280	TOK	In	BOS	in\P
4281	TOK	chronic		chronic\JA
4282	TOK	myelogenous		myelogenous\JA
4283	TOK	leukemia		leukemia\N5S
---	DLE	(		=\DELIM
##	TAG	<num>
4284	TOK	CML		CML\X
##	TAG	</num>
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
4285	TOK	which		which\RW63N-
4286	TOK	is		be\V6FDRS3
4287	TOK	discussed		discuss\VMC----
4288	TOK	in		in\P
4289	TOK	more		more\DDC7
4290	TOK	detail		detail\VMF6R66
4291	TOK	later		later\DGC7
---	DLD	,		=\DELIM
4292	TOK	increased		increase\VMC----
4293	TOK	expression		expression\N5S
4294	TOK	and		and\CC
4295	TOK	malignant		malignant\JA
4296	TOK	transformation		transformation\N5S
4297	TOK	are		be\V6FDR66
4298	TOK	related		relate\VMC----
4299	TOK	to		to\P
4300	TOK	the		the\AT---6
4301	TOK	translocation		translocation\N5S
4302	TOK	of		of\P
4303	TOK	the		the\AT---6
4304	TOK	abl		abl\N5S
4305	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
4306	TOK	oncogene		oncogene\N5S
4307	TOK	from		from\P
4308	TOK	its		its\APS3N6
4309	TOK	normal		normal\JA
4310	TOK	position		position\N5S
4311	TOK	on		on\P
4312	TOK	chromosome		chromosome\N5S
##	TAG	<num>
4313	TOK	9		9\X
##	TAG	</num>
4314	TOK	to		to\P
4315	TOK	the		the\AT---6
4316	TOK	breakpoint		breakpoint\N5S
4317	TOK	in		in\P
4318	TOK	chromosome		chromosome\N5S
##	TAG	<num>
4319	TOK	22		22\X
##	TAG	</num>
4320	TOK	in		in\P
4321	TOK	a		a\AI---S
4322	TOK	hematopoietic		hematopoietic\JA
4323	TOK	stem		stem\N5S
4324	TOK	cell		cell\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4325	TOK	The	BOS	the\AT---6
##	TAG	<num>
4326	TOK	9		9\X
##	TAG	</num>
---	DLD	;		=\DELIM
##	TAG	<num>
4327	TOK	22		22\X
##	TAG	</num>
4328	TOK	translocation		translocation\N5S
4329	TOK	directly		directly\DGA7
4330	TOK	contributes		contribute\VMFDRS3
4331	TOK	to		to\P
4332	TOK	the		the\AT---6
4333	TOK	development		development\N5S
4334	TOK	of		of\P
4335	TOK	the		the\AT---6
4336	TOK	malignant		malignant\JA
4337	TOK	phenotype		phenotype\N5S
4338	TOK	and		and\CC
4339	TOK	is		be\V6FDRS3
4340	TOK	also		also\DGA7
4341	TOK	a		a\AI---S
4342	TOK	strong		strong\JA
4343	TOK	diagnostic		diagnostic\JA
4344	TOK	indicator		indicator\N5S
4345	TOK	of		of\P
##	TAG	<num>
4346	TOK	CML		CML\X
##	TAG	</num>
---	DLE	,		=\DELIM
4347	TOK	as		as\P
4348	TOK	other		other\JA
4349	TOK	characteristic		characteristic\JA
4350	TOK	translocations		translocation\N5P
4351	TOK	are		be\V6FDR66
4352	TOK	in		in\P
4353	TOK	other		other\JA
4354	TOK	specific		specific\JA
4355	TOK	types		type\N5P
4356	TOK	of		of\P
4357	TOK	cancer		cancer\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4358	TOK	Cytogenetic	BOS	cytogenetic\JA
4359	TOK	changes		change\N5P
4360	TOK	are		be\V6FDR66
4361	TOK	hallmarks		hallmark\N5P
4362	TOK	of		of\P
4363	TOK	cancer		cancer\N5S
4364	TOK	and		and\CC
4365	TOK	are		be\V6FDR66
4366	TOK	much		much\DGA7
4367	TOK	more		more\DDC7
4368	TOK	common		common\JA
4369	TOK	in		in\P
4370	TOK	later		late\JC
4371	TOK	and		and\CC
4372	TOK	more		more\DDC7
4373	TOK	malignant		malignant\JA
4374	TOK	or		or\CC
4375	TOK	invasive		invasive\JA
4376	TOK	stages		stage\N5P
4377	TOK	than		than\CS
4378	TOK	in		in\P
4379	TOK	earlier		early\JC
4380	TOK	stages		stage\N5P
4381	TOK	of		of\P
4382	TOK	tumor		tumor\N5S
4383	TOK	development		development\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<loc pos="DGA7">
4384	TOK	So far	BOS	So_far\DGA7
##	TAG	</loc>
---	DLE	,		=\DELIM
4385	TOK	most		most\DDS7
4386	TOK	of		of\P
4387	TOK	the		the\AT---6
4388	TOK	cytogenetic		cytogenetic\JA
4389	TOK	studies		study\N5P
4390	TOK	of		of\P
4391	TOK	tumor		tumor\N5S
4392	TOK	progression		progression\N5S
4393	TOK	have		have\V6F6R66
4394	TOK	been		be\VMC----
4395	TOK	concerned		concern\VMC----
4396	TOK	with		with\P
4397	TOK	leukemias		leukemia\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4398	TOK	In	BOS	in\P
##	TAG	<num>
4399	TOK	CML		CML\X
##	TAG	</num>
---	DLE	,		=\DELIM
##	TAG	<loc pos="DGA7">
4400	TOK	for example		for_example\DGA7
##	TAG	</loc>
---	DLE	,		=\DELIM
4401	TOK	at		at\P
4402	TOK	the		the\AT---6
4403	TOK	blast		blast\N5S
4404	TOK	crisis		crisis\N5S
4405	TOK	stage		stage\VMF6R66
---	DLD	,		=\DELIM
4406	TOK	there		there\DGA7
4407	TOK	may		may\VOFDR66
4408	TOK	be		be\VMI----
4409	TOK	several		several\JA
4410	TOK	additional		additional\JA
4411	TOK	cytogenetic		cytogenetic\JA
4412	TOK	abnormalities		abnormality\N5P
---	DLD	,		=\DELIM
4413	TOK	including		including\P
4414	TOK	numerical		numerical\JA
4415	TOK	or		or\CC
4416	TOK	structural		structural\JA
4417	TOK	changes		change\N5P
---	DLD	,		=\DELIM
4418	TOK	such		such\JA
4419	TOK	as		as\P
4420	TOK	a		a\AI---S
4421	TOK	second		second\MOS
4422	TOK	copy		copy\N5S
4423	TOK	of		of\P
4424	TOK	the		the\AT---6
##	TAG	<num>
4425	TOK	9		9\X
##	TAG	</num>
---	DLD	;		=\DELIM
##	TAG	<num>
4426	TOK	22		22\X
##	TAG	</num>
4427	TOK	translocation		translocation\N5S
4428	TOK	chromosome		chromosome\N5S
4429	TOK	or		or\CC
4430	TOK	an		an\AI---S
4431	TOK	isochromosome		isochromosome\N5S
4432	TOK	for		for\P
##	TAG	<na type="code">
4433	TOK	17q		noanat\W
##	TAG	</na>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4434	TOK	In	BOS	in\P
4435	TOK	advanced		advance\VMC----
4436	TOK	stages		stage\N5P
4437	TOK	of		of\P
4438	TOK	other		other\JA
4439	TOK	forms		form\N5P
4440	TOK	of		of\P
4441	TOK	leukemia		leukemia\N5S
---	DLD	,		=\DELIM
4442	TOK	translocations		translocation\N5P
4443	TOK	are		be\V6FDR66
4444	TOK	common		common\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4445	TOK	A	BOS	a\AI---S
4446	TOK	focus		focus\N5S
4447	TOK	of		of\P
4448	TOK	cancer		cancer\N5S
4449	TOK	research		research\N5S
4450	TOK	is		be\V6FDRS3
4451	TOK	the		the\AT---6
4452	TOK	cytogenetic		cytogenetic\JA
4453	TOK	and		and\CC
4454	TOK	molecular		molecular\JA
4455	TOK	definition		definition\N5S
4456	TOK	of		of\P
4457	TOK	these		this\AD---P
4458	TOK	abnormalities		abnormality\N5P
---	DLD	,		=\DELIM
4459	TOK	many		many\AI---P
4460	TOK	of		of\P
4461	TOK	which		which\RW63N-
4462	TOK	are		be\V6FDR66
4463	TOK	already		already\DGA7
4464	TOK	known		know\VMC----
4465	TOK	to		to\P
4466	TOK	be		be\VMI----
4467	TOK	related		relate\VMC----
4468	TOK	to		to\P
4469	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
4470	TOK	oncogenes		oncogene\N5P
4471	TOK	and		and\CC
4472	TOK	presumably		presumably\DGA7
4473	TOK	allow		allow\VMF6R66
4474	TOK	enhanced		enhance\VMC----
4475	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
4476	TOK	oncogene		oncogene\N5S
4477	TOK	expression		expression\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4478	TOK	Another	BOS	another\JA
4479	TOK	important		important\JA
4480	TOK	mechanism		mechanism\N5S
4481	TOK	for		for\P
4482	TOK	overexpression		overexpression\N5S
4483	TOK	is		be\V6FDRS3
4484	TOK	gene		gene\N5S
4485	TOK	amplification		amplification\N5S
---	DLE	,		=\DELIM
4486	TOK	a		a\AI---S
4487	TOK	process		process\N5S
4488	TOK	that		that\RW63N6
4489	TOK	is		be\V6FDRS3
4490	TOK	rare		rare\JA
4491	TOK	or		or\CC
4492	TOK	nonexistent		nonexistent\JA
4493	TOK	in		in\P
4494	TOK	normal		normal\JA
4495	TOK	cells		cell\N5P
4496	TOK	but		but\CC
4497	TOK	sometimes		sometimes\DGA7
4498	TOK	common		common\JA
4499	TOK	in		in\P
4500	TOK	cancer		cancer\N5S
4501	TOK	cells		cell\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4502	TOK	Amplified	BOS	amplify\VMC----
4503	TOK	segments		segment\N5P
4504	TOK	of		of\P
##	TAG	<name>
4505	TOK	DNA		DNA\N46
##	TAG	</name>
4506	TOK	are		be\V6FDR66
4507	TOK	often		often\DGA7
4508	TOK	detected		detect\VMC----
4509	TOK	as		as\P
##	TAG	<num>
4510	TOK	two		two\X
##	TAG	</num>
4511	TOK	types		type\N5P
4512	TOK	of		of\P
4513	TOK	cytogenetic		cytogenetic\JA
4514	TOK	change		change\N5S
---	DLD	,		=\DELIM
4515	TOK	double		double\JA
4516	TOK	minutes		minute\N5P
---	DLE	(		=\DELIM
4517	TOK	very		very\JA
4518	TOK	small		small\JA
4519	TOK	accessory		accessory\N5S
4520	TOK	chromosomes		chromosome\N5P
---	DLD	)		=\DELIM
4521	TOK	and		and\CC
4522	TOK	homogeneously		homogeneously\DGA7
4523	TOK	staining		stain\VMG----
4524	TOK	regions		region\N5P
---	DLE	(		=\DELIM
##	TAG	<name>
4525	TOK	HSRs		HSRs\N46
##	TAG	</name>
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
4526	TOK	that		that\RW63N6
4527	TOK	do		do\V6FDR66
4528	TOK	not		not\DGA7
4529	TOK	band		band\VMI----
4530	TOK	normally		normally\DGA7
4531	TOK	and		and\CC
4532	TOK	contain		contain\VMF6R66
4533	TOK	multiple		multiple\JA
---	DLD	,		=\DELIM
4534	TOK	amplified		amplify\VMC----
4535	TOK	copies		copy\N5P
4536	TOK	of		of\P
4537	TOK	a		a\AI---S
4538	TOK	particular		particular\JA
##	TAG	<name>
4539	TOK	DNA		DNA\N46
##	TAG	</name>
4540	TOK	segment		segment\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4541	TOK	How	BOS	how\DGAW
4542	TOK	and		and\CC
4543	TOK	why		why\CS
4544	TOK	double		double\JA
4545	TOK	minutes		minute\N5P
4546	TOK	and		and\CC
##	TAG	<name>
4547	TOK	HSRs		HSRs\N46
##	TAG	</name>
4548	TOK	occur		occur\VMF6R66
4549	TOK	is		be\V6FDRS3
4550	TOK	poorly		poorly\DGA7
4551	TOK	understood		understand\VMC----
---	DLD	,		=\DELIM
4552	TOK	but		but\CC
4553	TOK	amplified		amplify\VMC----
4554	TOK	regions		region\N5P
4555	TOK	are		be\V6FDR66
4556	TOK	known		know\VMC----
4557	TOK	to		to\P
4558	TOK	include		include\VMI----
4559	TOK	extra		extra\JA
4560	TOK	copies		copy\N5P
4561	TOK	of		of\P
4562	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
4563	TOK	oncogenes		oncogene\N5P
4564	TOK	with		with\P
4565	TOK	effects		effect\N5P
4566	TOK	on		on\P
4567	TOK	cell		cell\N5S
4568	TOK	growth		growth\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<loc pos="DGA7">
4569	TOK	For example	BOS	For_example\DGA7
##	TAG	</loc>
---	DLE	,		=\DELIM
4570	TOK	the		the\AT---6
4571	TOK	N		N\N5P
---	DLD	-		=\DELIM
4572	TOK	myc		myc\N5S
4573	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
4574	TOK	oncogene		oncogene\N5S
4575	TOK	is		be\V6FDRS3
4576	TOK	amplified		amplify\VMC----
4577	TOK	up		up\P
4578	TOK	to		to\P
##	TAG	<num>
4579	TOK	200		200\X
##	TAG	</num>
4580	TOK	times		time\N5P
4581	TOK	in		in\P
##	TAG	<num>
4582	TOK	40		40\X
##	TAG	</num>
4583	TOK	percent		percent\N56
4584	TOK	of		of\P
4585	TOK	neuroblastomas		neuroblastoma\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4586	TOK	The	BOS	the\AT---6
4587	TOK	phenomenon		phenomenon\N5S
4588	TOK	is		be\V6FDRS3
4589	TOK	thought		think\VMC----
4590	TOK	to		to\P
4591	TOK	be		be\VMI----
4592	TOK	related		relate\VMC----
4593	TOK	to		to\P
4594	TOK	tumor		tumor\N5S
4595	TOK	progression		progression\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
4596	TOK	Table	BOS	table\VMF6R66
##	TAG	<num>
4597	TOK	2	EOS	2\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
4599	TOK	Mechanisms	BOS	mechanism\N5P
4600	TOK	of		of\P
##	TAG	<name>
4601	TOK	Activation of Proto-Ocogenes	EOS	Activation_of_Proto-Ocogenes\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
4603	TOK	Mechanism	BOS	mechanism\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4604	TOK	Type	BOS	type\N5S
4605	TOK	of		of\P
##	TAG	<name>
4606	TOK	Gene Activated		Gene_Activated\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4607	TOK	Result	BOS	result\VMF6R66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4608	TOK	Regulatory	BOS	regulatory\JA
4609	TOK	mutation		mutation\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4610	TOK	Growth	BOS	growth\N5S
4611	TOK	factor		factor\N5S
4612	TOK	genes		gene\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4613	TOK	Increased	BOS	increase\VMC----
4614	TOK	expression		expression\N5S
4615	TOK	or		or\CC
4616	TOK	secretion		secretion\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4618	TOK	Structural	BOS	structural\JA
4619	TOK	mutation		mutation\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4620	TOK	Growth	BOS	growth\N5S
4621	TOK	factor		factor\N5S
4622	TOK	receptors		receptor\N5P
---	DLD	,		=\DELIM
4623	TOK	signal		signal\N5S
4624	TOK	transducing		transduce\VMG----
4625	TOK	proteins		protein\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4626	TOK	Allows	BOS	allow\VMFDRS3
4627	TOK	autonomy		autonomy\N5S
4628	TOK	of		of\P
4629	TOK	expression		expression\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4630	TOK	Translocation	BOS	translocation\N5S
---	DLD	,		=\DELIM
4631	TOK	retroviral		retroviral\JA
4632	TOK	insertion		insertion\N5S
---	DLD	,		=\DELIM
4633	TOK	gene		gene\N5S
4634	TOK	amplification		amplification\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4635	TOK	Nuclear	BOS	nuclear\JA
4636	TOK	oncogenes		oncogene\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
4637	TOK	Overexpression	BOS	Overexpression\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
4638	TOK	Table	BOS	table\VMF6R66
##	TAG	<num>
4639	TOK	3	EOS	3\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
4641	TOK	Characteristic	BOS	characteristic\JA
##	TAG	<name>
4642	TOK	Chromosome Translocations		Chromosome_Translocations\N46
##	TAG	</name>
4643	TOK	in		in\P
##	TAG	<name>
4644	TOK	Selected Human Malignancies	EOS	Selected_Human_Malignancies\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
4646	TOK	Neoplasm	BOS	neoplasm\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4647	TOK	Chromosome	BOS	chromosome\N5S
##	TAG	<abbr>
4648	TOK	Translocation.		Translocation.\N5S
##	TAG	</abbr>
4649	TOK	xxx		noanat\W
4650	TOK	of		of\P
4651	TOK	cases		case\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<name>
4652	TOK	Proto-Oncogene Affected	BOS	Proto-Oncogene_Affected\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
4653	TOK	Burkitt	BOS	Burkitt\N46
##	TAG	</name>
4654	TOK	lymphoma		lymphoma\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4655	TOK	Chronic	BOS	chronic\JA
4656	TOK	myelogenous		myelogenous\JA
4657	TOK	leukemia		leukemia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4659	TOK	Acute	BOS	acute\JA
4660	TOK	lymphocyte		lymphocyte\N5S
4661	TOK	leukemia		leukemia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4662	TOK	Acute	BOS	acute\JA
4663	TOK	lymphoblastic		lymphoblastic\JA
4664	TOK	leukemia		leukemia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4665	TOK	Acute	BOS	acute\JA
4666	TOK	promyelocytic		promyelocytic\JA
4667	TOK	leukemia		leukemia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4668	TOK	Chronic	BOS	chronic\JA
4669	TOK	lymphocytic		lymphocytic\JA
4670	TOK	leukemia		leukemia\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4672	TOK	Follicular	BOS	follicular\JA
4673	TOK	lymphoma		lymphoma\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4674	TOK	Requirement	BOS	requirement\N5S
4675	TOK	for		for\P
4676	TOK	More		more\N5S
4677	TOK	than		than\CS
##	TAG	<name>
4678	TOK	One Activated Gene		One_Activated_Gene\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
4679	TOK	An	BOS	an\AI---S
4680	TOK	important		important\JA
4681	TOK	aspect		aspect\N5S
4682	TOK	of		of\P
4683	TOK	the		the\AT---6
4684	TOK	initiation		initiation\N5S
4685	TOK	and		and\CC
4686	TOK	promotion		promotion\N5S
4687	TOK	of		of\P
4688	TOK	carcinogenesis		carcinogenesis\N5S
4689	TOK	by		by\P
4690	TOK	activated		activate\VMC----
4691	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
4692	TOK	oncogenes		oncogene\N5P
4693	TOK	is		be\V6FDRS3
4694	TOK	that		that\CS
4695	TOK	mutation		mutation\N5S
4696	TOK	of		of\P
4697	TOK	a		a\AI---S
4698	TOK	single		single\JA
4699	TOK	gene		gene\N5S
4700	TOK	alone		alone\DGA7
4701	TOK	seems		seem\VMFDRS3
4702	TOK	unable		unable\JA
4703	TOK	to		to\P
4704	TOK	achieve		achieve\VMI----
4705	TOK	transformation		transformation\N5S
---	DLD	;		=\DELIM
4706	TOK	rather		rather\DGA7
---	DLD	,		=\DELIM
4707	TOK	separate		separate\JA
4708	TOK	genes		gene\N5P
4709	TOK	with		with\P
4710	TOK	complementary		complementary\JA
4711	TOK	effects		effect\N5P
4712	TOK	seem		seem\VMF6R66
4713	TOK	to		to\P
4714	TOK	be		be\VMI----
4715	TOK	required		require\VMF6A66
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4716	TOK	Although	BOS	although\CS
4717	TOK	the		the\AT---6
4718	TOK	details		detail\N5P
4719	TOK	of		of\P
4720	TOK	the		the\AT---6
4721	TOK	experiments		experiment\N5P
4722	TOK	demonstrating		demonstrate\VMG----
4723	TOK	that		that\CS
4724	TOK	normal		normal\JA
4725	TOK	cells		cell\N5P
4726	TOK	require		require\VMF6R66
4727	TOK	cooperation		cooperation\N5S
4728	TOK	between		between\P
4729	TOK	different		different\JA
4730	TOK	activated		activate\VMC----
4731	TOK	oncogenes		oncogene\N5P
##	TAG	<loc pos="P">
4732	TOK	in order to		in_order_to\P
##	TAG	</loc>
4733	TOK	undergo		undergo\VMI----
4734	TOK	transformation		transformation\N5S
4735	TOK	are		be\V6FDR66
4736	TOK	not		not\DGA7
4737	TOK	described		describe\VMC----
4738	TOK	here		here\DGA7
---	DLD	,		=\DELIM
4739	TOK	the		the\AT---6
4740	TOK	conclusion		conclusion\N5S
4741	TOK	is		be\V6FDRS3
4742	TOK	an		an\AI---S
4743	TOK	important		important\JA
4744	TOK	one		one\RIS3N-
---	DLD	:		=\DELIM
4745	TOK	malignant		malignant\JA
4746	TOK	transformation		transformation\N5S
4747	TOK	is		be\V6FDRS3
4748	TOK	a		a\AI---S
4749	TOK	multi		multi\N5P
---	DLI	-		=\DELIM
4750	TOK	event		event\N5S
4751	TOK	process		process\VMF6R66
---	DLD	,		=\DELIM
4752	TOK	not		not\DGA7
4753	TOK	to		to\P
4754	TOK	be		be\VMI----
4755	TOK	achieved		achieve\VMC----
4756	TOK	by		by\P
4757	TOK	a		a\AI---S
4758	TOK	single		single\JA
4759	TOK	step		step\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
##	TAG	<name>
4760	TOK	Tumor-Suppressor Genes	BOS	Tumor-Suppressor_Genes\N46
##	TAG	</name>
tf	TOK		EOS	=\DELS
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
4762	TOK	Whereas	BOS	whereas\CS
4763	TOK	the		the\AT---6
4764	TOK	products		product\N5P
4765	TOK	of		of\P
4766	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
4767	TOK	oncogenes		oncogene\N5P
4768	TOK	promote		promote\VMF6R66
4769	TOK	growth		growth\N5S
---	DLD	,		=\DELIM
4770	TOK	the		the\AT---6
4771	TOK	products		product\N5P
4772	TOK	of		of\P
4773	TOK	tumor		tumor\N5S
---	DLI	-		=\DELIM
4774	TOK	suppressor		suppressor\N5S
4775	TOK	genes		gene\N5P
4776	TOK	normally		normally\DGA7
4777	TOK	block		block\VMF6R66
4778	TOK	abnormal		abnormal\JA
4779	TOK	growth		growth\N5S
4780	TOK	and		and\CC
4781	TOK	malignant		malignant\JA
4782	TOK	transformation		transformation\N5S
---	DLD	,		=\DELIM
4783	TOK	and		and\CC
4784	TOK	contribute		contribute\VMF6R66
4785	TOK	to		to\P
4786	TOK	malignancy		malignancy\N5S
4787	TOK	only		only\DGA7
4788	TOK	when		when\CS
4789	TOK	the		the\AT---6
4790	TOK	function		function\N5S
4791	TOK	of		of\P
4792	TOK	both		both\RIP3N-
4793	TOK	alleles		allele\N5P
4794	TOK	is		be\V6FDRS3
4795	TOK	lost		lose\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4796	TOK	In	BOS	in\P
4797	TOK	other		other\JA
4798	TOK	words		word\N5P
---	DLD	,		=\DELIM
4799	TOK	in		in\P
4800	TOK	contrast		contrast\N5S
4801	TOK	to		to\P
4802	TOK	mutations		mutation\N5P
4803	TOK	in		in\P
4804	TOK	proto		proto\N5P
---	DLI	-		=\DELIM
4805	TOK	oncogenes		oncogene\N5P
---	DLD	,		=\DELIM
4806	TOK	which		which\RW63N-
4807	TOK	are		be\V6FDR66
4808	TOK	dominant		dominant\JA
4809	TOK	in		in\P
4810	TOK	their		their\APP3N6
4811	TOK	action		action\N5S
---	DLD	,		=\DELIM
4812	TOK	mutations		mutation\N5P
4813	TOK	in		in\P
4814	TOK	tumor		tumor\N5S
---	DLE	-		=\DELIM
4815	TOK	suppressor		suppressor\N5S
4816	TOK	genes		gene\N5P
4817	TOK	are		be\V6FDR66
4818	TOK	recessive		recessive\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
4819	TOK	The	BOS	the\AT---6
##	TAG	<name>
4820	TOK	Two-Hit Origin of Cancer	EOS	Two-Hit_Origin_of_Cancer\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
4822	TOK	The	BOS	the\AT---6
4823	TOK	existence		existence\N5S
4824	TOK	of		of\P
4825	TOK	recessive		recessive\JA
4826	TOK	mutations		mutation\N5P
4827	TOK	leading		lead\VMG----
4828	TOK	to		to\P
4829	TOK	cancer		cancer\N5S
4830	TOK	was		be\V6F-A66
4831	TOK	originally		originally\DGA7
4832	TOK	suggested		suggest\VMC----
4833	TOK	in		in\P
4834	TOK	the		the\AT---6
##	TAG	<na type="code">
4835	TOK	1960s		noanat\W
##	TAG	</na>
4836	TOK	by		by\P
##	TAG	<name>
4837	TOK	DeMars		DeMars\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4838	TOK	He	BOS	he\RPS3MN
4839	TOK	made		make\VMF6A66
4840	TOK	the		the\AT---6
4841	TOK	prescient		prescient\JA
4842	TOK	suggestion		suggestion\N5S
4843	TOK	that		that\CS
4844	TOK	some		some\AG---6
4845	TOK	forms		form\N5P
4846	TOK	of		of\P
4847	TOK	cancer		cancer\N5S
4848	TOK	might		may\VOFDR66
4849	TOK	be		be\VMI----
4850	TOK	initiated		initiate\VMC----
4851	TOK	when		when\CS
4852	TOK	a		a\AI---S
4853	TOK	cell		cell\N5S
4854	TOK	in		in\P
4855	TOK	a		a\AI---S
4856	TOK	person		person\N5S
4857	TOK	heterozygous		heterozygous\JA
4858	TOK	for		for\P
4859	TOK	a		a\AI---S
4860	TOK	recessive		recessive\JA
4861	TOK	germline		germline\N5S
4862	TOK	mutation		mutation\N5S
4863	TOK	undergoes		undergo\VMFDRS3
4864	TOK	a		a\AI---S
4865	TOK	second		second\MOS
---	DLD	,		=\DELIM
4866	TOK	somatic		somatic\JA
4867	TOK	mutation		mutation\N5S
---	DLD	,		=\DELIM
4868	TOK	thus		thus\DGA7
4869	TOK	rendering		render\VMG----
4870	TOK	the		the\AT---6
4871	TOK	cell		cell\N5S
4872	TOK	homozygous		homozygous\JA
---	DLD	,		=\DELIM
4873	TOK	giving		give\VMG----
4874	TOK	rise		rise\N5S
4875	TOK	to		to\P
4876	TOK	a		a\AI---S
4877	TOK	tumor		tumor\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4878	TOK	This	BOS	this\AD---S
---	DLE	"		=\DELIM
4879	TOK	two		two\MCP
---	DLI	-		=\DELIM
4880	TOK	hit		hit\VMF6-66
---	DLD	"		=\DELIM
4881	TOK	hypothesis		hypothesis\N5S
4882	TOK	was		be\V6F-A66
4883	TOK	expanded		expand\VMC----
4884	TOK	by		by\P
##	TAG	<name>
4885	TOK	Knudson		Knudson\N46
##	TAG	</name>
---	DLE	(		=\DELIM
##	TAG	<num>
4886	TOK	1971		1971\X
##	TAG	</num>
---	DLE	)		=\DELIM
---	DLD	,		=\DELIM
4887	TOK	who		who\RW63N-
4888	TOK	proposed		propose\VMF6A66
4889	TOK	that		that\CS
4890	TOK	forms		form\N5P
4891	TOK	of		of\P
4892	TOK	cancer		cancer\N5S
4893	TOK	such		such\RIS3N-
4894	TOK	as		as\P
4895	TOK	retinoblastoma		retinoblastoma\N5S
---	DLE	,		=\DELIM
4896	TOK	which		which\RW63N-
4897	TOK	occur		occur\VMF6R66
4898	TOK	in		in\P
4899	TOK	both		both\RIP3N-
4900	TOK	hereditary		hereditary\JA
4901	TOK	and		and\CC
4902	TOK	sporadic		sporadic\JA
4903	TOK	forms		form\N5P
---	DLD	,		=\DELIM
4904	TOK	could		can\VOFDA66
4905	TOK	be		be\VMI----
4906	TOK	explained		explain\VMC----
4907	TOK	on		on\P
4908	TOK	the		the\AT---6
4909	TOK	basis		basis\N5S
4910	TOK	that		that\CS
4911	TOK	in		in\P
4912	TOK	the		the\AT---6
4913	TOK	hereditary		hereditary\JA
4914	TOK	form		form\N5S
4915	TOK	the		the\AT---6
4916	TOK	first		first\MOS
4917	TOK	mutation		mutation\N5S
4918	TOK	is		be\V6FDRS3
4919	TOK	carried		carry\VMC----
4920	TOK	in		in\P
4921	TOK	the		the\AT---6
4922	TOK	germline		germline\N5S
---	DLD	,		=\DELIM
4923	TOK	whereas		whereas\CS
4924	TOK	in		in\P
4925	TOK	the		the\AT---6
4926	TOK	sporadic		sporadic\JA
4927	TOK	form		form\N5S
4928	TOK	both		both\RIP3N-
4929	TOK	mutations		mutation\N5P
4930	TOK	are		be\V6FDR66
4931	TOK	somatic		somatic\JA
---	DLD	,		=\DELIM
4932	TOK	occurring		occur\VMG----
4933	TOK	in		in\P
4934	TOK	the		the\AT---6
4935	TOK	same		same\JA
4936	TOK	somatic		somatic\JA
4937	TOK	cell		cell\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4938	TOK	The	BOS	the\AT---6
4939	TOK	normal		normal\JA
4940	TOK	genes		gene\N5P
4941	TOK	are		be\V6FDR66
4942	TOK	now		now\DGA7
4943	TOK	known		know\VMC----
4944	TOK	as		as\P
4945	TOK	tumorsuppressor		tumorsuppressor\N5S
4946	TOK	genes		gene\N5P
---	DLD	,		=\DELIM
4947	TOK	which		which\RW63N-
4948	TOK	play		play\VMF6R66
4949	TOK	regulatory		regulatory\JA
4950	TOK	roles		role\N5P
4951	TOK	in		in\P
4952	TOK	cell		cell\N5S
4953	TOK	proliferation		proliferation\N5S
---	DLD	,		=\DELIM
4954	TOK	differentiation		differentiation\N5S
---	DLD	,		=\DELIM
4955	TOK	and		and\CC
4956	TOK	other		other\JA
4957	TOK	basic		basic\JA
4958	TOK	cellular		cellular\JA
4959	TOK	functions		function\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
4960	TOK	Inactivation	BOS	inactivation\N5S
4961	TOK	of		of\P
4962	TOK	tumor		tumor\N5S
---	DLI	-		=\DELIM
4963	TOK	suppressor		suppressor\N5S
4964	TOK	genes		gene\N5P
4965	TOK	by		by\P
4966	TOK	mutation		mutation\N5S
4967	TOK	or		or\CC
4968	TOK	some		some\AG---6
4969	TOK	other		other\JA
4970	TOK	mechanism		mechanism\N5S
4971	TOK	leads		lead\VMFDRS3
4972	TOK	to		to\P
4973	TOK	loss		loss\N5S
4974	TOK	of		of\P
4975	TOK	regulation		regulation\N5S
4976	TOK	and		and\CC
4977	TOK	therefore		therefore\DGA7
4978	TOK	is		be\V6FDRS3
4979	TOK	oncogenic		oncogenic\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
##	TAG	<name>
4980	TOK	Tumor-Suppressor Genes	BOS	Tumor-Suppressor_Genes\N46
##	TAG	</name>
4981	TOK	in		in\P
##	TAG	<name>
4982	TOK	Many Forms of Cancer	EOS	Many_Forms_of_Cancer\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
4984	TOK	As	BOS	as\CS
4985	TOK	described		describe\VMC----
4986	TOK	in		in\P
4987	TOK	detail		detail\N5S
4988	TOK	later		later\DGC7
---	DLD	,		=\DELIM
4989	TOK	tumor		tumor\N5S
---	DLI	-		=\DELIM
4990	TOK	suppressor		suppressor\N5S
4991	TOK	genes		gene\N5P
4992	TOK	have		have\V6F6R66
4993	TOK	been		be\VMC----
4994	TOK	implicated		implicate\VMC----
4995	TOK	in		in\P
4996	TOK	several		several\JA
##	TAG	<loc pos="JA">
4997	TOK	Mendelian		mendelian\JA
##	TAG	</loc>
4998	TOK	forms		form\N5P
4999	TOK	of		of\P
5000	TOK	cancer		cancer\N5S
---	DLD	,		=\DELIM
5001	TOK	including		including\P
5002	TOK	retinoblastoma		retinoblastoma\N5S
---	DLD	;		=\DELIM
##	TAG	<name>
5003	TOK	Wilms		Wilms\N46
##	TAG	</name>
5004	TOK	tumor		tumor\N5S
---	DLD	;		=\DELIM
5005	TOK	familial		familial\JA
5006	TOK	polyposis		polyposis\N5S
5007	TOK	coli		coli\N5P
---	DLD	;		=\DELIM
5008	TOK	neurofibromatosis		neurofibromatosis\N5S
---	DLD	,		=\DELIM
5009	TOK	type		type\N5S
##	TAG	<num>
5010	TOK	1		1\X
##	TAG	</num>
---	DLD	;		=\DELIM
5011	TOK	and		and\CC
5012	TOK	the		the\AT---6
5013	TOK	rare		rare\JA
5014	TOK	form		form\N5S
5015	TOK	of		of\P
5016	TOK	familial		familial\JA
5017	TOK	cancer		cancer\N5S
5018	TOK	known		know\VMC----
5019	TOK	as		as\P
##	TAG	<name>
5020	TOK	Li-Fraumeni		Li-Fraumeni\N46
##	TAG	</name>
5021	TOK	syndrome		syndrome\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
5022	TOK	Although	BOS	although\CS
5023	TOK	in		in\P
5024	TOK	each		each\RIS3N-
5025	TOK	of		of\P
5026	TOK	these		this\AD---P
5027	TOK	disorders		disorder\N5P
5028	TOK	autosomal		autosomal\JA
5029	TOK	dominant		dominant\JA
5030	TOK	inheritance		inheritance\N5S
5031	TOK	is		be\V6FDRS3
5032	TOK	either		either\RIP3N-
5033	TOK	the		the\AT---6
5034	TOK	rule		rule\N5S
5035	TOK	or		or\CC
##	TAG	<loc pos="DGA7">
5036	TOK	at least		at_least\DGA7
##	TAG	</loc>
5037	TOK	seen		see\VMC----
5038	TOK	in		in\P
5039	TOK	a		a\AI---S
5040	TOK	proportion		proportion\N5S
5041	TOK	of		of\P
5042	TOK	cases		case\N5P
---	DLD	,		=\DELIM
5043	TOK	loss		loss\N5S
5044	TOK	or		or\CC
5045	TOK	alteration		alteration\N5S
5046	TOK	of		of\P
5047	TOK	both		both\RIP3N-
5048	TOK	copies		copy\N5P
5049	TOK	of		of\P
5050	TOK	the		the\AT---6
5051	TOK	responsible		responsible\JA
5052	TOK	tumor		tumor\N5S
---	DLI	-		=\DELIM
5053	TOK	suppressor		suppressor\N5S
5054	TOK	gene		gene\N5S
5055	TOK	is		be\V6FDRS3
5056	TOK	required		require\VMC----
5057	TOK	for		for\P
5058	TOK	tumor		tumor\N5S
5059	TOK	development		development\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
5060	TOK	The	BOS	the\AT---6
5061	TOK	explanation		explanation\N5S
5062	TOK	of		of\P
5063	TOK	this		this\AD---S
5064	TOK	seeming		seeming\JA
5065	TOK	paradox		paradox\N5S
5066	TOK	is		be\V6FDRS3
5067	TOK	that		that\CS
5068	TOK	a		a\AI---S
5069	TOK	single		single\JA
5070	TOK	functional		functional\JA
5071	TOK	copy		copy\N5S
5072	TOK	of		of\P
5073	TOK	a		a\AI---S
5074	TOK	tumor		tumor\N5S
---	DLI	-		=\DELIM
5075	TOK	suppressor		suppressor\N5S
5076	TOK	gene		gene\N5S
5077	TOK	is		be\V6FDRS3
5078	TOK	enough		enough\JA
5079	TOK	to		to\P
5080	TOK	provide		provide\VMI----
5081	TOK	a		a\AI---S
5082	TOK	normal		normal\JA
5083	TOK	cellular		cellular\JA
5084	TOK	phenotype		phenotype\N5S
---	DLD	;		=\DELIM
5085	TOK	however		however\DGA7
---	DLD	,		=\DELIM
5086	TOK	a		a\AI---S
5087	TOK	cell		cell\N5S
5088	TOK	in		in\P
5089	TOK	which		which\RW63N-
5090	TOK	one		one\MCS
5091	TOK	copy		copy\N5S
5092	TOK	is		be\V6FDRS3
5093	TOK	already		already\DGA7
5094	TOK	altered		alter\VMC----
5095	TOK	or		or\CC
5096	TOK	lost		lose\VMF6A66
---	DLD	,		=\DELIM
5097	TOK	by		by\P
5098	TOK	either		either\AG---6
5099	TOK	germline		germline\N5S
5100	TOK	or		or\CC
5101	TOK	somatic		somatic\JA
5102	TOK	mutation		mutation\N5S
---	DLD	,		=\DELIM
5103	TOK	will		will\VOFDR66
5104	TOK	lose		lose\VMI----
5105	TOK	its		its\APS3N6
5106	TOK	ability		ability\N5S
5107	TOK	to		to\P
5108	TOK	suppress		suppress\VMI----
5109	TOK	tumor		tumor\N5S
5110	TOK	development		development\N5S
5111	TOK	if		if\CS
5112	TOK	by		by\P
5113	TOK	chance		chance\N5S
5114	TOK	it		it\RPS3N6
5115	TOK	acquires		acquire\VMFDRS3
5116	TOK	a		a\AI---S
5117	TOK	somatic		somatic\JA
5118	TOK	mutation		mutation\N5S
5119	TOK	at		at\P
5120	TOK	the		the\AT---6
5121	TOK	remaining		remain\VMG----
5122	TOK	allele		allele\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
5123	TOK	Because	BOS	because\CS
5124	TOK	tumors		tumor\N5P
5125	TOK	are		be\V6FDR66
5126	TOK	clonal		clonal\JA
5127	TOK	by		by\P
5128	TOK	nature		nature\N5S
---	DLD	,		=\DELIM
5129	TOK	this		this\AD---S
5130	TOK	event		event\N5S
5131	TOK	can		can\VOFDR66
5132	TOK	cause		cause\VMI----
5133	TOK	a		a\AI---S
5134	TOK	tumor		tumor\N5S
##	TAG	<loc pos="CS">
5135	TOK	even if		even_if\CS
##	TAG	</loc>
5136	TOK	it		it\RPS3N6
5137	TOK	happens		happen\VMFDRS3
5138	TOK	in		in\P
5139	TOK	only		only\DGA7
5140	TOK	one		one\MCS
5141	TOK	of		of\P
5142	TOK	the		the\AT---6
5143	TOK	numerous		numerous\JA
5144	TOK	cells		cell\N5P
5145	TOK	of		of\P
5146	TOK	a		a\AI---S
5147	TOK	tissue		tissue\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
5148	TOK	The	BOS	the\AT---6
5149	TOK	significance		significance\N5S
5150	TOK	of		of\P
5151	TOK	tumor		tumor\N5S
---	DLI	-		=\DELIM
5152	TOK	suppressor		suppressor\N5S
5153	TOK	genes		gene\N5P
5154	TOK	is		be\V6FDRS3
5155	TOK	not		not\DGA7
5156	TOK	limited		limit\VMC----
5157	TOK	to		to\P
5158	TOK	autosomal		autosomal\JA
5159	TOK	dominant		dominant\JA
5160	TOK	forms		form\N5P
5161	TOK	of		of\P
5162	TOK	cancer		cancer\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
5163	TOK	As	BOS	as\DGA7
5164	TOK	described		describe\VMC----
5165	TOK	later		later\DGC7
---	DLD	,		=\DELIM
5166	TOK	tumor		tumor\N5S
---	DLI	-		=\DELIM
5167	TOK	suppressor		suppressor\N5S
5168	TOK	genes		gene\N5P
5169	TOK	a		a\AI---S
5170	TOK	re		re\N5S
5171	TOK	also		also\DGA7
5172	TOK	involved		involve\VMC----
5173	TOK	in		in\P
5174	TOK	the		the\AT---6
5175	TOK	progression		progression\N5S
5176	TOK	of		of\P
5177	TOK	several		several\JA
5178	TOK	common		common\JA
---	DLD	,		=\DELIM
5179	TOK	nonheritable		nonheritable\JA
5180	TOK	forms		form\N5P
5181	TOK	of		of\P
5182	TOK	cancer		cancer\N5S
---	DLD	,		=\DELIM
5183	TOK	such		such\JA
5184	TOK	as		as\P
5185	TOK	colorectal		colorectal\JA
5186	TOK	cancer		cancer\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
5187	TOK	Tumor	BOS	tumor\N5S
##	TAG	<name>
5188	TOK	Progression		Progression\N46
##	TAG	</name>
5189	TOK	by		by\P
##	TAG	<name>
5190	TOK	Clonal Evolution	EOS	Clonal_Evolution\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
5192	TOK	The	BOS	the\AT---6
5193	TOK	scheme		scheme\N5S
5194	TOK	just		just\DGA7
5195	TOK	outlined		outline\VMF6A66
---	DLD	,		=\DELIM
5196	TOK	whereby		whereby\CS
5197	TOK	the		the\AT---6
5198	TOK	development		development\N5S
5199	TOK	of		of\P
5200	TOK	malignancy		malignancy\N5S
5201	TOK	requires		require\VMFDRS3
5202	TOK	only		only\DGA7
5203	TOK	the		the\AT---6
5204	TOK	activation		activation\N5S
5205	TOK	of		of\P
5206	TOK	a		a\AI---S
5207	TOK	proto		proto\JA
---	DLI	-		=\DELIM
5208	TOK	oncogene		oncogene\N5S
5209	TOK	or		or\CC
5210	TOK	loss		loss\N5S
5211	TOK	of		of\P
5212	TOK	function		function\N5S
5213	TOK	of		of\P
5214	TOK	both		both\RIP3N-
5215	TOK	alleles		allele\N5P
5216	TOK	of		of\P
5217	TOK	a		a\AI---S
5218	TOK	tumor		tumor\N5S
---	DLI	-		=\DELIM
5219	TOK	suppressor		suppressor\N5S
5220	TOK	gene		gene\N5S
---	DLD	,		=\DELIM
5221	TOK	is		be\V6FDRS3
5222	TOK	grossly		grossly\DGA7
5223	TOK	oversimplified		oversimplify\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
5224	TOK	Instead	BOS	instead\DGA7
---	DLD	,		=\DELIM
5225	TOK	tumor		tumor\N5S
5226	TOK	formation		formation\N5S
5227	TOK	is		be\V6FDRS3
5228	TOK	a		a\AI---S
5229	TOK	multistep		multistep\JA
5230	TOK	process		process\N5S
5231	TOK	involving		involve\VMG----
5232	TOK	a		a\AI---S
5233	TOK	succession		succession\N5S
5234	TOK	of		of\P
5235	TOK	genetic		genetic\JA
5236	TOK	changes		change\N5P
5237	TOK	in		in\P
5238	TOK	the		the\AT---6
5239	TOK	evolving		evolve\VMG----
5240	TOK	tumor		tumor\N5S
5241	TOK	cell		cell\N5S
5242	TOK	population		population\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
5243	TOK	One	BOS	one\RIS3N-
5244	TOK	of		of\P
5245	TOK	the		the\AT---6
5246	TOK	surprising		surprising\JA
5247	TOK	findings		finding\N5P
5248	TOK	about		about\P
5249	TOK	tumor		tumor\N5S
5250	TOK	progression		progression\N5S
5251	TOK	is		be\V6FDRS3
5252	TOK	that		that\CS
5253	TOK	loss		loss\N5S
5254	TOK	or		or\CC
5255	TOK	inactivation		inactivation\N5S
5256	TOK	of		of\P
5257	TOK	the		the\AT---6
5258	TOK	same		same\JA
5259	TOK	gene		gene\N5S
5260	TOK	may		may\VOFDR66
5261	TOK	contribute		contribute\VMI----
5262	TOK	to		to\P
5263	TOK	the		the\AT---6
5264	TOK	development		development\N5S
5265	TOK	of		of\P
5266	TOK	several		several\JA
5267	TOK	different		different\JA
5268	TOK	common		common\JA
5269	TOK	cancers		cancer\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
##	TAG	<loc pos="DGA7">
5270	TOK	For example	BOS	For_example\DGA7
##	TAG	</loc>
---	DLE	,		=\DELIM
5271	TOK	the		the\AT---6
5272	TOK	p53		p53\N5S
5273	TOK	gene		gene\N5S
5274	TOK	on		on\P
5275	TOK	the		the\AT---6
5276	TOK	short		short\JA
5277	TOK	arm		arm\N5S
5278	TOK	of		of\P
5279	TOK	chromosome		chromosome\N5S
##	TAG	<num>
5280	TOK	17		17\X
##	TAG	</num>
5281	TOK	is		be\V6FDRS3
5282	TOK	missing		missing\JA
5283	TOK	or		or\CC
5284	TOK	abnormal		abnormal\JA
5285	TOK	in		in\P
5286	TOK	cells		cell\N5P
5287	TOK	of		of\P
5288	TOK	sporadic		sporadic\JA
5289	TOK	lung		lung\N5S
5290	TOK	and		and\CC
5291	TOK	breast		breast\N5S
5292	TOK	cancers		cancer\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
5293	TOK	The	BOS	the\AT---6
5294	TOK	retinoblastoma		retinoblastoma\N5S
5295	TOK	gene		gene\N5S
5296	TOK	is		be\V6FDRS3
5297	TOK	missing		missing\JA
5298	TOK	or		or\CC
5299	TOK	defective		defective\JA
5300	TOK	in		in\P
5301	TOK	nearly		nearly\DGA7
5302	TOK	all		all\AG---6
5303	TOK	cases		case\N5P
5304	TOK	of		of\P
5305	TOK	small		small\JA
---	DLI	-		=\DELIM
5306	TOK	cell		cell\N5S
5307	TOK	carcinoma		carcinoma\N5S
5308	TOK	of		of\P
5309	TOK	the		the\AT---6
5310	TOK	lung		lung\N5S
5311	TOK	and		and\CC
5312	TOK	in		in\P
5313	TOK	many		many\AI---P
5314	TOK	other		other\JA
5315	TOK	cases		case\N5P
5316	TOK	of		of\P
5317	TOK	lung		lung\N5S
5318	TOK	cancer		cancer\N5S
---	DLD	,		=\DELIM
5319	TOK	but		but\CC
5320	TOK	not		not\DGA7
5321	TOK	in		in\P
5322	TOK	cancers		cancer\N5P
5323	TOK	such		such\RIS3N-
5324	TOK	as		as\P
5325	TOK	colon		colon\N5S
5326	TOK	cancer		cancer\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
5327	TOK	Although	BOS	although\CS
5328	TOK	the		the\AT---6
5329	TOK	full		full\JA
5330	TOK	picture		picture\N5S
5331	TOK	of		of\P
5332	TOK	secondary		secondary\JA
5333	TOK	genetic		genetic\JA
5334	TOK	changes		change\N5P
5335	TOK	and		and\CC
5336	TOK	their		their\APP3N6
5337	TOK	role		role\N5S
5338	TOK	in		in\P
5339	TOK	tumor		tumor\N5S
5340	TOK	progression		progression\N5S
5341	TOK	is		be\V6FDRS3
5342	TOK	not		not\DGA7
5343	TOK	yet		yet\DGA7
5344	TOK	clear		clear\JA
---	DLD	,		=\DELIM
5345	TOK	it		it\RPS3N6
5346	TOK	is		be\V6FDRS3
5347	TOK	already		already\DGA7
5348	TOK	obvious		obvious\JA
5349	TOK	that		that\CS
5350	TOK	several		several\JA
5351	TOK	mutations		mutation\N5P
5352	TOK	at		at\P
5353	TOK	different		different\JA
5354	TOK	loci		locus\N5P
5355	TOK	are		be\V6FDR66
5356	TOK	required		require\VMC----
5357	TOK	if		if\CS
5358	TOK	a		a\AI---S
5359	TOK	tumor		tumor\N5S
5360	TOK	is		be\V6FDRS3
5361	TOK	to		to\P
5362	TOK	reach		reach\VMI----
5363	TOK	its		its\APS3N6
5364	TOK	full		full\JA
5365	TOK	malignant		malignant\JA
5366	TOK	potential		potential\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
5367	TOK	The	BOS	the\AT---6
5368	TOK	products		product\N5P
5369	TOK	of		of\P
5370	TOK	several		several\JA
5371	TOK	tumor		tumor\N5S
---	DLI	-		=\DELIM
5372	TOK	suppressor		suppressor\N5S
5373	TOK	genes		gene\N5P
5374	TOK	have		have\V6F6R66
5375	TOK	been		be\VMC----
5376	TOK	isolated		isolate\VMC----
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
5377	TOK	Because	BOS	because\CS
5378	TOK	tumor		tumor\N5S
---	DLI	-		=\DELIM
5379	TOK	suppressor		suppressor\N5S
5380	TOK	genes		gene\N5P
5381	TOK	and		and\CC
5382	TOK	their		their\APP3N6
5383	TOK	products		product\N5P
5384	TOK	are		be\V6FDR66
5385	TOK	by		by\P
5386	TOK	nature		nature\N5S
5387	TOK	protective		protective\JA
5388	TOK	against		against\P
5389	TOK	cancer		cancer\N5S
---	DLD	,		=\DELIM
5390	TOK	it		it\RPS3N6
5391	TOK	is		be\V6FDRS3
5392	TOK	hoped		hope\VMC----
5393	TOK	that		that\CS
5394	TOK	their		their\APP3N6
5395	TOK	understanding		understanding\N5S
5396	TOK	will		will\VOFDR66
5397	TOK	eventually		eventually\DGA7
5398	TOK	lead		lead\VMI----
5399	TOK	to		to\P
5400	TOK	improved		improve\VMC----
5401	TOK	methods		method\N5P
5402	TOK	of		of\P
5403	TOK	anticancer		anticancer\JA
5404	TOK	therapy		therapy\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<head>
5405	TOK	Table	BOS	table\VMF6R66
##	TAG	<num>
5406	TOK	4	EOS	4\X
##	TAG	</num>
##	TAG	</head>
##	TAG	<head>
5408	TOK	Products	BOS	product\N5P
5409	TOK	of		of\P
##	TAG	<name>
5410	TOK	Selected Tumor-Suppressor Genes	EOS	Selected_Tumor-Suppressor_Genes\N46
##	TAG	</name>
##	TAG	</head>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
5412	TOK	Tumor-Suppresor Gene	BOS	Tumor-Suppresor_Gene\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
5413	TOK	Gene	BOS	gene\N5S
##	TAG	<name>
5414	TOK	Product		Product\N46
##	TAG	</name>
5415	TOK	and		and\CC
##	TAG	<name>
5416	TOK	Possible Functions		Possible_Functions\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
5417	TOK	Disorders	BOS	disorder\N5P
5418	TOK	in		in\P
##	TAG	<name>
5419	TOK	Which Gene Affected		Which_Gene_Affected\N46
##	TAG	</name>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
5420	TOK	Familial	BOS	familial\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
5421	TOK	Sporadic	BOS	sporadic\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
5423	TOK	Retinoblastoma	BOS	retinoblastoma\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
5424	TOK	Small	BOS	small\JA
---	DLI	-		=\DELIM
5425	TOK	cell		cell\N5S
5426	TOK	lung		lung\N5S
5427	TOK	carcinomas		carcinoma\N5P
---	DLD	;		=\DELIM
5428	TOK	lung		lung\N5S
5429	TOK	cancers		cancer\N5P
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
5430	TOK	Wilms	BOS	Wilms\N46
##	TAG	</name>
5431	TOK	tumor		tumor\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
5432	TOK	Lung	BOS	lung\N5S
5433	TOK	cancer		cancer\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
##	TAG	<name>
5434	TOK	Li-Fraumeni	BOS	Li-Fraumeni\N46
##	TAG	</name>
5435	TOK	syndrome		syndrome\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
5436	TOK	Lung	BOS	lung\N5S
5437	TOK	cancer		cancer\N5S
---	DLD	;		=\DELIM
5438	TOK	breast		breast\N5S
5439	TOK	cancer		cancer\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
5440	TOK	Neurofibromatosis	BOS	neurofibromatosis\N5S
---	DLD	,		=\DELIM
5441	TOK	type		type\N5S
##	TAG	<num>
5442	TOK	1		1\X
##	TAG	</num>
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
5443	TOK	Unknown	BOS	unknown\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	<p>
##	TAG	<s>
5444	TOK	Unknown	BOS	unknown\JA
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	<s>
5445	TOK	Colorectal	BOS	colorectal\JA
5446	TOK	cancer		cancer\N5S
---	DLD	.	EOS	=\DELIM
##	TAG	</s>
##	TAG	</p>
##	TAG	</div1>
